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Abstract 
 
Proteins are the functional machines of nature and play an essential role in life. 
Understanding the structure and function of proteins is central to numerous 
areas of science and technology, including biotechnological, pharmaceutical 
and chemical industries. Protein crystals are an important objective for many 
researchers, but even though there are many examples of protein crystals 
reported, there are still many uncertainties in controlling the crystallisation 
process. In addition, while protein crystals have mostly been obtained for 
characterisation purposes, there are other applications where defined 
assemblies of proteins, either crystals or self-assembled protein nanoparticles, 
are desirable. These include industrial biocatalysis, therapeutic protein 
formulations, and even energy-harvesting systems. Accordingly, there remains 
a high demand for well-defined protein crystals or nanoscale aggregates. 
A variety of techniques have been used to produce protein crystals, the typical 
strategy involves the addition of nucleants surface, or surface-active materials 
into the crystallisation solution. 6ROXWLRQ µDGGLWLYHV¶ RI GLYHUVH W\SHV KDYH
proven crucial in the control of protein crystallisation. These additives can act 
via multiple roles in a crystallisation process, such as by enhancing 
intermolecular contacts between protein macromolecules, or disrupting 
unfavourable intermolecular association, or diminishing interactions between 
protein and solvent. Synthetic polymers are important additives for protein 
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crystallisation control as there are many possible chemistries which can be 
introduced into the backbone and side-chains, giving a very wide range of 
functional behavior. However, because there are so many factors which can 
affect crystallisation, many of which are still poorly understood, to date only a 
very few classes of polymers have been studied as additives for protein 
crystallisation. Moreover, the mechanisms governing their interactions with 
protein crystals or surrounding solvent are elusive. 
In the study presented here, we show that polymers designed with varying 
degrees of charge, molecular weight and backbone structure influenced the 
crystallisation of three target proteins: hen-egg white lysozyme (HEWL); 
concanavalin A (Con A); and bovine liver catalase (BLC). Polymers were 
SUHSDUHG DV µDGGLWLYHV¶ LQWR SURWHLQ VROXWLRQ to influence the proteins 
crystallisation process, leading to changes in size, habit, morphology and even 
polymorph of the final crystals. A simple model linking polymer structure and 
charge to protein isoelectric point (pI) and crystallisation rate is proposed. 
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CHAPTER 1 
 
1. Introduction 
1.1 Introduction to chapter 
The overall aim of this project was to generate various polymers with varying 
degrees of charge, molecular weight and backbone structure, and then to study 
their roles as VROXWLRQµDGGLWLYHV¶ in model protein crystallisation process. This 
chapter will explain why we need protein crystals, the importance of protein 
crystallisation and will focus on polymer additives in protein crystallisation. It 
will cover general principles of crystallisation, various crystallisation 
techniques, research and challenge in the crystallisation of protein so far, and 
an introduction of synthetic methods of polymers and three different model 
protein targets: hen egg white lysozyme (HEWL), concanavalin A (Con A) and 
bovine liver catalase (BLC).  
 
1.2 General protein introduction 
1.2.1 Analysis of protein structure 
Proteins are a heterogeneous class of biological macromolecules with 
diameters of 1-100 nm. They are polypeptides made of many amino acids, 
which linked together via peptide bonds in a linear chain-like arrangement. 
Natural proteins are formed by up to 20 standard L-alpha amino acids, which 
DOVR UHIHUUHG WR DV µUHVLGXHV¶ Protein differs from one another due to the 
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difference of their order of the amino acid residues, which is defined by the 
sequence of their gene. A specific sequence of the amino acid residues in a 
pURWHLQ LV FDOOHG µSULPDU\ VWUXFWXUH¶ The µsecondary structure¶ refers to local 
sub-structures. Some areas within a protein are folded or coiled to form 
secondary structure, which are maintained by hydrogen bonding between 
amino acids in different regions. There are two kinds of secondary structure: 
alpha-helices or beta-pleated sheets. 
7KHµWHUWLDU\VWUXFWXUH¶LVWKHILQDOWKUHH-dimensional structure of a protein. The 
alpha-helices or beta-pleated sheets are folded further to form a compact 
globular structure, which driven by various interactions between atoms and 
molecules, including van der Waals forces, hydrogen bonding, electronic 
interactions between charged groups and hydrophobic interactions; and, 
stabilised by covalent disulphide bonds or salt bridges. Moreover, some 
proteins, which consist of several protein molecules (so called multi-subunit) 
as single large proteins have another level of structure: µTXDWHUQDU\VWUXFWXUH¶ 
In this protein, each subunit has its own three-dimensional tertiary structure. 
All subunits associated with each other to form the final functional protein by 
the same non-covalent interactions or disulphide bonds as that stabilise the 
tertiary structure. The level of protein structures is shown in Figure 1-1. 
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Figure 1-1. Main protein structure levels.1 The amino acid sequence of a 
protein¶s polypeptide chain is called primary structure and F, T, P, A, V etc. 
represent different amino acids: F represents phenylalanine, T represents 
threonine, P represents proline, A represents alanine, V represents valine, H 
represents histidine, L represents leucine, D represents aspartic acid, K 
represents lysine, S represents serine, Y represents tyrosine. C represents 
carboxyl group, N represents amino group. 
 
The tertiary or quaternary structure of a protein can play a vital role to 
understanding the function of protein macromolecules. Currently, two main 
methods have been employed for determining the three-dimensional structure 
of a protein: nuclear magnetic resonance (NMR) spectroscopy and X-ray 
crystallography. Although the NMR method can resolve the atomic structure of 
many small proteins, there is an upper molecular weight limit of about 25 kDa, 
or approximately 220 amino acids long for the NMR method. However, the 
primary tool for determining the three dimensional structure of proteins at the 
moment is X-ray crystallography, which is much more suitable for determining 
the structure of larger proteins (> 20 kDa),2 but is dependent on the availability 
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of good quality protein crystals. For the X-ray crystallography method, the 
target proteins must undergo crystallisation first, in order to provide a high 
quality single crystal. X-rays can be considered waves of electromagnetic 
radiation. The regular arrays of atoms in the crystal cause the beams of X-ray 
to diffract into many directions. By measuring the intensities and angles of 
these diffracted beams, a three-dimensional picture of electron density within 
the crystal can be obtained by a crystallographer. Then this three-dimensional 
image can be used to identify the protein structure. Thus, protein crystallisation 
serves as a basis for X-ray crystallography.3 By using X-ray method, the 
studies of the structures of myoglobin in 1950 and hemoglobin in 1955 were 
awarded the Nobel Prize in Chemistry in 1962. Now, almost 80 % of all 
protein structures are determined by X-ray crystallography.4 
The information of tertiary or quaternary structure of the protein is useful in 
numerous ways. Furthermore, protein crystallographic study is becoming an 
essential interest in many science and technology areas today, including 
biotechnological, pharmaceutical and chemical industries, such as drug design 
and protein engineering (Figure 1-2).5 
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Figure 1-2. Use of protein crystallography.5 Diagram showing the application 
of the crystalline protein in various science areas, by the pathway of 
combination of X-ray crystallography, computer graphic analysis and synthetic 
chemistry. 
 
One application of protein crystallography is the rational drug design. Once the 
tertiary or quaternary structure of the protein is elucidated, it can be used to 
identify their active sites, possible areas of interactions with other 
macromolecules, or similarities in structures with other known proteins. For 
example, in some diseases, such as cancer, some proteins are always 
considered as drug targets, because they can activate certain biological 
pathways of the disease. Once the structure of these proteins is known, the 
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information can be used to guide the design of molecules to fit the active sites 
of the protein, thereby modifying its function. Typically these designed 
molecules will be inhibitors of protein function, thus the molecules act as drugs. 
This kind of method for drug development is known as structure-based design. 
For example, imatinib, marketed as Glivec or Gleevec, is a tyrosine kinase 
inhibitor used in the treatment of multiple cancers.6 
Besides structure and function characterisation purposes, protein 
crystallography is also important in industrial biocatalysis. The stability of 
biocatalysts in a reaction environment is a key issue in industrial biocatalysis. 
One approach to increasing their operational stability is crystallisation.7 
Cross-linked protein crystals (CLPCs) with high activity and stability have 
been studied in biocatalytic applications. For instance, xylose isomerase 
crystals cross-linked with glutaraldehyde and L-lysine have been used as a 
catalyst for the isomerization of D-glucose to D-fructose.8, 9  
Aside from the above aspects, the isolation of proteins in crystalline form is 
essential in many key pharmaceutical areas.5 There are other applications 
where defined assemblies of proteins, either crystals or self-assembled protein 
nanoparticles, are desirable. These include protein formulations. 
 
1.2.2 Protein therapeutics 
Proteins are involved in key cellular functions in the body, which provide the 
foundations to maintain the homeostasis of the organism. An increased 
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understanding of the roles of proteins in health and disease is crucial for the 
identification of new treatment options. Currently, the use of proteins as novel 
drugs is now well accepted in the treatment of certain diseases. Moreover, 
recent recombinant DNA techniques allow the production of novel proteins in 
large quantities.10, 11 Protein drugs have several advantages over small drug 
molecules, such as proteins often have highly specific action, do not interfere 
with normal biological processes, and therefore, adverse effects are decreased. 
Moreover, protein therapeutics is more tolerated, because the body produces a 
lot of proteins naturally. Despite these advantages, the use of protein drugs in 
vivo still has some obstacles, including high molecular weight, structural 
fragility, short life time and highly sensitive to enzymes.12, 13, 14 The oral route 
of administration for proteins is problematic; generally they have very poor 
pharmacokinetics. Protein drugs macromolecules are easily degraded and 
denatured by the enzymes; the high acidity of the stomach could destroy them 
before they reach the intestine for absorption; and they must cross several 
biological barriers before reach the site of action.15 Therefore, improving the 
stability of protein drugs is very essential for their applications. 
One method is encapsulating proteins inside biodegradable polymer shells, 
which serves to protect the protein from clearing by the body and allow for the 
sustained and targeted delivery of protein drugs. Poly(lactic-co-glycolic acid) 
(PLGA) polymers have been studied and used for encapsulating of proteins.16 
The encapsulation of the protein is typically via emulsification17, 18 or direct 
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incorporation of solid protein19, 20 as shown in Figure 1-3.21 
 
Figure 1-3. Encapsulation of therapeutic protein into polymeric particles by a) 
emulsification and b) solid incorporation method, taken from Reference.21 
 
For the emulsification method, the protein is dissolved in an aqueous solution 
first and then dispersed in an organic polymer solution to get a protein in 
polymer solution. After evaporated the organic solvent, PLGA was precipitated 
around protein macromolecules to form microspheres.17, 18 For the direct 
incorporation of solid protein method, micronised solid protein is directly 
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suspended in an organic polymer solution via sonication. Then microspheres 
are obtained after the solution is frozen and organic solvent is extracted.19, 20 
This encapsulating protein inside biodegradable polymer shells method does 
not alter the native properties of the protein. Moreover, it can provide a 
sustained release of the protein over a few hours or days.21 
Another method is making the protein more stable by changing some of its 
amino acids, which can optimize the hydrogen bonding and electrostatic 
interactions of protein.22, 23 For instance, granulocyte-colony stimulating factor 
(G-CSF) is limited by its low stability, by engineering of its structure, its 
thermal stability was enhanced of up to 13 °C; the shelf time was improved, 
and the activity was retained in vitro.23 
Moreover, attaching and conjugating the protein to a polymer chain is a 
successful approach. Polyethylene glycol (PEG) is the most commonly 
employed polymer. The polymer can alter the solubility of protein and creates a 
protection barrier on the surface of the protein.24  
In addition of all above methods, making protein nanocrystals or 
nanoaggregates (i.e. particles bigger than an individual protein molecule, but 
small enough to be colloidally stable) is another essential approach in protein 
therapeutics. Crystallised protein drug macromolecules remain in active form 
within the crystal lattice and hence are protected during storage and drug 
release process.25 Moreover, protein crystals can act as carrier-free delivery 
systems; have the ability of sustained release for the protein drugs, which 
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reduces in frequency of intakes, adverse effects and patient compliance.26 
Furthermore, subtle changes in protein crystallisation conditions may result in 
multiple crystal structures from the same crystallising molecules, so called 
µpolymorphs¶. Different polymorphs have different physical properties, for 
instance crystal habit, melting point and dissolution rate. If produced different 
polymorphs have different dissolution rate and solubility, they can alter 
important pharmacokinetic factors, such as absorption rate, drug availability.27 
For some unstable protein crystals, if different polymorphs of proteins were 
produced, which can enhance their stability; this might change the storage shelf 
life of the proteins similar as small drug molecules.28 Therefore, proteins as 
drugs, in the form of crystals, can show promise in controlled and sustained 
delivery and aid in their formulation. 
 
1.3 Crystals 
Crystals are physically homogeneous solids, whose atoms, ions, or molecules 
are in accordance with an ordered pattern extending in all three spatial 
dimensions. Many of them have a particular well-defined geometrical shape, 
with regular faces and sharp edges.29 Crystals exist widely in nature; the vast 
majority of solids are crystals, such as ice, salts and rocks. Figure 1-4 is a 
model of crystal structure of calcium fluoride. 
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Figure 1-4. The crystal structure of Fluorite (CaF2). The lattice is a cubic 
crystal system with unit cell dimensions of a = b = c = 5.46 Å, Į ȕ Ȗ 
Calcium ions (red) reside at the vertices and face centers of a cube, with 
fluorine ions (green) in the tetrahedral interstices. Calcium ion centers are 
8-FRRUGLQDWHEHLQJFHQWHUHGLQDµER[¶IRUIOXRULQHLRQV)OXRULQHLRQFHQWHU
is coordinate to 4 calcium ions. 
 
Crystallisation is the process by which crystals are formed. The crystallisation 
process of molecules from a solution is a reversible equilibrium phenomenon, 
driven by the minimization of the free energy of the system.30 For a stable 
solution, the solute is fully dissolved, and the system is at equilibrium. 
However, if more solute molecules are added to the solution, and they could 
not dissolve completely, thus, a new state (the so-FDOOHGµsupersaturated state¶
will appear. A supersaturated solution represents a chemical system which is 
not at equilibrium.31, 32, 33 The system is thermodynamically driven to a new 
CHAPTER 1. Introduction 
48 
 
equilibrium state with a new minimized free energy. Particular interactions 
occur between individual solute molecules and they are forced out from the 
solution and start to form amorphous aggregates. If these interactions are 
geometrically favorable, these amorphous aggregates will form crystal nuclei. 
As a result, individual solute molecules align themselves in a repeating series 
RIµXQLWFHOOV¶E\DGRSting a consistent orientation. 7KHFU\VWDOOLQHµODWWLFH¶then 
forms together by non-covalent interactions.34 
There are seven crystal lattice systems including triclinic, monoclinic, 
orthorhombic, rhombohedral, tetragonal, hexagonal and cubic as shown in 
Table 1-1. One type of symmetry used to categorize crystal structures: axis; 
and the parameters used to give unit cell, which are the lengths of the cell 
HGJHVDEDQGFDQGWKHDQJOHVEHWZHHQWKHPĮȕDQGȖ 
Table 1-1. Seven crystal lattice systems in three dimensions 
Lattice System Axis of Symmetry Axial Length 
of Unit Cell Inter Axial Angles 
Triclinic 0 axes DEF ĮȕȖ 
Monoclinic 1 two-fold axis DEF Į Ȗ ȕ 
Orthorhombic 3 two-fold axes DEF Į ȕ Ȗ  
Rhombohedral 1 three-fold axis a = b = c Į ȕ Ȗ 
Tetragonal 1 four-fold axis D EF Į ȕ Ȗ  
Hexagonal 1 six-fold axis D EF Į ȕ Ȗ  
Cubic Minimum of 4 
three-fold axes a= b = c Į ȕ Ȗ  
 
There are three stages of crystallisation: nucleation, growth, and cessation of 
growth. Nucleation is the initial step of the formation of a crystal from a 
solution. It normally occurs at nucleation sites on surfaces contacting the liquid. 
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Figure 1-5 shows the process of molecules transfer from solution to crystal. 
First, individual solute molecules come together at a supersaturated state and 
produce a stable aggregate. The aggregate must get large enough and first reach 
a µcritical size¶, which is defined by the competition of the ratio of the surface 
area of the aggregate to its volume.35, 36 Once the critical size is reached and 
exceeded, the aggregate becomes a critical nucleus and can grow further. If the 
size of the aggregate is smaller than the critical nucleus size, it would 
spontaneously dissolve in the solution.37 This phenomenon is known as 
Gibbs-Thomson effect; and small free Gibbs energy change is the driven force 
of molecules transfer from solution to crystal. 
 
Figure 1-5. Diagram showing the transfer of molecules from solution to crystal 
according to Gibbs energy change. 
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For a spherical nucleus with radius r in the classic case:38  
¨Gr = (4/3) ʌU3 ¨*v ʌU2 Ȗ 
Where Gv is the *LEEVYROXPHHQHUJ\DQGȖ LV WKH VXUIDFHHQHUJ\7KHJUDSK
(Figure 1-6) below shows the variation in the Gibbs free energy of nucleation 
with the increasing size of the radius. 
 
Figure 1-6. Thermodynamics of nucleation, according to Gibbs free energy. 
For a spherical nucleus with a radius r > r*, the Gibbs free energy will decrease 
if the nucleus grows. The r* LV WKHFULWLFDOQXFOHXVVL]Hǻ** is the nucleation 
barrier. 
 
Since the degree of occurrence of nucleation and crystal size are determined by 
the degree of supersaturation of the solution, which is in turn related to the 
solubility of solute molecules, to some extent by the degree of supersaturation 
this means that the nucleation can be controlled. The solution with a higher 
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solubility has many more molecules when at a supersaturated state than the 
solution with lower solubility, can increase the chance of collisions of diffusing 
molecules. This leads to an increase in a probability of the formation of stable 
aggregate. If the number of solute molecules was finite, in this case, it would 
result in the formation of many small crystals. While, at lower solute 
concentrations, it is not easy to form individual stable aggregate; thus this 
condition is much more favoring the formation of single crystals. 
Once the critical nuclei are formed, then by adding more atoms, ions and 
molecules into the characteristic arrangement of the crystalline lattice, crystal 
growth stage happens. When the solution is supersaturated, nucleation and 
crystal growth occur simultaneously. They all are driven by the existence of 
supersaturation. Thus, either of them can be predominant. This means crystal 
size can in principle be controlled. If the nucleation is predominant over crystal 
growth, the system tends to produce a large number of small crystals. 
Otherwise, if the crystal growth is predominant, a small number of large 
crystals tends to result. 
The growth of crystals is strongly affected by diffusion and convection effects. 
The concentration of solute molecules in the regions near the growing crystal is 
lower than the rest of the solution, leading to the formation of density gradients 
in the solution,35 under the effects of gravity convection currents form in these 
zones.39 These convection currents in turn dominate the diffusion rate. 
Finally, crystal growth will be terminated for several reasons. The main reason 
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is that, as the crystallising solute concentration decreases, the solution system 
reaches equilibrium, or the crystal has reached a particular size and cannot 
grow further.40 7KLVPD\EHDUHVXOWRI WKHµSRLVRQLQJ¶RI WKHJURZWKVXUIDFH. 
For example, some damaged crystallising solute molecules, which are on the 
growth surface of crystal, could result in the interruption of the crystal lattice 
growth. 
 
1.4 Protein crystals 
Proteins have become particular targets for crystallisation in recent years owing 
to their growing importance in pharmaceutical applications. Protein 
crystals contain protein molecules, similar as other materials, but much larger. 
However, unlike other compound crystals, protein crystals are composed of 
about 60 %-70 % solvent content.41 The entire crystal consists of large solvent 
channels that solvent and other small molecules can diffuse through freely. 
Thus, their packing in the crystals composes of many holes that are filled with 
water molecules (ordered or disordered), thus, protein crystals are extremely 
fragile and instable.42 An example of protein crystal lattice structure is shown 
in Figure 1-7, the structure of chymotrypsinogen crystal, showing the large 
solvent channels penetrating the unit cell.43 
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Figure 1-7. A view of the crystal structure of chymotrypsinogen. The molecular 
packing in the unit cell of chymotrypsinogen crystal consists of several large 
holes of solvent channels.43 
 
In the protein crystal, the contacts between protein molecules are quite 
complex, involving a delicate balance of specific and nonspecific flexible 
interactions,44, 45 such as hydrogen bonds, salt bridges, electrostatic interactions, 
van der Waals interactions and hydrophobic interactions. All these interactions 
together provide for the maintenance of the crystal. In the entire crystal system, 
the number of these protein-protein interactions is far exceeding the number of 
crystalline protein molecules, this can explain the differences between protein 
molecules and small molecules crystals.46 
 
1.4.1 Some history of protein crystallisation 
Protein crystallisation started at 19th century. The first reported protein 
crystallisation was by Hünefeld in 1840, even before X-ray was known. The 
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protein was hemoglobin, which was from the earthworm. Hünefeld pressed the 
ZRUP¶VEORRGEHWZHHQ WZR VOLGHVRIJODVV DQGFDXVHG WKe dehydration of the 
protein, resulting in flat plate-like hemoglobin crystals.47 After that, many 
researchers focused on studying the crystallisation of hemoglobin from various 
sources and tried to find a standard procedure in the next several years.48, 49 
However, there was no general procedure for hemoglobin crystal growth, until 
in 1851, Fünke found and reported the successful and reproducible methods for 
the crystallisation of hemoglobin.50 
Following hemoglobin, other proteins such as plant seed reserve proteins were 
widely investigated in the last quarter of the 19th century by many researchers 
such as Osborne.51 The meaning of these researches for us today is that 
researchers developed several crystallisation approaches and now still used in 
common, included slow cooling, dialysis against low concentration of an ionic 
solution and use of organic solvents such as alcohol as precipitants. 
Between 1900 and 1940, researchers started to turn their attention on enzymes, 
such as urease52 and insulin.53 Crystallisation was then considered as an 
important tool in purifying complex proteins. After the use of X-rays for 
medical purposes, Laue reported the diffraction of X-rays by crystals for the 
first time in 1912. Then Ewald and Bragg gave birth to the field of X-ray 
crystallography, which considered as an important tool for structure analysis of 
proteins. Today, about 83 % of protein structures deposited in the Protein Data 
Bank (PDB) was obtained by X-ray crystallography.54 
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1.4.2 Principle of protein crystallisation 
In general, protein crystallisation from solution is an extremely complex 
process. As mentioned in section 1.3, nucleation is the vital step in the 
crystallisation process and has been well studied in detail.55, 56 The 
crystallisation solution must reach a supersaturation state and overcome the 
free energy barrier for aggregation first, and then nucleation could occur. There 
is a classical phase diagram of the solubility curve showing the explanation of 
crystal nuclei formation and growth,57 which illustrate the change of protein 
molecules concentration against crystallising agent concentration (Figure 1-8).  
 
Figure 1-8. Crystallisation phase diagram of solubility curve showing how the 
solubility varies with the concentration of crystallising agent. The 
concentration area is divided by the solubility curve into two spaces: 
undersaturated and supersaturated zone. The supersaturated zone comprises of 
metastable, nucleation and precipitation zones.57 
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The whole concentration space is divided by the solubility curve into two areas: 
the undersaturated and supersaturated zones. The area under the solubility 
curve is undersaturated zone, where the protein concentrations below its 
solubility limit. In such solution, no crystallisation will takes place. Above the 
solubility curve is the supersaturation zone, which comprises of three zones: 
metastable zone, nucleation zone and precipitation zone depending on the level 
of supersaturation. In the metastable zone, the supersaturation is too small; 
nucleation does not spontaneously occur. However, if the solution is seeded 
first, crystals may grow. It is therefore possible to induce nucleation in a 
selective and deliberate way to control the number of nuclei and the 
supersaturation point at which they will grow.58 In the nucleation zone, the 
supersaturation is large enough, critical nuclei can form, spontaneous 
nucleation occurs, and crystals can grow rapidly. In the precipitation zone, the 
supersaturation is too large, protein aggregates rapidly precipitate from the 
solution.32 
 
1.4.3 Methods of protein crystallisation 
Protein crystallisation from a solution can be affected by many factors, 
including biochemical factors, such as protein sample purity, storage and pI; 
chemical factors, such as sample concentration, precipitant type, precipitant 
concentration, ionic strength, environment buffer and pH; physical factors, 
such as temperature, time, viscosity, sample handling and methodology.59, 60 
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Besides these most well-known factors, there are still many other factors which 
can in principle influence protein crystallisation, including exactly known ones 
or not known ones. There are no systematic studies of all these factors on 
protein crystallisation due to the amount of parameter space to cover.  
In order to form high quality crystals, the protein must ideally 100 % pure 
without any contaminations. Any contamination may lead to poorer crystals, or 
an amorphous precipitate, or no precipitation at all. Based on the above 
parameters, many different methods and approaches for creating 
supersaturation and thus inducing the nucleation process are possible. 
One method for protein crystallisation is controlling the solubility of the 
protein (that is, alter the supersaturation),59, 61 which is always very sensitive to 
temperature and pH as known.62, 63 Protein solubility is temperature dependent, 
due to protonation and deprotonation reaction constants of the amino acid side 
chains in the protein structure being temperature dependent.64 In many cases, 
temperature maintains constant during crystallisation to obtain fine crystals. 
Most proteins are crystallised at 4 °C or 18-22 °C. Temperature also affects the 
kinetic energy of crystallisation, at lower temperatures the protein molecules 
have lower kinetic energy and can aggregate in an ordered manner more easily. 
Thus, many earlier proteins crystallisation were induced by slow cooling.65 For 
example, glucagon crystallised by dissolving in solution and cooling from 
60 °C to room temperature.66  
Another method for inducing protein crystallisation is to control the 
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environment pH. Most proteins tend to share the ability to form crystals and 
crystallise at biological pH of 6.5-7.5. Different pH can produce different 
packing orientations of unit cell,67 because of that different pH can change the 
electrostatic character of protein macromolecules. The choice of pH is 
according to the optimum pH required (does not denature the protein) and also 
considering the isoelectric point of the protein (pI), because of solubility 
minimum at its pI. 
Besides the control of temperature and pH, chemical precipitating agents are 
common used methods for achieving supersaturation of proteins and inducing 
crystallisation. Precipitating agents for protein crystallisation are generally 
divided into three main categories: salts, such as ammonium sulfate; organic 
solvents, such as ethanol; and large polymer precipitating agents.68 
Moreover, various physical techniques have been developed for reaching 
supersaturation thus inducing protein crystallisation. Among them, three main 
methods are commonly used: batch and micro-batch; dialysis; and vapour 
diffusion. 
Batch method is a simple and old crystallisation technique. In this method, by 
mixing the concentrated protein with concentrated precipitating agent, the 
solution immediately reaches a high supersaturated state and therefore, 
crystallisation is induced. This method usually needs large volumes of 
solutions (upward of 1 mL), and typically results in larger crystals. Chayen 
designed micro-batch method (1992)69 as shown in Figure 1-9 and stated an 
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approach of rapid protein crystallisation by using very small sample droplets as 
little as 1 µl into an inert oil. The oil can prevent the evaporation of solvent. 
 
Figure 1-9. Micro-batch crystallisation technique. 
 
There are some disadvantages by using micro-batch method. First, if the 
precipitant concentration which chosen isQ¶W high enough to obtain 
supersaturation, crystallisation will never occurs. Furthermore, it is very 
difficult to manipulate of the crystals from the droplet covered by the oil. 
Contrary to batch method, in dialysis method, the solution composition is 
changed by diffusion of small molecules. In a dialysis crystallisation 
experiment, the protein solution is contained in a dialysis semipermeable 
membrane, surrounded by a large volume of precipitant solution. For example, 
in button dialysis crystallisation (Figure 1-10), a dialysis membrane covers the 
dialysis button, which allowing the diffusion of solvent into the protein 
solution through the dialysis membrane. The solute molecules in the protein 
solution slowly equilibrate against the large volume of precipitant solution, 
leading to protein crystallisation within the dialysis button. 
Oil 
Protein Drop & Precipitant Drop 
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Figure 1-10. Button dialysis crystallisation technique. 
 
However, dialysis method does not work with some precipitant solutions, such 
as concentrated PEG solutions. Because PEG solutions prefer to draw all the 
water out of the button faster than dialysis occurs, thus, protein will precipitate 
rapidly rather than crystallise. 
The most popular technique is vapour diffusion method. By using this method, 
we can screen a large number of crystallisation conditions by varying the 
composition of each well solution. In the vapour diffusion method, protein 
solutions achieve supersaturation by the evaporation and diffusion of water 
between solutions with different concentrations slowly. The technique used 
during this research was the vapour diffusion method. There are three kinds of 
vapour diffusion methods: hanging drop, sandwich drop and sitting drop 
(Figure 1-11).  
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Figure 1-11. Vapour diffusion techniques: hanging drop, sandwich drop and 
sitting drop.  
 
A drop of 1:1 protein: precipitant solution is normally used in the sample well 
in the crystallisation experiment. In the hanging drop method, the protein and 
precipitant solution droplet is suspended from a coverslip. The volume of the 
droplet is limited; otherwise, it will fall down. In the sandwich drop method, 
protein and precipitant solution droplet is in contact with both an upper and a 
lower surface. This method is rarely used due to the two coverslips will reduce 
the exposure area of the droplet and slow down the rate of water evaporation. 
In the sitting drop method, protein and precipitant solution droplet is supported 
by a surface. It is easy to conduct and require very small amount of sample. 
Using this method, crystallisation takes place when the concentrations of 
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protein and precipitant increase in the droplet by water vapor from the droplet 
to the reservoir solution. This process will last until the concentration of 
precipitant in the droplet equals that of the reservoir solution. 
 
1.5 Use of additives in protein crystallisation 
A variety of approaches have been used to aid the production of protein 
crystals; the most common strategy involves the addition of nucleants, 
typically surfaces or surface-active materials into the crystallisation solution.70 
6ROXWLRQµDGGLWLYHV¶of many types have proven useful in the control of protein 
crystallisation.71 These additives can act via multiple mechanisms,72 i.e. they 
can serve to bridge protein segments, electrostatically, or via hydrogen bonding 
or hydrophobic interactions.5, 72, 73 It is also possible for additives to diminish 
interactions between protein macromolecules and solvent73, 74, 75 to act as 
solubility-modifying detergents;76 or to stabilise intermediate 
structures/conformations of proteins during the early stages of crystallisation.75, 
77, 78
 There are two principal types of additives, including soluble materials, 
which added into the crystallisation solution directly, such as precipitants; and 
non-dissolved solid surfaces, which act as heterogeneous nucleants. 
 
1.5.1 Non polymer methods 
1.5.1.1 Salts 
Salts act as precipitating agents, according to the µVDOWLQJRXW¶principle.79 The 
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ionic strength of the solution increases by adding salts, which in turn leads to a 
decrease in protein solubility. A simple explanation of the salting out effect is 
that salt ions, principally anions, compete with protein for solvent molecules, 
i.e. water, thus, salts can dehydrate the protein macromolecules.80 When the 
concentration of salts is sufficiently high and the competition is intense enough, 
protein molecules are forced to neutralise their surface charges by interacting 
with one another and then precipitate from the solution, which may result in an 
ordered arrangement of proteins in the crystalline form. Figure 1-12 shows the 
typical protein solubility behavior over the entire range of salt concentrations, 
LQFOXGLQJµVDOWLQJLQ¶DQGµVDOWLQJRXW¶UHJLRQV.46 
 
Figure 1-12. The solubility curves of a typical protein, enolase, as a function of 
ionic strength produced by two types of salts.46 The regions of the curves with 
lower ionic strength where the solubility increases are called µsalting in¶ region; 
the regions of the curves with higher ionic strength where the solubility 
decreases are called the µsalting out¶ region.  
 
The µ+RIPHLVWHU VHULHV¶ VKRZV WKH RUGHU RI salting out effect of the ions,81 
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SO42- > HPO42- > CH3COO- > citrate3- > tartrate2- > HCO3- > CrCO3- > Cl- > 
NO3- > ClO3- for anionic proteins, while cationic ones are reverse.63, 82 The 
salts commonly used in protein crystallisation involve ammonium or sodium 
sulfate, ammonium or sodium acetate, sodium or potassium phosphate, sodium 
or ammonium citrate and sodium chloride.59, 60 
 
1.5.1.2 Organic solvents 
Organic solvents can also promote protein crystallisation by a similar 
competition with protein for water molecules. They can bind to water 
molecules and alter the interaction between water and protein molecules by 
H-bonding, thus leading to solvent competition and forcing protein molecules 
out of the solution. Besides, they may DOVRKDYHµH[FOXGHGYROXPHHIIHFWV¶E\
hydrophobic exclusion of protein solutes. Furthermore, they can reduce the 
dielectric constant of the medium. Coulomb interactions between the individual 
protein molecules become stronger. Thus, they decrease the capacity of protein 
molecules and force them out of the solution.83, 84 Organic solvents should be 
added very slowly to mix thoroughly and used at very low temperature or 
below 0 °C to avoid volatilization.5 The common organic solvents are ethanol, 
acetone and dioxane.85  
 
1.5.1.3 Insoluble surfaces 
Crystallisation controlled by insoluble solid surfaces is an approach to template 
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protein crystal growth via heterogeneous nucleation. A number of insoluble 
solid additives has been studied in protein crystallisation, such as 
minerals,86,87,88 human hair,89 hydrophobic self-assembled monolayers,90 
porous glass and silicon,91, 92 silicon-based devices,93 and chemically treated 
substrate surfaces, i.e. glass94 and mica.95 
Figure 1-13 is an example shows heterogeneous nucleation facilitated by the 
insoluble solid surface. First, the heterogeneous nucleant attracts and 
immobilises protein molecules on to its surface through some chemical, 
electrostatical or structural favor interactions to form protein aggregates. Then 
these protein aggregates start to form ordered nuclei by adopting a consistent 
orientation, and are capable of further growth.5 
 
Figure 1-13. Schematic representation of heterogeneous nucleation facilitate by 
the insoluble solid surface. 
 
The mechanisms by which these insoluble solid surfaces induce heterogeneous 
nucleation are various. They potentially include: some materials with similar 
lattice characteristics with protein crystalline lattice that may affect protein 
crystallisation process,87 utilisation of the surface microstructure,92, 96 i.e. 
roughness to promote protein nucleation, or use of surface chemistry properties 
to afford some specific interactions with protein molecules.95 
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One example of insoluble solid additives is mineral. For instance, McPherson 
et al. tested fifty different mineral samples as heterogeneous nucleants to 
mediate crystallisation of four common proteins: canavalin, concanavalin B, 
beef liver catalase and hen egg lysozyme.87 Some example images of protein 
crystals are shown in Figure 1-14. They stated that, by the use of mineral 
surfaces, nucleation of canavalin and beef liver catalase was promoted at lower 
critical supersaturation levels, and the crystal habit of each of four proteins was 
modified. Moreover, the mineral apophyllite with a close lattice match to 
lysozyme, had a clear influence on the nucleation and crystal growth of protein 
crystal, which could illustrate the possible mechanism involved a direct lattice 
match.87 
 
Figure 1-14. Some example images of protein crystals the nucleated and grew 
on the mineral substrate surfaces.87 A and D: Lysozyme crystals on lepidolite 
and magnetite. B and C: Concanavalin B crystals on gypsum and aragonite. 
 
Another example of insoluble solid additives for enhancing the nucleation of 
protein crystals is porous substrate, i.e. glass and silicon.58, 91, 96 For example, 
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Chayen et al. used porous silicon, which composed of nanoscale crystalline 
silicon wires and dots surrounded by voids, to enhance nucleation and 
crystallisation of proteins.92 The mechanism they proposed involved local 
supersaturation of protein molecules associated with the fractality of the porous 
substrate. The local concentration of protein molecules, which were inside and 
in the close vicinity of the pores was sufficient for aggregation and possibly 
induced nucleation (Figure 1-15). 
 
Figure 1-15. Schematic representation of crystal nucleation in a pore, which 
explains the mechanism of porous substrates induce protein crystallisation.97 (a) 
Protein molecules reside in the corner of the pore and start to aggregate until a 
critical nucleus forms. (b) The crystal keeps on growing until the entire pore is 
full of protein molecules. (c) In the close vicinity of the pore, another critical 
nucleus is then formed, thus protein crystal can breakout from the pore. 
 
Chemically treated substrate surfaces are another type of commonly used 
insoluble solid additives for facilitating protein crystallisation. For instance, 
Ripamonti et al. prepared chemically modified mica sheets by mixed mica with 
n-propyltriethoxysilane and 3-aminopropyltriethoxysilane in different ratios to 
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vary the density of ionisable groups on the mica surfaces; and then tested them 
as heterogeneous nucleant surfaces for proteins crystallisation.95 They 
suggested a possible mechanism may involve that the chemically treated mica 
sheet surfaces could afford some interactions between the ionisable groups on 
the mica surfaces and charged residues of the protein, which may facilitate the 
aggregation and nucleation of protein molecules. 
 
1.5.2 Polymer additives 
Although the above additives have effectiveness on enhancing protein 
crystallisation, however, they still have some disadvantages. For example, 
some of them require high concentration, meaning that their affinity is low,70 
such as salts and organic solvents. They must interact with a large number of 
water molecules to alter the free energy of protein molecules. For 
non-polymeric insoluble solid surfaces, they are random substances, have no 
designed specificity for proteins. Moreover, it is not easy to apply a systematic 
range of non-polymeric insoluble solid surfaces for screening experiments to 
find an optimized crystallisation condition that would have otherwise been 
missed.98 None of them has EHHQ SURYHQ DV µXQLYHUVDO¶ KHWHURQXFOHDQWV WR
enhance the crystallisation for the majority of proteins.99  
Synthetic polymers are important additives for protein crystallisation control as 
there are many possible chemistries which can be introduced into the backbone 
and side-chains, giving a very wide range of functional behaviour.5, 100, 101 
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Polymers have also been successfully applied as additives in mediating 
crystallisation of inorganic materials,102 organic molecules,101, 103, 104, 105 as well 
as some key drugs such as paracetamol.106, 107 Proteins35, 108 and nucleic acids109 
have become particular targets for polymer-mediated crystallisation in recent 
years owing to their growing importance in pharmaceutical applications. 
Polymers provide an ideal approach to control and investigate the majority of 
protein crystallisations in a reproducible and universal manner; including 
finding the optimal crystallisation conditions by a systematic screening 
experiment of altering the chemical characteristics and functionalities. 
Fundamentally, there are two types of polymers to be distinguished, insoluble 
polymer surfaces and soluble polymer additives. 
 
1.5.2.1 Insoluble polymer surfaces 
Protein crystallisation control by insoluble polymer additives is an approach by 
which the insoluble polymer surfaces serve as templates, scaffolds or 
heterogeneous nucleants to promote protein nucleation or template selective 
polymorphs of protein crystals.71, 100  
One application of insoluble polymer surfaces is the use of molecularly 
imprinted polymers (MIPs) as surfaces for the selective nucleation of crystals 
via heterogeneous nucleation. Molecular imprinting is a technique by which 
selective recognition sites can be constructed in polymer matrices, and then 
used for molecular recognition of memorable template molecules.110, 111 
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Molecularly imprinted polymers are prepared via molecular imprinting 
technique. They are formed in the presence of the template molecule, which 
will be extracted afterwards, resulting in complementary cavities in the 
polymer with high affinity for the templating species.112, 113, 114 Vulfson et al. 
reported that polymers, when imprinted with inorganic material, calcite, were 
able to induce the nucleation of calcite under conditions favouring the growth 
of aragonite (Figure 1-16).115 Followed the same principle of MIPs employed 
in the crystallisation of inorganic small molecules, MIPs was also studied in 
protein crystallisation. Takeuchi et al. demonstrated the effectiveness of 
different protein-imprinted polymer arrays with acidic or basic functional 
monomers to classify five tested proteins. They concluded that 
protein-imprinted polymers could offer a new approach to characterise and 
profile various proteins in nature.116 Furthermore, Chayen et al. found that 
some MIPs induced crystallisation of proteins and yielded crystals in the 
FRQGLWLRQV WKDW GLGQ¶W DIIRUG FU\VWDls otherwise. Moreover, MIPs acted as 
heterogeneous nucleants and could facilitate the formation of protein crystals in 
the metastable zone of the crystallisation phase diagram, which would 
otherwise been missed.114 
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Figure 1-16. Schematic representation of the molecular imprinting process and 
selective crystallisation of calcium carbonate. Functional monomers adsorbed 
to a calcite crystal surface, followed by cross-linking to convert monomer 
self-assemblies into a polymer matrix. Template calcite crystal was removed by 
washing with acidified aqueous methanol solution to produce imprinted 
polymer surfaces. Thus, the imprinted polymer surfaces can be used to 
template selective polymorphs of calcium carbonate crystal.115  
 
In a separate but related approach, a range of insoluble polymer surface 
libraries has been used to facilitate proteins crystallisation via heterogeneous 
nucleation. For example, Matzger et al. reported a heteronucleant approach by 
applying polymers as heteronucleant surfaces to achieve functional diversity 
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and flexibility of crystallisation formats. They applied functionally diverse 
polymer libraries, such as commercially available polymers and cross-linked 
copolymers for hen egg-white lysozyme, concanavalin A and bovine liver 
catalase crystallisation and concluded that the insoluble polymer surface 
libraries can be successfully applied, such as allowing nucleation rate control 
of lysozyme, improved lysozyme crystal size, new form access of concanavalin 
A and formation of high quality bovine liver catalase crystal.99 
All the above mentioned previous work shows that the use of polymers as solid 
surfaces is an important and successful approach to mediate protein 
crystallisation via heterogeneous nucleation. Currently, there is a lack of 
surface characterisation on polymer surfaces. Moreover, by using this method, 
there is a great need for the clear understanding of the mechanisms of how 
these polymers work.  
 
1.5.2.2 Soluble polymer additives 
Soluble polymer additives have attracted interest from researchers in 
polymer-mediated protein crystallisation. Compared to insoluble polymer 
surfaces that act as templates or heterogeneous nucleants, soluble polymeric 
additives can influence the biomolecule crystallisation process leading to 
changes in size, habit and even polymorph of the final crystals.71 The 
mechanisms by which polymers act include complexation of electrolytes, thus 
changing the local ionic strength;71 the masking or neutralizing of charges on 
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proteins, which in turn enhances the role of hydrophobic association between 
protein chains,117, 118 or via hydrogen bonding or hydrophobic interactions to 
diminish the interactions between protein macromolecules and the 
solvent,5,72,73 or by simple viscosity modification which changes the kinetics of 
crystal growth. Polymeric additives can also stabilise transient protein-protein 
aggregates by adsorption on their surfaces, leading to faster nucleation and 
altered crystalline polymorph,78, 119, 120 or through attachment to specific crystal 
faces which then influences the direction of further crystal growth.100 
Cölfen et al. used a variety of polymers, such as glycopolymers, 
low-molar-mass polymers and block copolymers to investigate additives 
controlled mineral crystallisation, such as barium and calcium carbonate. 
Compared to insoluble polymer surfaces, different types of soluble polymer 
additives with diverse functional groups can have big influences on 
crystallisation of minerals, even can alter the final crystal 
morphology.71,100,121,122 
Crystallisation of proteins would follow the same general principle as that of 
small molecules.109, 123 Some polymers have been studied as additives i.e. 
nucleants/precipitants for protein crystallisation. They have been pioneered by 
Polson and co-workers. They used many polymers, such as polyethylene glycol 
(PEG), dextran, polyvinyl alcohol and polyvinyl pyrrolidone, as precipitants 
for protein fractionation. They proposed that, among the polymers they had 
used, PEG 6,000 was appeared to be the most suitable protein precipitant 
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because its low viscosity, stability and because it did not denature the proteins 
at room temperature.124  
,QVSLUHGE\3ROVRQ¶VUHVXOWs, McPherson et al. applied different sizes of PEG: 
400, 1,000, 4,000, 6,000 and 20,000 to mediate 22 proteins, such as gene, 
Į-amylase, a protein of unknown function from turkey liver, catalase, abrin, 
ovalbumin, canavalin and horse albumin. They reported that six proteins were 
crystallised for the first time by screening of five different molecular weight 
sizes of PEG; one proteinĮ-amylase easily afforded crystals when PEG was 
employed; one other protein that of unknown function from turkey liver 
yielded excellent quality crystals whereas only poor-quality crystals have been 
obtained previously. Moreover, they found that the PEGs were active in 
helping to crystallise a wide range of proteins and exhibited greater 
applicability than other previously used reagents.125 PEG remains in 
widespread use to aid protein crystallisation because it is stable, neutral, 
hydrophilic and its solutions are of low viscosity compared to other 
polymers.124, 125  
Based on the previous studies, McPherson et al. also screened and assessed 
various chemicals mixed with PEG 3,350 acting as mixed additives on 81 
different proteins. They stated that mixed additives, which composed of 
polyvalent, charged groups, i.e. di and tri carboxylic acids, diamino compounds, 
or bearing one or more sulfonyl or phosphate groups were the most promising 
types of additives to affect protein crystallisation.72 They proposed a novel 
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approach to crystallise proteins by combination of small molecules with simple 
polymer additives. 
More recently, Yao et al. used some functional polymers, such as 
poly(PEGMA), PDMAEMA and some block copolymers to control of 
lysozyme crystallisation. They showed that only poly(PEGMA) mixed with 
lysozyme solution could not afford any lysozyme crystals, but PDMAEMA 
and some block copolymers, which contained high content of the PDMAEMA, 
such as PDMAEMA-b-poly(PEGMA-OH) and 
PDMAEMA-b-PBMA-b-poly(PEGMA), had a clear influence on the 
crystallisation of lysozyme and were able to modulate the shape of crystals but 
depending on their concentration in protein solution.108 
However, because there are so many factors which can affect crystallisation 
processes from solution, many of which are still poorly understand, to date 
only a limited number of polymer additives have been successfully applied in 
proteins crystallisation, most are PEGs and PEG derivatives. In addition, some 
of the previous work did not show clear crystal packing information.108 
Moreover, most of the studies are descriptive; the interactions between some of 
the existing polymer additives and protein macromolecules or surrounding 
solvent are still unclear, and the mechanisms by which protein crystals form in 
the presence of these polymers needs to be further investigated.100, 108 
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1.6 Polymers and polymer synthesis 
Polymers are macromolecules, which are composed of a large number of small 
molecules combined with each other in a repeating order. These small 
molecules are so called monomers, and the reactions by which they link 
together are so called polymerisations. There may be hundreds, thousands, tens 
of thousands, or more monomer molecules in a polymer molecule. There are 
two common laboratory synthetic methods used to made polymers: stepwise 
and chain polymerisation.126 
The first polymerisation method is stepwise polymerisation, which sometimes 
FODVVLILHG DV µFRQGHQVDWLRQ polymerisation¶ ,W LV GHILQHG WKDW PRQRPHUV DOO
combine together, thus the molecular weight increases slowly by losing small 
molecules, such as water. With this method, the molecular weight of polymer 
increases at a very slow rate at lower conversions, and only at very high 
conversion (i.e., > 95 %) can reach relatively high molecular weight. Step 
growth polymerisation is always used to yield branched and networked 
polymers.127 
The second one is chain growth polymerisation. It is generally following three 
steps: chain initiation, chain propagation and termination of the active chain 
ends. There are several types of synthesis depending on the active site (Table 
1-2). 
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Table 1-2. Types of chain growth polymerisation 
Active sites Synthesis type 
Carbanion Anionic polymerisation 
Carbenium ion Cationic polymerisation 
Free radical Free radical polymerisation 
 
The initiation of anionic polymerisation is usually by strong anions. 
Theoretically, there is no formal termination for anionic polymerisation method, 
because of that proton transfer from the solvent or other positive materials 
rarely take place. The initiation of cationic polymerisation is by strong protic 
acid. However, this method is extreme sensitive to the reaction conditions, such 
as solvent types, solvent purity and temperature. Among the above chain 
growth polymerisations, the most significant method is free radical 
polymerisation. Atom transfer radical polymerisation (ATRP) and reversible 
addition-fragmentation chain transfer polymerisation (RAFT) are the most 
extensively studied synthetic methods. 
 
1.6.1 Atom transfer radical polymerisation (ATRP) 
ATRP was first reported by Wang and Matyjaszewski in 1994,128 which is one 
of the most commonly used methods of controlled radical polymerisation. It 
provides a simple route to many well-defined functional polymers with 
controlled molecular weight and narrow molecular weight distribution.129, 130 A 
general ATRP reaction usually comprises of a transition metal and ligand based 
catalyst and alkyl halides act as the initiator.129 
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The ATRP polymerisation as shown in Figure 1-17 starts with the homolytic 
cleavage of the carbon-halogen bond of the initiator R-X, resulting in a single 
electron i.e. free radical at the carbon center (R) and a halogen radical (X). 
The halogen radical can bind to metal to change its oxidation state131 (Figure 
1-17A). This process is reversible; the halogen can reunite with the initiator to 
make it inactive again (Figure 1-17B). Thus, the initiator is only active for a 
short time before becoming dormant.132 When the initiator is active, it can 
consume monomers and propagate (Figure 1-17C). 
 
Figure 1-17. General scheme of an ATRP reaction. A: Initiation; B: Dormant 
species in ATRP; C: Propagation. M represents monomer; P represents a 
polymer with a number of monomer units. 
 
Several parameters can affect an ATRP reaction. The initiator can affect the 
initiating efficiency. The faster the initiation, the slower termination and the 
faster propagation, more monomers are combined together to form a polymer 
with a narrow molecular weight distribution.133 The catalyst is a very important 
parameter in an ATRP reaction, because it determines the equilibrium constant 
 
 
 R-X   +   Cu(B)-X/Ligand             R   &XC)-X2/Ligand  
 
 
 
 P-X   +   Cu(B)-X/Ligand             P   +  Cu (C)-X2/Ligand 
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between active and deactivated species. The catalyst system usually contains a 
transition metal and a ligand. The most commonly studied transition metal in 
an ATRP reaction is copper, due to its low cost and readily accessible redox 
character. The ligand must have strong complexion with copper134 and can 
stabilise Cu (II) compared to Cu (I). Besides, the choice of monomers is also 
very crucial. Monomers that are typically used in ATRP involve various vinyl 
polymers, which can stabilise the propagating radicals,135 such as styrene,136, 137 
methacrylate,137, 138 2-(dimethylamino)ethyl methacrylate139 and 
acrylonitrile.140 In addition to initiator, catalyst, ligand and monomer, solvent 
and temperature can influence the kinetics of ATRP as well.135 
A wide range of polymers has been created with controlled functionalities and 
compositions via functionalised initiators.141, 142 This approach has been used 
for the synthesis of methacrylate monomers showing fast ATRP kinetics with 
low polydispersities by using Cu (I) Br/2,2-bipyridine catalytic system.143  
Polymers synthesised with ATRP in this project include 
poly(ethyleneglycol)methyl ether-methacrylate [p(PEGMA475)], 
poly[2-(dimethylamino)ethyl methacrylate] [p(DMAEMA] and a random 
copolymer of PEGMA475 & DMAEMA (Figure 1-18). From previous 
UHVHDUFKHUV¶ studies, PEG has been found to be an effective additive in 
promoting the crystallisation of a range of proteins. However, PEG itself has 
limited chemical functionality, and cannot be derivatised easily to introduce 
groups which can form specific bonds with protein peptide residues. We thus 
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chose PEGMA475, as a neutral methacrylate derivative of PEG to obtain a 
polymer, p(PEGMA475), analogous to PEG but with hydrophilic side-chain 
functionality and a hydrophobic main-chain. Poly(PEGMA)-based materials 
have been shown to mediate protein crystallisation in solution.108 To test the 
effects of varying degrees of charge on protein crystallisation, another 
methacrylate monomer: DMAEMA was either homopolymerised or 
copolymerised with PEGMA475 to form cationic polymers. The amine 
functionalities were designed to enhance water solubility of the polymers144 
and also to provide lone-pair donor or charged residues dependent on pH and 
degree of protonation or quaternisation. 
 
Figure 1-18. Structures of PEGMA475 and DMAEMA monomers. X denotes 
the number of repeating units. 
 
1.6.2 Reversible addition-fragmentation chain transfer polymerisation 
(RAFT) 
Reversible addition-fragmentation chain transfer polymerisation (RAFT) is 
another most important controlled radical polymerisation. It was discovered at 
CSIRO in 1998.145 It commonly uses thiocarbonylthio compounds,146 such as 
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dithioesters as the RAFT agents to mediate the polymerisation via a reversible 
chain-transfer process (Figure 1-19). 
 
Figure 1-19. Mechanism of an ideal RAFT polymerisation.147 Pn represents a 
polymeric radical with n monomer units; Pm represents a polymeric radical 
with m monomer units; X normally represents sulfur; the Z group primarily 
affects the stability and activity of the S=C bond.145 
 
In an ideal RAFT reaction, initiation is started by an initiator, which 
decomposes to form two free radicals ,, these then react with monomer (M) 
to obtain a chain growth polymeric free radical (Pn) (Figure 1-19a). Then the 
chain growth polymeric free radical (3Q) starts to propagate and reacts with 
the RAFT agent, to form an intermediate RAFT adduct radical. There is a 
RAFT pre-equilibrium here between the intermediate RAFT adduct radical and 
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a polymeric RAFT agent & a leaving group radical (R) (Figure 1-19b). This 
leaving group radical (5) then reacts with the monomer to form another chain 
growth polymeric free radical (Pm) (Figure 1-19c). Group R must be a good 
leaving group and able to react with monomer to aid the fragmentation process. 
Then the main RAFT equilibrium process takes place, in which all chain 
growth polymeric free radicals share the radical among them, leading to chain 
growth (Figure 1-19d).147 It is very essential that the radicals are shared equally, 
thus, all the chains have the equal opportunities to propagate, and maintain well 
defined polymer characteristics. The termination of RAFT polymerisation 
involves a process called bi-radical termination to form dead polymers (Figure 
1-19e). 
In comparison to ATRP, a larger variety of monomers can be synthesised via 
RAFT polymerisation,148 especially water-soluble polymers,149 such as vinyl 
aromatics, acrylates, acrylamides, acrylonitrile, vinyl acetate and vinyl 
amides.150, 151 Polymers synthesised via RAFT in this project include 
poly[N-(3-(dimethylamido)propyl) methacrylamide] [p(DMAPMAm)], 
poly(2-acrylamido-2-methyl-1-propanesulfonic acid) [p(AMPS)], 
poly(2-acrylamidoacetic acid) [p(2-AmAA)] and poly(4-acrylamidobutanoic 
acid) [p(4-AmBA)]. Similar as DMAEMA, a methacrylamide monomer: 
DMAPMAm, which has tertiary amines groups, was selected to afford positive 
charges and form another type of cationic polymer. For the choice of anionic 
polymers, they were chosen according to the pKa of the polymers, and also 
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considering the protein crystallisation pH, at which the polymers could provide 
charged residues. Three acrylamide monomers, including AMPS, 2-AmAA and 
4-AmBA, which have ionisable sulfonic acid or carboxyl groups were 
homopolymerised to generate anionic water soluble homopolymers in this 
project (Figure 1-20). 
 
Figure 1-20. Structures of DMAPMAm, AMPS, 2-AmAA and 4-AmBA 
monomers. 
 
1.7 Protein targets 
Hen egg-white lysozyme (HEWL), concanavalin A (Con A) and bovine liver 
catalase (BLC) were the protein targets used for crystallisation during this 
research, because of their range of size and charge. The isoelectric point (pI) of 
HEWL is 11.35, when at its crystallisation pH 4.8, HEWL macromolecules are 
positively charged, i.e. cationic.152 The isoelectric point (pI) of Con A is 4.5,153 
when at crystallisation pH 8.5, Con A macromolecules are anionic. The 
isoelectric point (pI) of BLC is 5.4,154 and when at crystallisation pH of 6.8, 
BLC macromolecules may carry some negative charges, hence being a weekly 
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anionic protein at this pH. 
 
1.7.1 Hen egg-white lysozyme (HEWL) 
Lysozyme is a single chain enzyme and 129 amino acid in length155 (E.C. 
3.2.1.17). It has a molecular weight (Mw) of 14.3 kDa, pI of 11.35, four 
disulphide bridJHV IRUPHG E\ Į-helices, and was discovered in 1922 by 
Fleming.156, 157 It is present in tears, saliva, mucus and the egg-white of 
chickens. Lysozyme protects the body from bacterial infection as a natural 
antibiotic. It can attack the cell wall of the bacteria by catalysing the hydrolytic 
cleavage of polysaccharides in the cell walls, leading to bacterial lysis.158  
HEWL has five structurally characterised crystal forms: monoclinic, triclinic, 
hexagonal, orthorhombic and tetragonal.159 It has been the most studied 
crystallisation system for the last 60 years. Alderton and Fevold first reported 
tetragonal HEWL crystals in 1946.160 Phillips and Johnson first applied X-ray 
crystallography to elucidate the three-dimensional structure of HEWL in 
1965.161, 162 So far there are about 750 lysozyme crystallographic structures 
which have been obtained and are available in the PDB (Berman et al., 2000). 
A model of the three-dimensional structure of HEWL is presented in Figure 
1-21. 
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Figure 1-21. The three-dimensional structure of HEWL obtained by crystal 
X-ray diffraction, at a resolution of 1.8 Å and a crystallographic R factor of 
17.3 %. This polymorph is the orthorhombic P212121, with unit cell dimensions 
of a = 30.6 Å, b = 56.3 Å, c = 73.2 Å, and one molecule per asymmetric unit. 
Structure includes Mg2+ and SO42- ions.163  
 
As mentioned in section 1.5.2, Matzger et al. applied a series of insoluble 
polymer surfaces to influence lysozyme crystallisation. They reported that 
HEWL crystallisation under conditions favouring the tetragonal form resulted 
in exclusively tetragonal crystals, but the insoluble polymer surfaces could 
successfully control lysozyme nucleation rate and improve lysozyme crystal 
size.159, 99 Moreover, Yao et al. used some soluble polymer additives to control 
lysozyme crystallisation via tetragonal crystal growth as well and stated that 
some polymers were able to modulate the shape of crystals.108 With this in 
mind, we chose HEWL as the first protein target. The main reason for the use 
of HEWL in this research is that it has become the most preferred 
crystallisation system for the majority of protein crystallisation studies. This is 
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because the fact that it is easily purified for commercially use, low cost and 
widespread. Moreover, from the literature HEWL is relatively straightforward 
to crystallise in a specific polymorph (the tetragonal form) within one day with 
little effort. 
 
1.7.2 Concanavalin A (Con A) 
Concanavalin A (Con A) is a lectin (carbohydrate-binding protein), which is 
extracted from the jack-bean. It binds to certain structures that are found in 
various sugars, glycoproteins, and glycolipids specifically.164 Like most lectins, 
Con A is a homotetramer, each sub-unit has a molecular weight of 25.5 kDa, 
two chains and 235 amino acids. Each monomer of Con A binds two metallic 
ions: usually Mn2+ at site S1 and Ca2+ at site S2.165 Con A was the first lectin 
which used as commercial basis, and now it is widely applied in biology and 
biochemistry. For example, Con A can be used to characterise surface structure 
of glycoproteins and other sugar-containing entities exposed on the membrane 
of various cells;166 and some research showed that the cancer cells can be 
aggregated readily by Con A while other cells cannot.167 
Con A was first crystallised by Sumner and Howell in 1936.168, 169 A later 
investigation of the structure of Con A was conducted by Greer et al. in 1970. 
They studied the X-ray diffraction of Con A crystal and found Con A 
crystallised in two space groups I222 or I212121.170 For the last 60 years, Con A 
has been studied widely and yielded more than 50 X-ray crystal structures, 
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including the native state of Con A bound to manganese and calcium,171, 172 
Con A bound with carbohydrates,173, 174, 175, 176 metal free Con A,177, 178 and Con 
A bound to other transition metals.179, 180 Currently, there are several common 
structurally characterised crystal forms of Con A, bound to manganese and 
calcium ions, including triclinic P1,181 orthorhombic I222,171 orthorhombic 
C2221172 and orthorhombic P212121.99 A model of crystallographic structure of 
Con A bound to manganese and calcium ions is presented in Figure 1-22. 
 
Figure 1-22. Crystallographic structure of a Con A tetramer (from jack bean), 
obtained by crystal X-ray diffraction, at a resolution of 2.4 Å. The space group 
I222 with unit cell dimensions of a = 63.15 Å, b = 86.91 Å, c = 89.25 Å. 
Monomers with color cyan, green, red and magenta; Calcium (gold) and 
manganese cations (grey) are depicted as spheres.182 
 
1.7.3 Bovine liver catalase (BLC) 
Catalase is a common enzyme in all living organisms. It protects cells against 
toxic effects of hydrogen peroxide to proteins, lipids, and nucleic acids, by 
catalysing the reaction of decomposition of hydrogen peroxide to water and 
oxygen.183 Catalase from bovine liver is a tetramer of four equal polypeptide 
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chains: each subunit is over 500 amino acids long184 and has a molecular 
weight of 60 kDa.  
Catalase from bovine liver was firstly crystallised by Sumner and Dounce in 
1937.185 After that, McPherson et al. introduced PEG 6,000 and 20,000 as 
additives to mediate catalase from sheep or deer liver crystallisation, and 
produced large size of sheep liver catalase crystal and deer liver catalase crystal 
with complex shape.125 Like Con A, the crystallisation and structural 
characterisation of catalase has been studied for almost 60 years. There were 
two common structurally characterised crystal forms of BLC crystal: trigonal 
P3221 (form I)186 and orthorhombic P212121 (form II)187. Recently, Matzger et 
al. applied polymer-induced heteronucleant for BLC crystallisation and 
obtained another orthorhombic form (form III).99, 188 A model of 
crystallographic structure of BLC (form II) is presented in Figure 1-23. 
 
Figure 1-23. Crystallographic structure of a BLC tetramer, at a resolution of 
2.69 Å and a crystallographic R factor of 20.5 %. It adopts the space group 
P212121 with unit cell dimensions of a = 68.65 Å, b = 173.74 Å, c = 186.32 Å. 
Monomers with different colors are equal.99 
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1.8 Aims and objectives of the project 
In this project, in order to probe some of the factors involved in 
polymer-mediated protein crystallisation, we set out to prepare different classes 
of polymers with varying degrees of charge, molecular weight and backbone 
structure, and then to study their roles as additives in model protein solutions. 
The guiding hypothesis was that specific functional polymers in solution could 
DOWHUWKHUDWHRISURWHLQFU\VWDOOLVDWLRQIURPVROXWLRQVDQGWKHUHE\LQÀXHQFHWKH
shape, size, and/or polymorph of the resultant crystals. 
The aim of this project was threefold. The first two objectives are shown in 
Figure 1-24. The first aim of this project was to design some key polymers 
with varying degrees of charge, molecular weight and backbone structure via 
proper ATRP or RAFT methods (Figure 1-24A). The polymers should be 
hydrophilic and stable when dissolved in protein crystallisation buffer solutions 
with different pH. They also need to be compatible with protein structures. 
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Figure 1-24. Schematic representation of protein crystallisation utilising 
polymer additives. A) Polymerisation of functional monomers to yield the 
polymer. B) 96-well crystallisation plate, each sample well (red) composes of 
protein and polymer additives. C) Polymer acts DVµDGGLWLYH¶WRmediate protein 
crystallisation. 
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The second aim was to use these polymers as solution additives to mediate 
various model proteins crystallisation via sitting drop vapour diffusion 
techniques (Figure 1-24C). In this research, hen egg white lysozyme (HEWL), 
concanavalin A (Con A) and bovine liver catalase (BLC) were selected as 
target proteins for crystallisation experiments. The first model protein was 
HEWL. HEWL macromolecules are positively charged at tetragonal 
crystallisation pH of 4.8, i.e. cationic. It is readily available and relatively 
straightforward to crystallise in the tetragonal form within one day. These facts 
allow us to develop experimental protocols to investigate the effects of these 
polymers successfully, such as alter protein crystal size, morphology, even 
crystal packing motifs, and obtain multiple forms from the same crystallisation 
condition. Besides the exploration of HEWL, we also aim to evaluate whether 
these polymers were suitable for other proteins, especially anionic proteins. 
Con A and BLC were selected as anionic model proteins for further 
crystallisation. 
The final objective was to examine the mechanisms of how these polymers 
affect protein crystallisation and to develop an understanding of the 
interactions between polymer and protein macromolecules or the surrounding 
solvent. Moreover, we hoped to establish structure-function relationships 
linking the types of polymers used in these experiments and the protein crystal 
habits produced would generated. These relationships might be used as models 
to guide a wide range of protein crystallisation experiments in the future. 
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Accordingly, with the polymer additives, proteins can be nucleated into 
particles (amorphous or crystalline) and obtain polymer & protein 
nanoaggregates or nanocrystals, which will be useful in pharmaceutical, 
biotechnological or chemical applications. 
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CHAPTER 2 
 
2. Materials, Instrumentation and General Methods 
2.1 Materials 
ƍ-Azobis(4-cyanovaleric acid) (V-501) was purchased from Fluka®, UK and 
recrystallised from MeOH by Dr. Francisco Fernandez-Trillo. 
2-(Ethylthiocarbonothioylthio)-2-methylpropanoic acid (CAT) was also kindly 
supplied by Dr. Francisco Fernandez-Trillo. A cationic/zwitterionic copolymer 
of [2-(methacryloyloxy)ethyl]trimethylammonium chloride and 
N-[2-(methacryloyloxy)ethyl]-dimethyl-(2-sulfoethan)aminium hydroxide 
[p(METMAC-co-MEDSAH)] was kindly supplied by Dr. E. Peter Magennis. 
HEWL, Con A and BLC were purchased from Sigma-Aldrich®, UK (L6876, 
C7275 and C40, respectively). They were all used without further purification. 
MRC 2 Well Crystallisation Plates (Swissci) (UVP plate, 96 reservoir wells, 
reservoir volume: 50 to 100 µl, with 2 corresponding sample wells: 5 µl max 
fill volume) were purchased from Hampton Research 8. 'XOEHFFR¶V
Phosphate Buffered Saline (DPBS) was purchased from Lonza Group Ltd. All 
solvents, reagents and proteins, were of analytical or HPLC grade and 
purchased from Sigma-Aldrich®, Acros® or Fisher Scientific®, UK without 
further purification unless otherwise. 
¾ 2-(Dimethylamino)ethyl methacrylate (DMAEMA) (98 %) ± Fluka 
¾ 2-(Ethylthiocarbonothioylthio)-2-methylpropanoic acid (CTA) ± 
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synthesised by Dr. Francisco Fernandez-Trillo, School of Pharmacy, the 
University of Nottingham 
¾ 2,2-Bipyridine (  %) ± Sigma Aldrich 
¾ 2-Acrylamido-2-methyl-1-propanesulfonic acid (AMPS) ± Sigma Aldrich 
¾ ƍ-Azobis(4-cyanovaleric acid) (V-501) (recrystallised from MeOH by 
Dr. Francisco Fernandez-Trillo) ± Fluka 
¾ 4-$PLQREXWDQRLFDFLG %) ± Acros Organics 
¾ Acrylic chloride (96 %) ± Alfa Aesar 
¾ Aluminium stubs with carbon tabs ± Agar Scientific 
¾ Aluminum oxide - Neutral grade ± Sigma Aldrich 
¾ Ammonium sulfate (  %) ± Sigma 
¾ Bovine liver catalase (BLC) &  units/mg protein) ± Sigma 
Aldrich 
¾ &HOOXORVHDFHWDWHPHPEUDQHȝP± Aldrich 
¾ Chloroform  (  %) ± Sigma Aldrich 
¾ Chloroform-d ± Sigma Aldrich 
¾ Concanavalin A (Con A) from Canavalia ensiformis (Jack bean) (C7275) 
± Sigma Aldrich 
¾ Copper (II) Bromide ± (CuBr2, 99 %) - Alfa Aesar 
¾ Deuterium oxide (D2O) ± Sigma Aldrich 
¾ Dialysis membrane (MWCO 1000, regenerated cellulose) ± Spectrapor 
¾ Diethyl ether (DQK\GURXV %) ± Sigma Aldrich 
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¾ Dimethyl sulfoxide-d6 ± Sigma Aldrich 
¾ 'XOEHFFR¶VSKRVSKDWHEXIIHUHGVDOLQH'3%6± Lonza Group Ltd 
¾ Ethanol (DQK\GURXV %) ± Sigma Aldrich 
¾ Ethyl acetate (anhydrous, 99.8 %) ± Sigma Aldrich 
¾ Ethylene glycol (anhydrous, 99.8 %) ± Sigma Aldrich 
¾ Glycerol anhydrous puriss ± (>99.5 %) - Fluka 
¾ Glycine (  %) ± Sigma Aldrich 
¾ Hen egg white lysozyme (HEWL) (L687 units/mg protein) ± 
Sigma Aldrich 
¾ Hydrochloric acid (HCl) (ACS reagent, 37 %) ± Sigma Aldrich 
¾ Methyl 2-bromopropionate (98 %) ± Sigma Aldrich 
¾ Methyl iodide (99 %) ± Sigma Aldrich 
¾ MRC 2 Well Crystallisation 96 Plate ± Hampton Research 
¾ N-(3-(dimethylamido)propyl)methacrylamide (DMAPMAm) ± Sigma 
Aldrich 
¾ Petroleum ether ± Sigma Aldrich 
¾ Poly(ethylene glycol) (PEG 4000) ± Sigma Aldrich 
¾ Poly(ethylene glycol) methyl ether methacrylate (PEGMA475) ± Sigma 
Aldrich 
¾ Poly(ethylene oxide) (PEO) ± Sigma Aldrich 
¾ Polystyrene ± Sigma Aldrich 
¾ Polyvinylpyrrolidone ± Sigma Aldrich 
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¾ Sodium acetate (anhydrous) ± Sigma Aldrich 
¾ Sodium chloride (NaCl) ± Fisher Scientific 
¾ Sodium phosphate (  %) ± Sigma Aldrich 
¾ Tetrahydrofuran (THF) (anhydrous,  %) ± Sigma Aldrich 
¾ Toluene (anhydrous, 99.8 %) ± Sigma Aldrich 
¾ Trifluoroacetic acid (  %) ± Sigma Aldrich 
¾ Trizma base (  %) ± Sigma 
 
2.2 Instrumentation 
Gel permeation chromatography (GPC) 
The polydispersity index (PDI) and molecular mass of the polymers were 
determined using Polymer Laboratories GPC-50 (Varian, Inc.) plus fitted with 
differential refractometer (RI), capillary viscometer (DP) and dual angle laser 
light-scattering (15° and 90°) detectors. The flow rate was 1.00 mL/min or 0.5 
mL/min and experiments were conducted at room temperature. Organic soluble 
polymer analysis was carried out on the GPC-50 Plus with Resipore Mixed-D 
columns (Agilent Tech. Inc.) (eluent-chloroform/5 % Et3N) calibrated with 
linear polystyrene standards. Cationic polymer analysis was carried out on the 
same GPC-50 Plus with CATSEC-300 (250 mm × 4.5 mm ID) column 
(eluent-200 mM NaCl with 0.1 % trifluoroacetic acid (v/v)) calibrated with 
polyvinylpyrrolidone (PVP) standards. Anionic polymer analysis was carried 
out on the same GPC-50 Plus with Polymer Labs aquagel-OH guard columns 
CHAPTER 2. Materials, Instrumentation and General Methods 
97 
 
îPPȝPPolymer Labs UK) (eluent-'XOEHFFR¶V3%6ZLWKRXW&D2+ 
and Mg2+ ions) calibrated with a single, narrow poly(ethylene oxide) (PEO) 
standard (Polymer Labs, Mp 128 kDa>Ș@G/JXVLQJDGQGFYDOXHRI
0.133 g/mL. Samples were prepared at 1-5 mg/mL in the mobile phase and 
injected 100 µL onto the column. Molecular weight and polydispersity index 
were calculated using Polymer Labs Cirrus 3.0 Software. 
 
NMR spectroscopy 
1H and 13C nuclear magnetic resonance (NMR) spectra were recorded on a 
Bruker Avance 400 MHz spectrometer. The instrument is fitted with a 5mm 
switchable quadruple probe for the detection of 1H, 13C, 19F and 31P, and also 
with z-axis pulsed field gradients for gradient shimming.  Chemical shifts 
were reported at 400 MHz (1H) and 101 MHz (13C) LQSSPįXQLWV relative to 
TMS in chloroform-d (CDCl3), tetramethylsilane (DMSO-d6), Methanol-d4, or 
D2O solutions. 
 
Infrared spectroscopy (IR) 
IR spectra of polymer samples (approximate 5 mg) were recorded on KBR 
discs on a Bio-rad FTS6000 Fourier Transform Spectrometer instrument. It is a 
high performance research grade multi-range FT-IR spectrometer, covering the 
spectral range 11,000-400 cm-1 capable of both rapid scan and step 
scan operation. Its high quality 60° Michelson air bearing 
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piezoscan interferometer features piezoelectric-based continuous dynamic 
alignment (which simultaneously maximizes the spectral throughput and 
minimizes the noise in the measurements) and a KBr beam splitter for the mid 
IR. This FTIR instrument employs external reflection, micro-ATR equipped 
using a silicon crystal. It is interfaced with a Nicolet Avatar 360 spectrometer 
and uses a liquid nitrogen cooled MCT (HgCdTe) detector. It focuses more 
than 150 mW of infrared power at the sample, by using a high wattage 
water-cooled ceramic source rather than air-cooled sources for the mid IR and 
a two-inch clear aperture through the interferometer. The system was cooled by 
liquid nitrogen for 10 min before the detection of the polymer sample. 
 
Dynamic light scattering (DLS) 
Dynamic Light Scattering (DLS) was measured by using a Viscotec Model 802 
instrument (Viscotek Europe Ltd.), equipped with an internal laser (825-832 
nm) and a maximum radiation power of 60 mW. From standard auto 
correlation functions, measured diffusion coefficients were related to particle 
hydrodynamic radius via the Stokes-Einstein Equation. 
RH = kT/6ʌȘ' 
Where RH is the hydrodynamic radius, k is the Boltzmann constant, T is the 
WHPSHUDWXUHDQGȘLVWKHYLVFRVLW\RIWKHVROYHQW,QDGGLWLRQLWZDs assumed 
that particles were spherical and non-interacting. 
Measurements quoted are the averages of samples with at least ten readings of 
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particle size recorded at 19 °C. Data processing was performed with the 
software program OmniSize 3.0 (Viscotek Europe Ltd.). 
 
Freeze drier 
Water was removed by immersing reagent tubes containing the samples in 
liquid nitrogen, once frozen the samples were placed on an Edwards Modulyo 
freeze drier equipped with an Edwards high vacuum pump for 3 days at -25 °C and 
the water was then removed.  
 
Rotary evaporator 
Solvents evaporated under reduced pressure on a Buchi Rotavapor R-200 
equipped with a B490 heating bath with 4 °C. 
 
Centrifuge 
Centrifugation was carried out on an Eppendorf Refrigerated Microcentrifuge. 
All protein solutions were centrifuged at 13,000 rpm for 5 minutes at 4 °C. 
Polypropylene micro-centrifuge tubes in size 1.5 mL (Sigma-Aldrich, T3406) 
with an integral flip cap were used here. 
 
Optical microscopy 
Protein crystals in the crystallisation plates were quantitatively observed using 
a Leica Stereomicroscope (63x magnification) with a Leica CLS1 50X 
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fan-cooled light source. A Nikon Coolpix 4500 digital camera was connected 
to image the crystals. 
 
Scanning electron microscope (SEM) 
The samples were loaded onto aluminium stubs with carbon tabs pre-fixed. 
These were then gold coated using an SCD 030 Blazers sputter coater for 5 
minutes at 30mA. The coated samples were transferred into a JEOL JSM 6060 
LV Scanning electron microscope and imaged at 20-30 kV. Prior to gold 
coating, protein crystals were taken out from the crystallisation plates, washed 
with crystallisation buffer solutions. 
 
X-ray crystallography  
Protein crystallographic analysis was carried out on a Rigaku micromax 007 
microfocus X-ray generator with high-flux Osmic confocal multi-layer optics. 
X-rays were collimated to a 0.3 mm beam with X-rays from the copper K alpha 
emission (1.5418 Angstroms). Diffraction patterns were collected on Rigaku 
R-Axis 4++ image plates. Crystals were maintained at temperatures of -180 °C 
by an X-stream 2000 nitrogen vapour system. 
In X-ray crystallography, X-ray beam is employed to hit the crystal samples. 
Atoms in the crystal scatter X-ray waves and will produce secondary spherical 
waves emanating from electrons. Those regular arrays of spherical waves 
QRUPDOO\LQVRPHVSHFLILFGLUHFWLRQVGHWHUPLQHGE\%UDJJ¶VODZ)LJXUH-1): 
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2 d sin ș = QȜ 
Here, d is the distance between diffracting planes; ș is the incident angle; n is 
any integer; and Ȝ is the wavelength of the beam. 
 
Figure 2-%UDJJ¶VGLIIUDFWLRQ7ZR LQFLGHQWEHDPV ZDYHOHQJWKȜ VFDWWHUHG
off two atoms in the crystalline.  
 
Therefore, X-rays are diffracted resulting in a pattern on the detector. Then the 
crystallographer can get a three-dimensional image of the density of electrons 
within the crystal by measuring the angles and intensities of these diffracted 
patterns. Thus, the mean atom positions, their chemical bonds and other 
information within the crystals can be determined. 
 
2.3 General methods 
General synthetic methods 
Poly[poly(ethylene glycol) methyl ether methacrylate475] [p(PEGMA475)], 
poly[2-(dimethylamino)ethyl methacrylate] [p(DMAEMA)] and a random 
copolymer of PEGMA475 and DMAEMA [p(DMAEMA-stat-PEGMA475)] 
were prepared by a variant of published ATRP route by using 
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Cu(I)Br/2,2-bipyridine (Bipy) catalytic system and methyl 2-bromopropionate 
(MBrP) as the initiator. Poly[N-(3-(dimethylamido)propyl)methacrylamide] 
[p(DMAPMAm)], poly(2-acrylamido-2-methyl-1-propanesulfonic acid) 
[p(AMPS)], poly(2-acrylamidoacetic acid) [p(2-AmAA)] and 
poly(4-acrylamidobutanoic acid) [p(4-AmBA)] were synthesised using RAFT 
methods. The polymerisation employed 
2-(ethylthiocarbonothioylthio)-2-methylpropanoic acid (CAT) as the RAFT 
DJHQW DQG ƍ-azobis(4-cyanovaleric acid) (V-501) as the initiator. A hybrid 
copolymer of [2-(methacryloyloxy)ethyl]trimethylammonium chloride and 
N-[2-(methacryloyloxy)ethyl]-dimethyl-(2-sulfoethan)aminium hydroxide 
[p(METMAC-co-MEDSAHH)] was kindly supplied by Dr. Eugene Peter 
Magennis. For more details see Chapter 3. 
 
General crystallisation method 
Crystallisation was performed in 96-well crystallisation plates, using the sitting 
drop vapour diffusion technique. Specifically, a solution (50 µL) of tested 
polymer buffer was pipetted in triplicate in the reservoir wells; protein solution, 
(1 µL) and buffered polymer solution (as described above, 1 µL) were pipetted 
into sample wells of the crystallisation plate. The plate was then sealed and 
incubated at 19 °C. More details are shown in Chapter 4.
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3. Preparation and Characterisation of Monomers and 
Polymers 
3.1 Introduction 
$V PHQWLRQHG LQ µ&KDSWHU ¶ although there are many examples of protein 
crystals reported, successful crystallisation of proteins from solution is still an 
extremely difficult task. Only a small number of techniques are suitable for 
helping proteins crystallise; besides, there are many uncertain and poorly 
understanding factors can affect and govern the crystallisation process from 
solution.59 
One essential strategy for protein crystallisation is using polymers as µDGGLWLYHV¶
into the protein solution.189 Synthetic polymers are important additives for 
protein crystallisation control as there are many possible functionalities can be 
introduced into the backbone and side-chains, giving a very wide range of 
functional behaviour.5, 100, 101 They can influence protein crystallisation process 
to a large extent in terms of size, habit, morphology and even polymorph of the 
crystal.71 Although a number of polymeric additives have been studied to 
influence protein crystallisation, most of the studies are descriptive; the 
interactions between some of the existing polymeric additives and protein 
macromolecules or surrounding solvent are still unclear, and the mechanisms 
by which protein crystals form in the presence of these polymers needs to be 
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further studied.100, 108 
In order to investigate some of the factors involved in polymer-mediated 
protein crystallisation, we designed various classes of polymers with varying 
degrees of charge, molecular weight and backbone structure, and then to study 
their role as additives in model protein solutions. In this paper, four classes of 
materials, including neutral, cationic, anionic and cationic/zwitterionic 
polymers based on methacrylate or (meth)acrylamide monomers were 
successfully prepared and shown in Figure 3-1. 
 
Figure 3-1. Structures of polymers, named P1 to P8. Neutral polymer: P1; 
cationic polymers: P2-4; anionic polymers: P5-7 and cationic/zwitterionic 
copolymer: P8. 
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3.2 Monomer synthesis 
3.2.1 2-Acrylamidoacetic acid (2-AmAA)190, 191 
 
Figure 3-2. Reaction scheme for the synthesis of 2-AmAA. 
 
2-AmAA was prepared in a 500 mL round bottomed flask with a magnetic 
stirrer, by adding glycine (22 mL, 133 mmol) to NaOH (2M, 264 mL) and 
cooling to 0 °C by using an ice bath. After glycine dissolved completely, 
acrylic chloride (24.1 g, 266 mmol) was added dropwise over a period of 30 
minutes via an addition funnel. The reaction mixture was stirred for 1 hour. 
The resulting mixture was acidified to pH 1.0 with HCl (1 M). The crude 
product was saturated with NaCl and extracted with ethyl acetate (EtOAc) five 
times from the acidified aqueous solution and then dried over magnesium 
sulfate. The solution volume was reduced to 25 mL with a rotary evaporator. 
The obtained solution was diluted with ethyl acetate and cool to 0 °C with 
vigorous stirring to precipitate a solid. After filtering, then the formed 
suspension was washed with ethyl acetate/diethyl ether (1:1) (200mL). The 
solvent was removed with a rotary evaporator. Precipitation was carried out 
another time, and the final white solid (6.62 g, 39 %) was dried under vacuum 
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overnight. Characterisation was carried out by 1H-NMR (Figure 3-3) and 
13C-NMR (Figure 3-4). 1H-NMR (400 MHz, DMSOįSSP(s-board, 
1H, COOH), 8.43 (s, 1H, NH), 6.29 (dd, J = 16.9, 10.2 Hz, 1H, CH=CH2), 6.11 
(d, J = 17.0 Hz, 1H, CH2=CH), 5.62 (d, J = 9.9 Hz, 1H, CH2=CH), 3.84 (d, J = 
5.3 Hz, 2H, CH2). 13C-NMR (101 MHz, DMSO į SSP  &22+
165.42 (CONH), 131.68 (-C=), 126.19 (=CH2), 40.00 (CH2). 
 
Figure 3-3. 1H-NMR spectra of 2-AmAA. 
 
Figure 3-4. 13C-NMR spectra of 2-AmAA. 
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2-AmAA monomer was synthesised by using similar conditions according to 
the reference with modification.190 The reaction was carried out in sodium 
hydroxide (2 M) solution using 1:2:4 molar ratio of glycine to acrylic chloride 
to sodium hydroxide at 0 °C. The mechanism of this acylation reaction is 
shown in Figure 3-5. 
 
Figure 3-5. Scheme of the mechanism of synthesis of 2-AmAA. 
 
3.2.2 4-Acrylamidobutanoic acid (4-AmBA)190, 191 
 
Figure 3-6. Reaction scheme for the synthesis of 4-AmBA. 
 
Similar to 2-AmAA, 4-AmBA synthesis was carried out in a 500 mL round 
bottomed flask with a magnetic stirrer, by adding 4-aminobutanoic acid 
(4-ABA) (10 g, 97.0 mmol) to NaOH (2M, 194 mL) and cooling to 0 °C by 
using an ice bath. After glycine dissolved completely, acrylic chloride (19 mL, 
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194 mmol) was added dropwise over a period of 30 min via an addition funnel. 
The reaction mixture was stirred for 1 hour. The pH of the resulting mixture 
was adjusted to 1.0 using HCl (1 M). The aqueous phase was saturated with 
NaCl and extracted with EtOAc (5 x), then dried over magnesium sulfate. The 
solution volume reduced in the rotary evaporator to 25mL. The obtained 
solution was allowed to precipitate in the freezer overnight, filtered, washed 
with cold EtOAc and dried under vacuum. The final white solid (7.2 g, 47 %) 
was yielded. Characterisation was carried out by 1H-NMR (Figure 3-7) and 
13C-NMR (Figure 3-8). 1H-NMR (400 MHz, DMSOįSSPs-board, 
1H, COOH), 8.10 (s, 1H, NH), 6.20 (dd, J = 16.8, 10.0 Hz, 1H, CH=CH2), 6.07 
(d, J = 16.8 Hz, 1H, CH2=CH), 5.56 (d, J = 9.7 Hz, 1H, CH2=CH), 3.14 (d, J = 
5.8 Hz, 2H, CH2-NH), 2.23 (t, J = 6.9 Hz, 2H, CH2-COOH), 1.70 (dd, J = 38.8, 
32.1 Hz, 2H, CH2CH2CH2). 13C-NMR (101 MHz, DMSO į SSP 
(COOH), 165.11 (CONH), 132.15 (-C=), 125.39 (=CH2), 39.64 (CH2NH), 
31.26 (CH2COOH), 24.93 (CH2-CH2-CH2). 
 
Figure 3-7. 1H-NMR spectra of 4-AmBA. 
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Figure 3-8. 13C-NMR spectra of 4-AmBA. 
 
As mentioned in the introduction chapter, the effect of polymer on protein 
crystallisation is likely to depend on the exact polymer functionality. 
Acrylamide monomers 2-AmAA and 4-AmBA were selected as anionic 
monomers, due to the presence of ionisable sulfonic groups, which could 
introduce of some negative charges during the protein crystallisation process. 
Then those two monomers were used for RAFT polymerisation to form 
hydrophilic homopolymers. However, the product yield of those monomers 
were not as high as literature reported (70 %),192 this may because of the 
inevitable loss during purification process.  
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3.3 Polymer synthesis 
3.3.1 Atom transfer radical polymerisation (ATRP) method 
General protocol for ATRP:143 
In a typical procedure, Cu(I)Br/2,2-bipyridine (Bipy) was the catalytic system 
and methyl 2-bromopropionate (MBrP) was the initiator. Polymerisation was 
conducted in a tube fitted with a two way stopcock and sealed with a septum. 
The polymerisation solution was degassed by three vacuum-nitrogen cycles 
and placed into an oil bath at 70 °C. An NMR spectrum was recorded at the 
beginning of the experiment. The reaction was stopped by removing the 
septum thus exposing the reaction to oxygen. After reaction, an NMR spectrum 
was recorded to calculate the degree of conversion. The reaction mixture was 
passed through aluminum oxide and washed through with chloroform to 
remove the catalyst. The polymer was precipitated in a 100:1 excess of 
petroleum ether to remove the un-reacted monomer. 
 
3.3.1.1 Polymer conversion calculations 
The overall monomer conversion was calculated by 1H-NMR spectra by 
comparing the vinyl proton signals from the monomers (5.6 and 6.1 ppm) to 
the overall integration from the OCH2 adjacent to the methacrylate group 
(4.01-4.48 ppm) for methacrylate-based monomers: PEGMA475 and 
DMAEMA. 
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3.3.1.2 Poly[poly(ethylene glycol) methyl ether methacrylate475] 
[p(PEGMA475)] (P1)193, 194 
 
Figure 3-9. Reaction scheme for the synthesis of p(PEGMA475) homopolymer 
(P1) via ATRP. 
 
In a typical ATRP procedure, 2,2-Bipyridine (0.13 g, 0.84 mmol), PEGMA475 
(3 g, 6.32 mmol), toluene (3.75 mL) and methyl 2-bromopropionate (MBrP) 
(0.07 g, 0.42 mmol) were added to a 10 mL tube fitted with a two way 
stopcock and sealed with a septum. The tube was connected to both a vacuum 
line and a nitrogen pump. The mixture was degassed by three freeze thaw 
cycles in liquid nitrogen. The frozen mixture was charged with nitrogen before 
the addition of Cu(I)Br (0.06 g, 0.42 mmol). The mixture was then degassed by 
three vacuum-nitrogen cycles and placed into an oil bath at 70 °C for 6 h. An 
NMR spectrum was recorded at the beginning of the experiment. Samples were 
taken at specific time points by piercing the septum with a syringe; the septum 
was resealed using parafilm. Air was removed from the syringe by purging it 
with nitrogen three times. The reaction was stopped by removing the septum 
thus exposing the reaction to oxygen. After reaction, NMR spectrum was 
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recorded to enable calculation of degree of conversion. The reaction mixture 
was passed through aluminum oxide and washed through with chloroform to 
remove the catalyst. The mixture was precipitated in a 100:1 excess of 
petroleum ether to remove the un-reacted monomer, and then yielded the 
polymer (1.9 g, 63 %). 1H-NMR (400 MHz, CDCl3įSSP-3.92 (m, 2H, 
COO-CH2-CH2O), 3.72-3.52 (m, 2xH, OCH2-(CH2)xO-CH3), 3.41-3.36 (m, 3H, 
OCH3), 2.39-1.56 (m, 2H, CH2-MA backbone), 1.18-0.55 (m, 3H, CH3-MA). 
IR Ȟ (cm-1) 2849 (C-H), 1721 (C=O), 1464, 1346 (C-H), 1240, 1089 (C-O), 
1026, 934, 846 (C-C). The 1H-NMR and 13C-NMR spectra of monomer 
PEGMA475 are shown in Appendix (Page 330). 
Overall monomer conversion was calculated from 1H-NMR spectra by 
comparing the vinyl proton signals from the monomers (5.6 and 6.1 ppm, 
Figure 3-10, signals a and b) to the overall integration from the OCH2 across 
the range 3.9 to 4.4 ppm (Figure 3-10, signal d). In the region of 3.9-4.4 ppm 
two protons of the remaining monomers resonate as well as two protons from 
the polymer. 
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Figure 3-10. 1H-NMR spectra for the polymerisation of PEGMA475 to yield 
p(PEGMA475) (P1). Top: Reaction mixture at the beginning of the 
polymerisation experiment. Bottom: Purified polymer P1. 
 
Figure 3-11. Representative FTIR for p(PEGMA475) (P1). 
 
P(PEGMA475) was synthesised by using the general ATRP method as above 
shown. The size of the polymer was controlled by the ratio of 
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[Monomer]:[Initiator]. Several experiments with different [Monomer]:[Initiator] 
ratios for the synthesis of p(PEGMA475) were carried out (Table 3-1). 
Table 3-1. Summary of synthesis of p(PEGMA475) (P1) via ATRP 
No. [M]:[I]c Conversion (1H-NMR) 
Time in 
minutes Mn (GPC) 
Mn 
(Theoretical) PDI 
1a 50:1 30 % 360 27109 7196 1.15 
2b 15:1 60 % 120 30815 4275 1.20 
3b 20:1 83 % 180 36388 7885 1.26 
4b 100:1 84 % 540 39405 39900 1.23 
a) Experimental conditions: 70 °C; Monomer/Toluene=1:2 (w/v); 
[I]/[CuBr]/[Bipy])=1/1/2. b) Experimental conditions: 70 °C; 
monomer/toluene=1:1.25 (w/v); [I]/[CuBr]/[Bipy])=1/1/2. c) Molar ratio of 
[Monomer]:[Initiator]. Theoretical, from monomer/initiator ratio and monomer 
conversion. GPC analysis (eluent-chloroform, poly(styrene) standards). 
Polydispersity index (PDI) from GPC. 
 
Table 3-1 shows a summary of p(PEGMA475) (P1) synthesised in this study and 
Figure 3-12 shows their kinetic plots. Generally, a conversion of 60 % was 
targeted to decrease the possibility of side reactions. Experiment 1 with 
[Monomer]:[Initiator] = 50:1, the conversion was about 30 % after 6 hours, and 
the PDI measured by GPC was found about 1.15 (Table 3-1, entry 1). The 
kinetic plot shows its slow initiation (Figure 3-12, 1). As the conversion of this 
experiment was relatively low, experiments 2-4 with different 
[Monomer]:[Initiator] ratios and a smaller amount of toluene were carried out. 
Generally the conversions were above 60 %, and the PDI measured by GPC 
were found about 1.20 (Table 3-1, entries 2-4). The polymerisation of 
p(PEGMA475) (P1) exhibited pseudo-first order kinetics and a linear increase of 
molecular weight with conversion (Figure 3-12) while the polydispersity of the 
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polymers was narrow throughout the polymerisation. In this way, several 
materials could be prepared, with different molecular weights. 
 
Figure 3-12. Some examples of kinetic plots for the synthesis of p(PEGMA475) 
(P1) in this study. 
 
The GPC used to determine molecular weight data (Mn GPC) for the synthesis 
of p(PEGMA475) showed large discrepancies compared to the theoretical 
number molecular weight (Mn Theoretical) in some experiments (Table 3-1, 
entries 1-3). Molar masses determined by GPC in chloroform will depend on 
how the polymer interacts with the column and how similar the polymer 
FRPSDUHG WR WKH VWDQGDUGV SRO\VW\UHQH )URP SUHYLRXV UHVHDUFKHUV¶ VWXG\
polymers with macromolecular brushes may provide unusual GPC results;195 
and the PDI may have been influenced by chain branching, thus, some side 
reactions may take place due to the presence of PEG-bismethacrylates as 
impurities in the PEGMA475 monomer supplied. 
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3.3.1.3 Poly[2-(dimethylamino)ethyl methacrylate] [p(DMAEMA)] 
(P2)196,197,198 
 
Figure 3-13. Reaction scheme for the synthesis of p(DMAEMA) (P2) via 
ATRP. 
 
Typically, the same ATRP procedure as described above (Section 3.3.1.2) was 
carried out. 2,2-Bipyridine (0.12 g, 0.76 mmol), DMAEMA (6 g, 38.2 mmol), 
toluene (6 mL), methyl 2-bromopropionate (MBrP) (0.06 g, 0.38 mmol) and 
Cu(I)Br (0.05 g, 0.38 mmol) were added to a tube fitted with a two way 
stopcock and sealed with a septum. After being degassed, the reaction mixture 
was charged with nitrogen and placed into an oil bath at 70 °C overnight. The 
reaction mixture was passed through aluminum oxide and washed through with 
chloroform to remove the catalyst. The polymer was precipitated in a 100:1 
excess of petroleum ether to remove the un-reacted monomer. Then a yellow 
compound was obtained (4.7 g, 78 %). 1H-NMR (400 MHz, CDCl3į SSP 
4.28-3.90 (m, 2H, OCH2), 2.73-2.42 (m, 2H, CH2N), 2.40-2.13 (m, 6H, 
N(CH3)2), 2.08-1.55 (m, 2H, CH2-MA backbone), 1.17-0.62 (m, 3H, CH3-MA). 
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IR Ȟ FP-1) 2933, 2762 (C-H), 1720 (C=O), 1447, 1384 (C-H), 1262, 1140 
(C-O), 1231 (C-N), 1013 (C-C). The 13C-NMR spectra of monomer 
DMAEMA is shown in Appendix (Page 331). 
 
Figure 3-14. 1H-NMR spectra for the polymerisation of DMAEMA to yield 
p(DMAEMA) (P2). Top: Monomer DMAEMA. Bottom: Purified polymer 
p(DMAEMA) (P2). 
 
Figure 3-15. Representative FTIR for p(DMAEMA) (P2). 
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Table 3-2 shows selected properties of p(DMAEMA) (P2) synthesised in this 
study. The size of the polymer was also controlled by the [Monomer]:[Initiator] 
ratio. Two repeat experiments with different [Monomer]:[Initiator] ratios were 
carried out. The PDI was measured by CHCl3 GPC (polystyrene standard) and 
found in the range 1.20-1.60. Experiments 1 and 2 with a molar ratio of 
[Monomer]:[Initiator] = 100:1, generally the conversion was about 28 % based 
on monomer masses after 6 hours, and the PDI measured by GPC was found 
about 1.30 (Table 3-2, entries 1 and 2). The conversions of these experiments 
were relatively low, a common method for resolving this problem is either 
prolong the reaction time or lower the ratio of [Monomer]:[Initiator]. Then, 
experiments 3 and 4 with a molar ratio of [Monomer]:[Initiator] = 50:1 were 
carried out (Table 3-2, entries 3 and 4). The conversion was about 70 % after 6 
hours, and the PDI measured by GPC was found about 1.52.  
Table 3-2. Summary of synthesis of p(DMAEMA) (P2) via ATRP 
No. [M]:[I]b Conversion Time (min) Mn (GPC) Mn (Theoretical) PDI 
1a 100:1 16 % 210 40816 2562 1.25 
2a 100:1 28 % 360 42403 4402 1.30 
3a 50:1 70 % 360 44171 5502 1.52 
4a 50:1 68 % 360 46299 5345 1.52 
a) Experimental conditions: 70 °C; Monomer/Toluene=1:1 (w/v); 
[I]/[CuBr]/[Bipy])=1/1/2. b) Molar ratio of [Monomer]:[Initiator]. Theoretical, 
from monomer/initiator ratio and monomer conversion. GPC analysis 
(chloroform, poly(styrene) standards). Polydispersity index (PDI) from GPC. 
 
Figure 3-16 shows selected kinetic plots for the synthesis of p(DMAEMA) (P2) 
by ATRP. The polymerisation of p(DMAEMA) (P2) exhibited pseudo-first 
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order kinetics and a linear increase of molecular weight with conversion. In 
this way, several materials could be prepared, with different molecular weights. 
 
Figure 3-16. Kinetic plots for the synthesis of p(DMAEMA) (P2) via ATRP 
method. Blue represents experiment 2 (Table 3-2, entry 2). Black represents 
experiment 3 (Table 3-2, entry 3) 
 
However, the number average molecular weights determined from GPC (Mn 
GPC) was much higher compared to the theoretical molecular weights (Mn 
Theoretical) based on monomer conversion (Table 3-2). Also, polymers had 
slightly broad molecular weight distributions. These results suggested that GPC 
with polystyrene standard and CHCl3 as the solvent may not a proper method 
for characterising this kind of polymer. Further GPC investigation may need by 
using more closely matched calibration standard rather than polystyrene. 
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3.3.1.4 Quaternisation of p(DMAEMA) (P2)199, 200, 190 
 
Figure 3-17. Reaction scheme for quaternisation of p(DMAEMA) (P2). 
 
In a round bottom flask with a magnetic stirring bar, p(DMAEMA) 
homopolymer (3 g) was dissolved in tetrahydrofuran (THF) (90 mL). The flask 
was sealed with a rubber septum and a molar equivalent of methyl iodide 
calculated was added via syringe. The mixture was left to react for 48 hours at 
room temperature. The color of the reaction mixture changed from dark yellow 
to light yellow. After this time the flask was opened and the solvent was 
removed under reduced pressure to yield a light yellow solid. Then around 10 
mL of deionised water was added and freeze dried to yield the desired polymer. 
1H-NMR (400 MHz, D22 į SSP -4.31 (m, 2H, OCH2-quatersied 
DMAEMA), 4.23-4.08 (m, 2H, OCH2-DMAEMA), 4.00-3.64 (m, 2H, 
CH2N(CH3)3), 3.41-3.03 (m, 9H, N(CH3)3), 2.94-2.80 (m, 2H, CH2N(CH3)2), 
2.54-2.33 (m, 6H, N(CH3)2), 2.19-1.77 (m, 4H, CH2-MA backbone), 1.23-0.71 
(m, 6H, CH3-MA). IR Ȟ FP-1) 3433 (R4N+), 2952 (C-H), 1720 (C=O), 1468 
(C-H), 1261, 1141 (C-O), 1226 (C-N), 946 (C-C). 
In this study, a modification was carried out on p(DMAEMA) (P2) to introduce 
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permanent positive charges by the addition of a methyl group to the 
p(DMAEMA) tertiary amine repeating unit with CH3I, i.e. quaternisation. The 
degrees of quaternisation were targeted at 25 %, 50 %, 75 % and 100 %. 
Characterisation was carried out by 1H-NMR and IR. An example of 1H-NMR 
spectra is shown in Figure 3-18. The experimental level of quaternisation was 
calculated through 1H-NMR by comparing relevant peaks in the quaternised 
(Figure 3-18, signal g) and un-quaternised p(DMAEMA) repeating units 
(Figure 3-18, signal d). 
 
Figure 3-18. 1H-NMR spectra for quaternised p(DMAEMA) (P2). 
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Figure 3-19. Representative FTIR for quaternised p(DMAEMA) (P2). 
 
3.3.1.5 Poly[2-(dimethylamino)ethyl methacrylate-stat-poly(ethylene glycol) 
methyl ether methacrylate475] [p(DMAEMA-stat-PEGMA475)] (P3)190,191,201 
 
Figure 3-20. Reaction scheme for the synthesis of a random copolymer: 
p(DMAEMA-stat-PEGMA475) (P3) via ATRP. 
 
2,2-Bipyridine (0.02 g, 0.14 mmol), DMAEMA (0.11 g, 0.70 mmol), 
PEGMA475 (3.01 g, 6.34 mmol), toluene (3.12 mL), methyl 2-bromopropionate 
(MBrP) (0.01 g, 0.07 mmol) and Cu(I)Br (0.01 g, 0.07 mmol) were added to a 
10 mL tube fitted with a two way stopcock and sealed with a septum and 
placed into an oil bath at 70 °C for 5 h 50 min. The reaction mixture was 
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passed through aluminum oxide and washed through with chloroform to 
remove the catalyst. The polymer was precipitated in a 100:1 excess of 
petroleum ether to remove the un-reacted monomer. This produced 0.78 g of 
polymer (25 % yield). 1H-NMR (400 MHz, CDCl3įSSP-4.05 (m, 4H, 
CO-OCH2) (both), 3.92-3.61 (m, 2xH, CO-OCH2-(CH2)xO-CH3), 3.60-3.51 (m, 
3H, OCH3), 2.52-2.32 (m, 2H, CH2N), 2.15-1.90 (m, 6H, N(CH3)2), 1.31-0.85 
(m, 4H, CH2-MA backbone) (Appendix Page 331). 
Figure 3-21 shows an example of 1H-NMR spectra for the polymerisation of 
DMAMEA and PEGMA475 to yield p(DMAEMA-stat-PEGMA475) (P3). 
Overall monomer conversion was calculated from 1H-NMR spectra (Figure 
3-21, signals a and b) by comparing the vinyl proton signals from the 
monomers (5.4-6.4 ppm) to the overall integration across the range 4.1 to 4.6 
ppm (Figure 3-21, signals c and f). 
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Figure 3-21. 1H-NMR spectra for the polymerisation of DMAMEA and 
PEGMA475 to yield p(DMAEMA-stat-PEGMA475) (P3). Top: Reaction mixture 
at the beginning of the polymerisation (T0). Bottom: Reaction mixture at 350 
min of the polymerisation (T350 min). 
 
A random copolymer of DMAEMA and PEGMA475 was synthesised via ATRP 
method as above and selected properties are shown in Table 3-3. With the ratio 
of [DMAEMA]:[PEGMA475]:[Initiator] = 10:90:1, the polymerisation of 
p(DMAEMA-stat-PEGMA475) (P3) proceeded slowly, only 25 % of conversion 
was achieved after 6 h, and the PDI measured by GPC was found about 1.29. 
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Further experiments with a longer reaction time or different 
[DMAEMA]:[PEGMA475]:[Initiator] ratios may need to be carried out. 
Table 3-3. Summary of synthesis of p(DMAEMA-stat-PEGMA475) (P3) 
DMAEMA PEGMA475 Conversion Time (min) Mn (GPC) PDI 
10 % 90 % 25 % 350 52915 1.29 
Experimental conditions: 70 °C; Monomers/Toluene=1:1 (w/v); 
[I]/[CuBr]/[Bipy])=1/1/2. GPC analysis (chloroform, poly(styrene) standards). 
Polydispersity index (PDI) from GPC. 
 
3.3.2 Reversible addition-fragmentation chain transfer polymerisation 
(RAFT) method 
General protocol for RAFT polymerisation:202 
2-(ethylthiocarbonothioylthio)-2-methylpropanoic acid (CAT) was employed 
as the 5$)7 DJHQW ƍ-azobis(4-cyanovaleric acid) (V-501) as the initiator. 
Polymerisations were conducted in round bottom flasks sealed with a rubber 
septum and parafilm. An NMR spectrum was recorded at the beginning of the 
experiment. The polymerisation solutions were degassed using argon for at 
least 10 min and transferred to an oil bath preheated to 70 °C. After reaction, 
the solution was quenched by cooling in ice-water and opening to air. Another 
NMR spectrum was recorded to enable calculation of degree of conversion. 
The polymer was purified by dialysis in water with dialysis membrane 
(MWCO 1000). The molar mass of all the polymers made was estimated from 
the monomer conversion and GPC data. For the removal of a RAFT end-group, 
the reaction was carried out at 70 °C. 
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3.3.2.1 Polymer conversion calculations 
The overall monomer conversion was calculated by 1H-NMR spectra by 
comparing the vinyl proton signals from the monomers (5.6 and 6.1 ppm) to 
the overall integration from CHCl3 (around 7.26 ppm) (50 µL was added to 
each NMR sample as the standard for calculation) in the case of 
(meth)acrylamide-based monomers, including DMAPMAm, AMPS, 2-AmAA 
and 4-AmBA. 
 
3.3.2.2 Poly[N-(3-(dimethylamido)propyl)methacrylamide] 
[p(DMAPMAm)] (P4) 
 
Figure 3-22. Reaction schemes for the synthesis of p(DMAPMAm) (P4) via 
RAFT method and the removal of RAFT end-group. 
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In a typical RAFT polymer synthesis experiment, DMAPMAm (1000 mg, 
5.874 mmol, 0.75 M) in acetate buffer solution (10 mM, 6.768 mL), 
2-(ethylthiocarbonothioylthio)-2-methylpropanoic acid (CAT) (0.059 mmol, 
0.24 M) in ethanol (0.245 mL) and V-501 (1.65 mg, 0.006 mmol, 0.03 M) in 
ethanol (0.196 mL) were prepared separately and then mixed together (to make 
a final ratio 100:1 of monomer to RAFT agent). The polymerisation was 
carried out overnight. The p(DMAPMAm)-RAFT was purified by dialysis 
against water and recovered as a light yellow powder (716.8 mg, 72 %) after 
freeze-drying from water (3 days). The p(DMAPMAm)-RAFT polymer (428 
mg) in water and V-501 (258 mg) in ethanol were prepared separately and then 
mixed together (to make a final ratio 1:30 of polymer to initiator). In order to 
remove the RAFT end-group, this mixture was degassed and reacted at 70 ºC 
overnight. The title compound p(DMAPMAm) (P4) was purified by dialysis 
against water and recovered as a white powder (369 mg, 86 %) after 
freeze-drying from water (3 days). 1H-NMR (400 MHz, D2O) į SSP
3.33-2.95 (m, 4H, NH-CH2-CH2-CH2), 2.96-2.71 (m, 6H, N(CH3)2), 2.04-1.48 
(m, 2H, NH-CH2-CH2), 1.18-0.69 (m, 2H, CH2-MAm backbone). IR ȞFP-1) 
3329 (N-H), 2963, 2687 (C-H), 1618 (C=O), 1522 (N-H), 1462 (C-H), 1202 
(C-N). The spectra of 13C-NMR of monomer DMAPMAm and GPC of 
polymer p(DMAPMAm) are shown in Appendix Page 332. 
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Figure 3-23. 1H-NMR spectra for the polymerisation of DMAPMAm to yield 
p(DMAPMAm) (P4). Top: Monomer DMAPMAm. Bottom: Purified polymer 
p(DMAPMAm) (P4). 
 
Figure 3-24. Representative FTIR for p(DMAPMAm) (P4). 
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P(DMAPMAm) (P4) homopolymers were synthesised using the general 
polymerisation procedure as described above. In the reaction conditions, CAT 
was used as chain transfer agent (CTA) and V-501 was used as a water-soluble 
initiator. DMAPMAm monomer was initially dissolved in 10 mM acetate 
buffer solution pH 5.5. CAT and V-501 were dissolved in ethanol to reach the 
concentration of 0.24 M and 0.03 M respectively as stock solutions. The above 
three portions were mixed to get a final molar ratio of 100:1:0.1 
(monomer:CAT:V-501) and monomer concentration of 0.75 M. Temperature 
was controlled to be 70 °C all through the reaction. After 16 hours reaction, the 
mixture was cloudy and hard to dissolve in any solvent. This phenomenon 
suggested that polymerisation was occurred. In order to obtain polymers with 
different molecular weights, synthesis of p(DMAPMAm) (P4) with three 
targeted degrees of polymerisation (DPs) 50, 100 and 200 were carried out. 
The stock solutions of CAT and initiator were fresh made for each 
polymerisation. Also, the oxygen-excluding process was checked and carried 
out very carefully. Cationic aqueous GPC was used to characterise 
p(DMAPMAm) (P4). A summary of properties for the synthesis of 
p(DMAPMAm) (P4) is shown in Table 3-4. Generally the conversion was 
above 70 % after 16 h 
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Table 3-4. Summary of synthesis of p(DMAPMAm) (P4) via RAFT 
No. [M]:[CAT]a DPb Conversion (1H-NMR) 
Time 
(h) 
Mn 
(GPC) PDI 
1a 
1b 50 
45 
38 
91 % 
77 % 
16 
19 
- 
5820 
- 
1.43 
2a 
2b 
2c 
100 
27 
88 
83 
27 % 
88 % 
83 % 
2.5 
16 
19 
- 
- 
9253 
- 
- 
1.50 
3a 
3b 200 
167 
150 
84 % 
75 % 
16 
19 
- 
15641 
- 
1.69 
a
 Molar ratio of [Monomer]:[Initiator] (targeted DP). b The actual degree of 
polymerisation (DP) in the brackets is the final value calculated from 1H-NMR. 
GPC analysis (eluent-200 mM NaCl with 0.1 % trifluoroacetic acid, 
polyvinylpyrrolidone standards). Polydispersity index (PDI) from GPC. 
 
3.3.2.3 Poly(2-acrylamido-2-methyl-1-propanesulfonic acid) [p(AMPS)] 
(P5)  
 
Figure 3-25. Reaction schemes for the synthesis of p(AMPS) (P5) via RAFT 
method and the removal of RAFT end-group. 
 
 
CHAPTER 3. Preparation and Characterisation of Monomers and Polymers 
131 
 
Similar RAFT experiment as DMAPMAm was carried out. AMPS (1000 mg, 
4.83 mmol, 0.75 M) in acetate buffer solution (10 mM, 6.43 mL), CAT (0.048 
mmol, 0.24 M) in ethanol (0.2 mL) and V-501 (1.4 mg, 0.005 mmol, 0.03 M) 
in ethanol (0.167 mL) were prepared separately and then mixed together (to 
make a final ratio 100:1 of monomer to RAFT agent). The polymerisation was 
carried out overnight. The p(AMPS)-RAFT was purified by dialysis against 
water and recovered as a light yellow powder (869 mg, 87 %) after 
freeze-drying from water (3 days). The p(AMPS)-RAFT (255 mg) in water and 
V-501 (200 mg) in ethanol were prepared separately and then mixed together 
(to make a final ratio 1:30 of polymer to initiator). In order to remove the 
RAFT end-group, this mixture was degassed and reacted at 70 ºC overnight. 
The title compound p(AMPS) (P5) was purified by dialysis against water and 
recovered as a white powder (230 mg, 90 %) after freeze-drying from water (3 
days). 1H-NMR (400 MHz, D22įSSP-7.20 (m, 1H, NH), 3.65-3.02 (m, 
2H, CH2-SO3H), 2.27-1.84 (m, 1H, CH-Am backbone), 1.61-1.30 (m, 6H, 
C(CH3)2). IR ȞFP-1) 3298 (N-H), 2916 (C-H), 1638 (C=O), 1531 (N-H), 1439 
(C-H), 1368 (C-N), 1179, 1040 (SO2), 621 (S-O). The spectra of 13C-NMR of 
monomer AMPS and GPC of polymer p(AMPS) are shown in Appendix Page 
333. 
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Figure 3-26. 1H-NMR spectra for the polymerisation of AMPS to yield 
p(AMPS) (P5). Top: Monomer AMPS. Bottom: Purified polymer p(AMPS) 
(P5). 
 
Figure 3-27. Representative FTIR for p(AMPS) (P5). 
 
P(AMPS) (P5) homopolymers were synthesised by using the general 
polymerisation procedure as described above. After 3 hours reaction, the 
mixture was cloudy and hard to dissolve in any solvent. This phenomenon 
suggested that polymerisation was occurred. In order to obtain polymers with 
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different molecular weights, synthesis of p(AMPS) homopolymer with four 
targeted degrees of polymerisation (DPs) 40, 70, 100 and 200 were carried out, 
generally the conversion was above 75 %. Aqueous GPC was used to 
characterise p(AMPS) (P5). A summary of synthesis of pAMPS (P5) is shown 
in Table 3-5. 
Table 3-5. Summary of synthesis of p(AMPS) (P5) via RAFT 
No. Monomer DPa Conversion (1H-NMR) 
Time 
(h) 
Mn 
(Theoretical) 
Mn 
(GPC) PDI 
1 AMPS 38 96 % 2 8100 - - 
2 AMPS 53 75 % 1 11208 - - 
3 AMPS 99 99 % 3 20120 21787 1.14 
4 AMPS 200 100 % 16 41674 47561 1.19 
a The actual degree of polymerisation (DP) in the brackets is the final value 
calculated from 1H-NMR. Theoretical, from monomer/initiator ratio and 
monomer conversion. GPC analysis (eluent-DPBS, poly(ethylene oxide) 
standards). Polydispersity index (PDI) from GPC. 
 
3.3.2.4 Poly(2-acrylamidoacetic acid) [p(2-AmAA)] (P6) 
 
Figure 3-28. Reaction schemes for the synthesis of p(2-AmAA) (P6) 
homopolymer via RAFT method and the removal of RAFT end-group. 
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2-AmAA (1000 mg, 7.75 mmol, 0.75 M) in acetate buffer solution (10 mM, 
10.3 mL), CAT (0.077 mmol, 0.24 M) in ethanol (0.322 mL) and V-501 (2.17 
mg, 0.008 mmol, 0.03 M) in ethanol (0.226 mL) were prepared separately and 
then mixed together. The polymerisation was carried out for 3 h. The polymer 
was purified by dialysis against water and recovered as a light yellow powder 
(542 mg, 54 %). In order to remove the RAFT end-group, the 
p(2-AmAA)-RAFT polymer (542 mg) in water and V-501 (150 mg) in ethanol 
were prepared separately and then mixed together. The title compound 
p(2-AmAA) was purified by dialysis against water and recovered as a white 
powder (490.8 mg, 91 %) after freeze-drying from water (3 days). 1H-NMR 
(400 MHz, D22 į SSP -3.27 (m, 2H, NH-CH2), 2.38-1.88 (m, 1H, 
CH-Am backbone), 1.79-1.17 (m, 2H, CH2-Am backbone). IR Ȟ FP-1) 3250 
(N-H), 2932 (C-H), 1549 (N-H), 1383 (C-O), 1233 (O-H), 1018 (C-N). The 
GPC spectra of polymer p(2-AmAA) are shown in Appendix Page 334. 
 
Figure 3-29. 1H-NMR spectra for p(2-AmAA) (P6). 
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Figure 3-30. Representative FTIR for p(2-AmAA) (P6). 
 
P(2-AmAA) (P6) homopolymers were also prepared by using the above 
polymerisation procedure similar as described in section 3.3.2.2. Table 3-6 
shows some properties of p(2-AmAA) (P6) prepared in this study. Synthesis of 
p(2-AmAA) homopolymer with several targeted degrees of polymerisation 
(DPs) 20, 50, 100 and 200 were carried out. Aqueous GPC was used to 
characterise p(2-AmAA) (P6). 
Table 3-6. Summary of synthesis of p(2-AmAA) (P6) via RAFT 
No. Monomer DPa Conversion (1H-NMR) 
Time 
(hours) 
Mn 
(Theoretical) 
Mn 
(GPC) PDI 
1 2-AmAA 18 90 % 3 2322 2501 - 
2 2-AmAA 46 80 % 2.5 6158 6153 1.07 
3 2-AmAA 72 72 % 2.5 9296 14513 1.05 
4 2-AmAA 150 75 % 16 19350 26205 1.09 
a The actual degree of polymerisation (DP) in the brackets is the final value 
calculated from 1H-NMR. Theoretical, from monomer/initiator ratio and 
monomer conversion. GPC analysis (eluent-DPBS, poly(ethylene oxide) 
standards). Polydispersity Index (PDI) from GPC. 
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3.3.2.5 Poly(4-acrylamidobutanoic acid) [p(4-AmBA)] (P7) 
 
Figure 3-31. Reaction schemes for the synthesis of p(4-AmBA) (P7) 
homopolymer via RAFT method and the removal of RAFT end-group. 
 
4-AmBA (2000 mg, 12.7 mmol, 0.75 M) in acetate buffer solution (10 mM, 
17.0 mL), CAT (0.127 mmol, 0.24 M) in ethanol (0.529 mL) and V-501 (3.57 
mg, 0.013 mmol, 0.03 M) in ethanol (0.372 mL) were prepared separately and 
then mixed together. The polymerisation was carried out overnight. The 
polymer was purified by dialysis against water and recovered as a light yellow 
powder (1804 mg, 90 %) after freeze-drying from water (3 days). The 
p(4-AmBA)-RAFT polymer (200 mg) in water and V-501 (150 mg) in ethanol 
were prepared separately and then mixed together to remove the RAFT 
end-group. The title compound p(4-AmBA) was purified by dialysis against 
water and recovered as a white powder (192.2 mg, 96 %) after freeze-drying 
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from water (3 days). 1H-NMR (400 MHz, D22 į SSP -2.92 (m, 2H, 
NH-CH2), 2.29-2.14 (m, 2H, CH2-COOH), 2.00-1.79 (m, 1H, CH-Am 
backbone), 1.79-1.57 (m, 2H, CH2-CH2-CH2), 1.58-1.25 (m, 2H, CH2-Am 
backbone). IR Ȟ FP-1) 3240 (N-H), 2916 (C-H), 1636 (C=O), 1535 (N-H), 
1395 (C-O), 1175 (O-H), 1042 (C-N). The GPC spectra of polymer p(4-AmBA) 
are shown in Appendix Page 334. 
 
Figure 3-32. 1H-NMR spectra for p(4-AmBA) (P7). 
 
Figure 3-33. Representative FTIR for p(4-AmBA) (P7). 
 
D2O 
a 
c 
b 
e d 
CHAPTER 3. Preparation and Characterisation of Monomers and Polymers 
138 
 
Similar as described in section 3.3.2.2, p(4-AmBA) (P7) homopolymers were 
synthesised with four targeted (theoretical) DPs 20, 50, 100 and 200. Aqueous 
GPC was used to characterise p(4-AmBA) (P7). Generally the conversion was 
around 90 % as shown in Table 3-7. 
Table 3-7. Summary of synthesis of p4-AmBA (P7) via RAFT 
No. Monomer DPa Conversion (1H-NMR) 
Time 
(h) 
Mn 
(Theoretical) 
Mn 
(GPC) PDI 
1 4-AmBA 21 92 % 3 3521 3492 1.09 
2 4-AmBA 50 100 % 16 8074 10829 1.04 
3 
4 
4-AmBA 
4-AmBA 
100 
200 
100 % 
100 % 
16 
16 
15924 
31624 
16804 
31132 
1.09 
1.06 
a The actual degree of polymerisation (DP) in the brackets is the final value 
calculated from 1H-NMR. Theoretical, from monomer/initiator ratio and 
monomer conversion. GPC analysis (eluent-DPBS, poly(ethylene oxide) 
standards). Polydispersity index (PDI) from GPC. 
 
3.3.3 Poly[[2-(methacryloyloxy)ethyl]trimethylammonium 
chloride-co-N-[2-(methacryloyloxy)ethyl]-dimethyl-(2-sulfoethan)aminium 
hydroxide] [p(METMAC-co-MEDSAH)] (P8) 
A cationic/zwitterionic copolymer of 
[2-(methacryloyloxy)ethyl]trimethylammonium chloride and 
N-[2-(methacryloyloxy)ethyl]-dimethyl-(2-sulfoethan)aminium hydroxide 
[p(METMAC-co-MEDSAH)] (P8) was synthesised and kindly supplied by Dr. 
Eugene Peter Magennis. Molar ratio of METMAC: MEDSAH was 1:1. 
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Figure 3-34. Reaction scheme for the synthesis of p(METMAC-co-MEDSAH) 
(P8) by Dr. Eugene Peter Magennis. 
 
To a reaction flask, 144 mg (0.695 mmol) of METMAC, 194 mg (0.695 mmol) 
RI0('6$+PJȝPRORI-(N-Morpholino)ethyl-2-bromobutyrate 
(1), 200 ȝ/ of a 0.069 M aqueous solution with CuBr2 and 
Tris(2-pyridylmethyl)amine (TPA), and 50 ȝ/ of DMSO were added. This 
mixture was degassed for 30 minutes over ice after which 270 ȝ/ of a degassed 
1 mg/mL solution of ascorbic acid were added to begin the polymerisation. The 
polymerisation was monitored by 1H-NMR spectroscopy over time and 
terminated by exposing to air. The polymers were obtained by dialysis against 
water for 3 days followed by freeze drying to yield a white amorphous solid 
(P8). 1H-NMR (D2O  0+] į SSP 4.49 (m, 4H, COCH2) (METMAC 
and MEDSHA), 3.78 (m, 4H, NCH2) (METMAC and MEDSAH), 3.60 (m, 2H, 
N(CH3)2CH2) (MEDSAH), 3.2 (m, 15H, N(CH3)) (both), 2.98 (m, 2H, CH2SO3) 
(MEDSAH), 2.28 (m, 2H, CH2CH2CH2) (MEDSAH), 2.30-1.75 (m, 4H, 
CH2-MA) (METMAC and MEDSAH), 0.99-2.00 (m, 6H, CH3) (METMAC 
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and MEDSAH). IR Ȟ FP-1) 3393 (R4N+), 2941 (C-H), 1715 (C=O), 1474 
(C-H), 1153, 1032 (SO2), 946 (C-C), 713 (S-O). 
 
Figure 3-35. Representative 1H-NMR spectra of p(METMAC-co-MEDSAH) 
(P8) by Dr. E. Peter Magennis. 
 
 
Figure 3-36. Representative FTIR for p(METMAC-co-MEDSAH) (P8). 
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3.4 General discussion and conclusions 
As mentioned in Introduction Chapter, the effects of polymers on protein 
crystallisation are expected to depend strongly on the polymer functionalities. 
)URP SUHYLRXV UHVHDUFKHUV¶ VWXGLHV 3(* KDV EHHQ IRXQG WR EH DQ HIIHFWLYH
additive in promoting the crystallisation of a range of proteins.124, 125 However, 
the PEG has a high molecular weight limitation of around 40 kDa,203 because 
PEG above that molecular weight will no longer cleared from the kidney.204 
Moreover, PEG itself has limited chemical functionality, and cannot be 
derivatised easily to introduce groups which can form specific bonds with 
protein peptide residues. We thus chose poly(ethylene glycol) methyl ether 
methacrylate475 (PEGMA475), as a neutral methacrylate derivative of PEG to 
obtain a polymer, p(PEGMA475) (P1), analogous to PEG but with hydrophilic 
side-chain functionality and a hydrophobic main-chain. The PEGMA exhibits a 
similar biocompatible profile as PEG however since the PEG side chain of the 
PEGMA is linked by a cleavable ester bond the size limitations for 
poly(PEGMA) will not be the same as for PEG. Moreover, 
poly(PEGMA)-based materials have been shown to mediate protein 
crystallisation in solution.108 
To test the effects of varying degrees of charge on protein crystallisation, 
monomers containing tertiary amines groups were selected to afford positive 
charges, including one methacrylate monomer 2-(dimethylamino)ethyl 
methacrylate (DMAEMA) was either homopolymerised (P2) and quaternised 
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or copolymerised with PEGMA475 (P3) and one methacrylamide monomer 
N-(3-(dimethylamido)propyl)methacrylamide (DMAPMAm), which was also 
homopolymerised (P4) to form cationic polymers. The tertiary amines 
functionalities were designed to enhance water solubility of the polymers205 
and also to provide lone-pair donor or charged residues dependent on pH and 
degree of protonation or quaternisation.  
Anionic polymers were chosen according to the pKa of the polymers, and also 
by considering the protein crystallisation pH, such that the polymers could 
provide charged residues under relevant crystallising conditions. We chose 
three acrylamide-based main chain monomers, including 
2-acrylamido-2-methyl-1-propanesulfonic acid (AMPS), 2-acrylamidoacetic 
acid (2-AmAA) and 4-acrylamidobutanoic acid (4-AmBA), due to the presence 
of ionisable sulfonic acid or carboxyl groups, which could introduce of some 
negative charges and generate anionic water soluble homopolymers (P5-7). 
Moreover, a cationic/zwitterionic copolymer of 
[2-(methacryloyloxy)ethyl]trimethylammonium chloride (METMAC) and 
N-[2-(methacryloyloxy)ethyl]-dimethyl-(2-sulfoethan)aminium hydroxide 
(MEDSAH) with both positive charges and zwitterionic components was 
prepared in order to span an even wider range of charge-charge interactions 
(P8). 
P(PEGMA475) (P1), p(DMAEMA) (P2), and a random copolymer of 
p(DMAEMA-stat-PEGMA475) (molar ratio of 1:9) (P3) were prepared by a 
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variant of published ATRP route, which has been used for the synthesis of 
methacrylate monomers showing fast ATRP kinetics with low polydispersities 
by using Cu(I)Br/2,2-bipyridine (Bipy) catalytic system and methyl 
2-bromopropionate (MBrP) as the initiator.143 N-Methylation of p(DMAEMA) 
with different degrees of quaternisation was carried out to vary the total 
permanent cation content by the addition of a methyl group to the tertiary 
amine repeating unit with CH3I according to literature procedure.199, 200 CHCl3 
was employed for the GPC analysis of those methacrylate polymers. However, 
those polymers produced had slightly broad PDIs from GPC analysis. Also the 
Mn differed from that calculated by 1H-NMR, is explained by the conventional 
calibration used on the GPC. This broadening suggests that more closely 
matched calibration standard rather than polystyrene may need in the future 
studies. 
Monomers 2-AmAA and 4-AmBA were prepared in good yields and high 
purity by modified literature protocols.190, 191 P(DMAPMAm) (P4), p(AMPS) 
(P5), p(2-AmAA) (P6) and p(4-AmBA) (P7) were synthesised using RAFT 
methods according to protocols described in the literature,202 because RAFT 
polymerisation is probably the most versatile and suitable for the synthesis of 
acrylamide based polymers.206 The polymerisation employed 
2-(Ethylthiocarbonothioylthio)-2-methylpropanoic acid (CAT) as RAFT agent 
DQG ƍ-azobis(4-cyanovaleric acid) (V-501) as the initiator. Aqueous 
conditions (eluent-200 mM NaCl with 0.1 % TFA or DPBS) were applied for 
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the GPC analysis of those (meth)acrylamide polymers. It is known that RAFT 
agent reacts with a propagating polymer chain and forms a macro-RAFT agent. 
In order to preclude the influence of dithioester on proteins, we used the same 
initiator to substitute dithioester on the polymer. A cationic/zwitterionic 
copolymer of p(METMAC-co-MEDSAH) (P8) was kindly supplied by Dr. E. 
Peter Magennis; METMAC: MEDSAH molar ratio is 1:1. 
In these ways, four classes of materials, including neutral, cationic, anionic and 
cationic/zwitterionic polymers based on methacrylate or (meth)acrylamide 
monomers with varying degrees of charge, molecular weight and backbone 
structure were successfully prepared and then investigated for crystallisation 
studies. 
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CHAPTER 4 
 
4. Application of Polymers to Hen Egg-white Lysozyme (HEWL) 
Crystallisation 
4.1 Introduction 
As µChapter 3¶ mentioned, four classes of materials, including neutral, cationic, 
anionic and cationic/zwitterionic polymers based on methacrylate or 
(meth)acrylamide monomers were successfully prepared. In the present chapter 
their effect as additives in crystallisation of HEWL is investigated. 
The first model protein was hen egg-white lysozyme (HEWL), as this protein 
has become the most preferred crystallisation system for the majority of protein 
crystallisation studies. It is readily available and relatively straightforward to 
crystallise in a specific polymorph (the tetragonal form) within one day. We 
then designed experimental protocols to investigate the effects of polymers on 
protein crystal size, crystal packing motifs, and polymorphic forms under 
crystallisation conditions normally favouring the tetragonal HEWL polymorph. 
The isoelectric point (pI) of HEWL is 11.35, therefore when at its 
crystallisation pH 4.8, HEWL macromolecules are positively charged, i.e. 
cationic (Table 4-1).152 
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Table 4-1. Summary of hen egg-white lysozyme (HEWL) 
a Isoelectric point (pI) is the pH at which a particular molecule or surface 
carries no net electrical charge. 
 
In order to investigate the effects of polymers on protein crystallisation, such as 
the use of polymers to help proteins crystallise, or the use of polymers to guide 
proteins to associate into protein-protein dimer, trimer and higher order 
complexes, we prepared different classes of polymers with varying degrees of 
charge, molecular weight and backbone structure, and then studied their role as 
additives in model protein solutions. The guiding hypothesis was that select 
functional polymers in the solution could enhance the rate of protein 
crystallisation from solutiRQV DV ZHOO DV LQÀXHQFH PRUSKRORJ\ VKDSH VL]H
habit and polymorph of the crystal. A simple hypothesis linking polymer 
structure and charge to the effect on protein crystallisation is proposed and 
shown in Figure 4-1. Details will discuss later. Protein crystallisation 
experiments were performed on 96-well plates, by using the sitting drop vapour 
diffusion technique. 
Protein pIa Mw (kDa) Crystallisation pH 
HEWL 
11.35 14.3 4.8 
CHAPTER 4. Application of Polymers to Hen Egg-white Lysozyme (HEWL) 
Crystallisation 
147 
 
 
Figure 4-1. Schematic representation of the interaction of various polymers 
with cationic HEWL in the protein crystallisation process. (A) Neutral polymer: 
H-bonding with water and thus promoting protein crystallisation via a 
dehydration mechanism. (B) Cationic polymer: charge-charge repulsions 
between cationic polymer and cationic HEWL. (C) Anionic polymer: attracting 
cationic HEWL for charge compensation. HEWL macromolecules are 
positively charged at tetragonal crystallisation pH of 4.8, i.e. cationic. Cl- ions 
are derived from the crystallisation buffer solutions. 
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4.2 Methods 
4.2.1 Crystallisation technique and plate 
The technique used for protein crystallisation was the sitting drop vapour 
diffusion method, which is the most popular, as it can be used to screen a broad 
range of crystallisation conditions, using small amounts of materials, but can 
also be scaled up in order to obtain large crystals for X-ray diffraction analysis. 
MRC 2 Well Crystallisation Plates (Swissci) (UVP plate, 96 reservoir wells, 
reservoir volume: 50 to 100 µl, with 2 corresponding sample wells: 5 µl max 
fill volume) were purchased from Hampton Research (Figure 4-2). Specifically, 
a solution (50 µL) of tested polymer buffer was pipetted in triplicate in the 
reservoir wells. Protein solution (1 µL) and buffered polymer solution (as 
described above, 1 µL) were pipetted into sample wells of the crystallisation 
plate. Generally, a drop of 1:1 protein: polymer solution was usually used here. 
 
Figure 4-2. MRC 2 Well Crystallisation Plate (Swissci), commercially 
available from Hampton Research. 
Sample well 
 
Reservoir well 
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The entire crystallisation plate system was sealed using transparent sealing tape 
(with a chemically inert adhesive). This prevents solvent being lost to the 
external environment. The differences in polymer and ions concentration 
between the drop and the reservoir solution causes water to evaporate from the 
drop, resulting in an increase of the supersaturation level within the sitting drop. 
This continues until the concentration of the polymer in the drop is the same as 
in the reservoir well solution. Thus, equilibration takes place through the 
vapour phase. Over time, protein nucleation will take place (Figure 4-3). 
 
Figure 4-3. Diagram depicting the sitting drop vapour diffusion technique. The 
reservoir has usually twice the polymer concentration than the sitting drop. 
Water vapour diffusion takes place in a single well environment. 
 
At the beginning of the experiment, water vapour diffusion from the sitting 
drop to the reservoir solution causes a reduction in the volume of the sitting 
drop, which in turn increases the supersaturation level of all the solutes within 
it. Over time, the rate of supersaturation eventually decreases due to the 
precipitation of protein or other solutes (Figure 4-4). 
CHAPTER 4. Application of Polymers to Hen Egg-white Lysozyme (HEWL) 
Crystallisation 
150 
 
 
Figure 4-4. The schematic representation of real-time protein concentration 
changes in the sitting drop.207 
 
4.2.2 Preparation of polymer solutions and stock buffer solutions 
Four classes of polymers including neutral, cationic, anionic and 
cationic/zwitterionic shown below were applied for HEWL crystallisation: 
¾ P(PEGMA475) (P1) ± Neutral; 
¾ Quaternised p(DMAEMA) (P2): 
Degrees of quaternisation: 25 %, 50 %, 75 % and 100 %; 
¾ A random copolymer [p(DMAEMA-stat-PEGMA475)] (P3); 
¾ P(DMAPMAm) (DPs: 38, 83 and 150) (P4); 
¾ P(AMPS) (DPs: 53, 99 and 200) (P5);  
¾ P(2-AmAA) (DPs: 18, 46, 72 and 150) (P6);  
¾ P(4-AmBA) (DPs: 21, 50, 100 and 200) (P7); 
¾ P(METMAC-co-MEDSAH) (P8) ± Cationic/zwitterionic. 
 
 
Cationic 
Anionic 
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The stock polymer solutions in H2O at a concentration of ~ 40 % (w/v) were 
prepared. In order to use polymers as part of the reservoir and sample solutions 
in HEWL crystallisation, it was necessary, to alter the pH to around 4.8,160 
which is chosen from the optimum pH (4.2-4.8) for the tetragonal 
crystal-inducing protocol of HEWL; and also considering the solubility of 
polymers. The stock buffer solutions of 0.25 M sodium acetate and 20 % (w/v) 
NaCl at pH 4.8 and 0.1 M sodium acetate at pH 4.8 were also prepared and 
filtered using a 0.2 ȝPFHOOXORVHDFHWDWHPHPEUDQHILOWHU 
By using the above mentioned pH-altered polymer solutions and the stock 
buffer solutions, the following polymer solutions were prepared at a final 
volume of 2 mL, 1 mL, 500 ȝ/ or 250 ȝ/: 0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 
10 %, 12 %, 14 %, 16 %, 18 %, 20 %, 22 % and 24 % (w/v) in 0.25 M sodium 
acetate and 20 % (w/v) NaCl at pH 4.8. All polymers with various 
concentrations were completely dissolved in the buffer solutions. 
 
4.2.3 Crystallisation protocol for tetragonal HEWL crystals160, 208 
HEWL was purchased from Sigma (catalogue number: L6876, EC: 3.2.1.17, pI: 
11.35, lysozyme activity: ~ 50,000 units/mg protein). 0.1 M sodium acetate 
VROXWLRQDWS+ZDVSUHSDUHGDQGILOWHUHGWKURXJKDȝPFHOOXORVHDFHWDWH
membrane filter. This was used to prepare the 50 mg/mL HEWL solution, 
which was then centrifuged at 13,000 rpm for 5 min at 4 °C. 
HEWL crystallisation was performed on a 96-well crystallisation plate, using 
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the sitting drop vapour diffusion technique, grown under conditions favouring 
the tetragonal form. All manual pipetting was conducted on an open lab bench. 
Specifically, 50 ȝ/ of polymer buffer solution (0.25 M sodium acetate and 20 % 
(w/v) NaCl at pH 4.8) was pipetted in triplicate in the reservoir well; 1 ȝ/ of 
protein (50 mg/mL HEWL in 0.1 M sodium acetate solution at pH 4.8) and 1 
ȝ/ polymer buffer solution taken from each reservoir were pipetted into 
corresponding sample well of the crystallisation plate. In each sample well, the 
polymer concentration was half of that in the reservoir well, the final 
concentration of HEWL in each sample well was 25 mg/mL. For control 
purposes, some wells contained no polymer in their solutions. The plate was 
then sealed and incubated at 19 °C. Crystals formed within 1-2 days. 
 
4.2.4 Crystal imaging 
For optical microscopy, HEWL crystals formed in the crystallisation plate were 
directly observed by using a Leica Stereomicroscope, with a Leica fan-cooled 
light source, connected to a Nikon Coolpix 4500 digital camera (4.0 
megapixels). 63 x magnifications were used to obtain the image of the whole 
sample well. Furthermore, in order to compare the effects of those polymers on 
protein crystallisation, we selected polymers with similar DP across the range 
of 80-100 for further image analysis by ImageJ. 
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4.2.5 X-ray crystallography 
In this study, HEWL crystals were determined by single crystal X-ray 
diffraction recorded at room temperature on an X-ray generator with high-flux 
Osmic confocal multi-layer optics. Crystals first were mounted in a loop, 
which is made of plastic or nylon and attached to a solid rod. Thus, HEWL 
crystals for diffraction were cryoprotected with mother liquor containing 30 % 
glycerol, then protein crystals were maintained at temperatures of -180 °C by 
an X-stream 2000 nitrogen vapour system.209, 99, 210 By this freezing process, 
the radiation damage of the X-rays and the noise in the Bragg peaks due to 
thermal motion can be reduced.211 
 
4.2.6 Dynamic light scattering (DLS) studies 
During crystallisation experiments, complex processes take place in the protein 
solution with an increase of supersaturation. The onset and rate of protein 
crystallisation in solution depend on the mechanism of how protein 
macromolecules incorporate with each other.118,212,213 This interaction among 
protein macromolecules can govern them aggregate together to form crystals or 
amorphous aggregates in a period time. 
In the present study, dynamic light scattering (DLS) is a sensitive and widely 
used method to determine the size and mode of aggregation of proteins and 
other biomolecules in solution, by detecting variations in size of 
macromolecules. DLS has already been successfully used to distinguish 
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between protein solutions leading to crystallisation or to amorphous 
precipitation.214 Moreover, it is a very helpful method to screen for the 
probability for crystal formation in the protein solution, for example, dispersity 
analysis to optimize the crystallisation conditions.215,216,217,218 
Therefore, in this research, DLS was applied to monitor model protein 
crystallisation process by determining the particle size directly in the protein 
crystallisation solution. HEWL was crystallised using batch crystallisation 
method, where the protein solution, the protein fully dissolved in the buffer, 
and the precipitant solution (e.g., salts, soluble polymer, and small organic 
molecules) are directly added together, immediately leading to a supersaturated 
protein solution.159 As the time increased, protein aggregates grew in size until 
the critical nucleus was reached and then capable of further growth. The 
increase size of aggregates in the crystallisation solution could be easily 
monitored by DLS. 
Selected polymers with similar DP across the range of 80-100 were employed 
for DLS studies, including p(PEGMA475) (P1), quaternised p(DMAEMA) (P2) 
(quaternised ratio 75 %), a mixture of two polymers: p(PEGMA475) and 
p(DMAEMA) (P1 & P2) (molar ratio 9:1), p(DMAPMAm) (P4) (DP 83), 
p(AMPS) (P5) (DP 99), p(2-AmAA) (P6) (DP 72) and p(4-AmBA) (P7) (DP 
100). For each experiment, 100 ȝ/ of 15 mg/mL HEWL in 0.1 M sodium 
acetate buffer at pH 4.8 was mixed with 100 ȝ/ of 1 mg/mL of polymer in 0.25 
M sodium acetate and 20 % (w/v) NaCl at pH 4.8 directly in the VISCOTEK 
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DLS Quartz cell and then monitored by VISCOTEK DLS (Figure 4-5). 
Temperature: 19 °C; Crystal Growth time: 7 hours.  
 
Figure 4-5. Schematic representation of protein crystallisation in the DLS 
quartz cell. 
 
4.2.7 Scanning electron microscope (SEM) analysis 
Scanning electron microscopy (SEM) is a technique that can be used to tackle 
the limited resolution of optical microscopy. It plays an essential role in the 
study of biological or pharmaceutical crystals.219 The output signals, which 
make up the SEM images, are reflected from an opaque surface. SEM images 
are then formed by topographic contrast. Thus, SEM is a very useful method to 
observe morphological characters of the crystals. 
Representative HEWL crystals grown in the presence of three selected 
polymers from each class, containing neutral p(PEGMA475) (P1), cationic 
quaternised p(DMAEMA) (P2) and anionic p(AMPS) (P5) using sitting drop 
vapor diffusion method, were subjected to SEM analysis in this project. Prior 
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to gold coating, protein crystals were taken out from the crystallisation plates, 
washed with crystallisation buffer solutions (mother liquor). The samples 
(protein crystals) were loaded onto aluminium stubs with carbon tabs 
pre-fixed.220,221 These were then gold coated using an SCD 030 Blazers sputter 
coater for 5 min at 30 mA. The coated samples were transferred into a JEOL 
JSM 6060 LV scanning electron microscope and imaged at 15-30 kV. 
 
4.3 Results and discussion 
4.3.1 HEWL crystallisation in the presence of neutral polymer in solution: 
p(PEGMA475) (P1) 
In order to investigate the influence of neutral p(PEGMA475) (P1) on HEWL 
crystallisation, we set out to prepare neutral p(PEGMA475) (P1) with a range of 
concentrations. By using the above mentioned pH-altered stock buffer solution, 
the following p(PEGMA475) (P1) (Mn~39.4 kDa) solutions with various 
concentration were prepared at a final volume of 1 mL, 500 ȝ/ or 250 ȝ/: 
0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 10 %, 12 %, 14 %, 16 %, 18 %, 20 %, 22 % 
and 24 % (w/v) in 0.25 M sodium acetate and 20 % (w/v) NaCl at pH 4.8. 50 
ȝ/ of polymer buffer solution was pipetted in triplicate in the reservoir well; 1 
ȝ/ of protein (50 mg/mL HEWL in 0.1 M sodium acetate solution at pH 4.8) 
and 1 ȝ/ polymer buffer solution taken from each reservoir were pipetted into 
corresponding sample well of the crystallisation plate. Some sample wells 
contained no polymer as the control. Table 4-2 shows HEWL crystallisation 
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plating method under p(PEGMA475) (P1). 
Table 4-2. HEWL crystallisation plate set up: p(PEGMA475) 
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Figure 4-6 shows the photomicrographs of HEWL crystals obtained in the 
presence of p(PEGMA475) (P1) (Mn~39.4 kDa) with various concentrations, as 
solute in the crystallisation solutions. HEWL crystallisation under conditions 
favouring the tetragonal form resulted in exclusively tetragonal crystals within 
1-2 days without any polymer (Figure 4-6, Control). Neutral p(PEGMA475) (P1) 
nucleated a few large crystals, most of the HEWL crystals were readily 
identified by their distinctive morphology as tetragonal. As the concentration 
of p(PEGMA475) (P1) in solution was increased, a similar increase in size and 
decrease in number of HEWL crystals were found. Moreover, the shape of 
crystals was quite different from that obtained in control experiments. Lower 
concentration of p(PEGMA475) (P1) in solution (< 2 %, w/v) resulted in 
concomitant formation of needles and tetragonal HEWL crystals. However, as 
the concentration of p(PEGMA475) (P1) was increased, only tetragonal crystals 
were formed. It is reported that HEWL needles have formed in solutions with 
high salt concentrations,222 and in the presence of acid-functionalized 
polymeric surfaces, such as cross-linked acrylic acid and methacrylic acid.159 
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p(PEGMA475) (Mn~39.4 kDa) 
 
Figure 4-6. Selected photomicrographs of HEWL crystals, grown in the 
presence of p(PEGMA475) (P1) (Mn~39.4 kDa) at various concentrations. 
,PDJH ODEHOOHGµ&RQWURO¶ UHSUHVHQWVHEWL crystals grown from sample wells 
without polymer. The scale bar was 500 µm. 
 
CHAPTER 4. Application of Polymers to Hen Egg-white Lysozyme (HEWL) 
Crystallisation 
160 
 
Figure 4-7 presents a summary of HEWL crystal size distribution by measuring 
WKHDYHUDJHOHQJWKȝPRIWKHODrgest diameter of each crystal at each polymer 
concentration and number distribution as well. Image analysis of 
photomicrograph data was done by using ImageJ software. There was a clear 
effect on HEWL crystallisation depending on the concentration of neutral 
p(PEGMA475) (P1). For cationic HEWL, as the concentration of neutral 
p(PEGMA475) (P1) in solution was increased, the size of crystals increased and 
the number decreased very clearly. 
 
Figure 4-7. Summary of photomicrograph analysis showing changes in the size 
and number of HEWL crystals, grown in the presence of neutral p(PEGMA475) 
(P1) at various concentrations. D $YHUDJH OHQJWK ȝP RI WKH ODUJHVW FU\VWDO
diameter; b) Experiment count for the number of crystals per sample well. 
 
Diffraction data were collected for HEWL crystals using single crystal X-ray 
diffraction recorded at room temperature. Figure 4-8 illustrates the diffraction 
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patterns of HEWL crystals obtained by X-ray crystallography and Table 4-3 
shows unit cell dimensions of HEWL crystals. Therefore, HEWL 
crystallisation in the presence of neutral p(PEGMA475) (P1) under the 
tetragonal-inducing protocol, resulted in tetragonal crystals, which were 
confirmed by single crystal X-ray diffraction. 
 
Figure 4-8. HEWL crystal photomicrographs and X-ray diffraction patterns 
yielded by the single HEWL crystal in the presence of neutral p(PEGMA475) 
(P1). ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV HEWL crystals grown from sample 
wells without p(PEGMA475) (P1). Two scattering angles: 0±1 degrees and 
90±1 degrees. 
Table 4-3. Unit cell dimensions of HEWL crystals formed in the absence 
(Control) and presence of neutral p(PEGMA475) (P1) 
 a, b, c (Å) ĮȕȖ Volume Unit cell lattice 
Control 78.64, 78.64, 37.07 90°, 90°, 90° 229,289 Tetragonal 
p(PEGMA475) 78.42, 78.42, 37.17 90°, 90°, 90° 228,638 Tetragonal 
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Figure 4-9 shows a summary of DLS data of HEWL crystallisation under 
neutral p(PEGMA475) (P1). Figure 4-9a shows autocorrelation functions, which 
were analysed to obtain the distribution of particle radii, as shown in Figure 
4-9b and Figure 4-9c. At the beginning of the experiment (T0), HEWL 
macromolecules were non-interacting in the solution. The scattering from 
rapidly diffusing small individual macromolecules, only remained correlated 
for very short times and the decay times were short. The average size of the 
particles in the crystallisation solution was around 200 nm, measured by size 
distribution. With the addition of p(PEGMA475) (P1), HEWL crystallisation 
initiated and aggregates formed. As the time increased, HEWL aggregates 
grew in size. Large particles diffused slower than small particles, and the 
correlation function decayed at a slower rate. After 420 minutes (T420min), the 
average size of the particles in the crystallisation solution was around 900 nm. 
The size of pure neutral p(PEGMA475) (P1) in the solution was also 
characterised by DLS and was found at around 7 nm. 
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Figure 4-9. Summary of DLS data of HEWL crystallisation in the presence of 
neutral p(PEGMA475) (P1). Pure neutral p(PEGMA475) (P1) in the solution was 
also characterised by DLS. a) representative autocorrelation functions; b) radii 
distribution by intensity; c) radii distribution by number. 
 
All other DLS data details, including autocorrelation functions and radii 
distribution by intensity at each time points are shown in the Appendix Pages 
335-336. Representative Tukey plots of DLS data show protein aggregates 
growth in size as a function of time during HEWL crystallisation experiments 
 
                   
         
a) 
T=420 min 
T=0 T=420 min 
b) 
c) 
T=0 
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with p(PEGMA475) (P1) (Figure 4-10). After the addition of neutral 
p(PEGMA475) (P1), a characteristic increase in protein aggregate size can be 
observed. For control purpose, HEWL crystallisation experiment in the absence 
of polymer was carried out as well. 
 
Figure 4-10. Variations in the size of HEWL aggregates or crystals in the 
solution as a function of time during crystallisation experiments induced by 
neutral p(PEGMA475) (P1). Control experiment contained no polymer. 
 
HEWL crystals, which grown in the presence of neutral p(PEGMA475) (P1) 
using sitting drop vapor diffusion method were then subjected to SEM analysis. 
The SEM results (Figure 4-11) show that HEWL crystals had not been purified 
completely, there were still some salts left in the samples. However, all images 
showed a striking feature of crystals: all HEWL crystals, formed without 
polymer (Control) or when in the presence of neutral p(PEGMA475) (P1) had 
sharp edges, even though the edges of HEWL crystals with slight etch defects. 
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Figure 4-11. SEM micrographs of HEWL crystals produced under tetragonal 
conditions: a) control, without any polymer. b) in the presence of p(PEGMA475) 
(P1). The scale bar was 100 ȝm.  
 
Compared with optical microscopy images, which protein crystals have 
striking features, including the presence of sharp edges and observation of 
nearly monodisperse crystallites, in SEM the HEWL crystals do not look so 
well defined. This may because of poor mechanical properties and stability of 
protein crystals.223 When protein crystals were taken out from the 
crystallisation plates and washed with crystallisation buffer solution, they were 
not handled easily and dehydrated slightly. Thus, a treatment for improving the 
stability of protein crystals may need in future study. There was insufficient 
time in the thesis period to conclude these experiments, but future work should 
consider this. 
All above results together illustrate that p(PEGMA475) (P1) acted as a solution 
additive and had the ability to influence HEWL crystallisation. We might 
expect that neutral p(PEGMA475), as a neutral methacrylate derivative of PEG, 
was non-ionic and thus would compete with protein solutes for water and 
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dehydrated protein macromolecules.125 Moreover, p(PEGMA475) may have 
µYROXPH-H[FOXGHG HIIHFWV¶ E\ K\GURSKRELF H[FOXVLRQ RI SURWHLQ VROXWHV224 
Neutral polymers of this type could also reduce the dielectric constant of the 
crystallisation solution, leading to an increase of the effective distance over 
which protein electrostatic effects would take place,225 consequently protein 
aggregation and phase separation was promoted.108 In turn, HEWL 
macromolecules may have been more able to associate with each other (Figure 
4-12). 
 
Figure 4-12. Schematic representation of hypothesis of HEWL crystallisation 
process without any polymer (A); and the interaction of p(PEGMA475) (P1) 
with HEWL in the protein crystallisation process (B). HEWL macromolecules 
are positively charged at tetragonal crystallisation pH of 4.8, i.e. cationic. Na+ 
and Cl- ions are derived from the crystallisation buffer solutions. 
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4.3.2 HEWL crystallisation in the presence of cationic polymers in solution 
4.3.2.1 HEWL crystallisation in the presence of quaternised p(DMAEMA) 
(P2) 
Quaternisation was carried out on p(DMAEMA) (P2) to introduce permanent 
positive charges by an addition of a methyl group to the p(DMAEMA) tertiary 
amine repeating unit. We used methyl iodide to quaternise two sizes of 
p(DMAEMA) with different molecular weights. Typically, similar 
crystallisation procedures as described in Section 4.3.1 were carried out. Five 
quaternised p(DMAEMA) (P2) with different quaternised ratios were applied 
for HEWL crystallisation: 
i) Quaternised p(DMAEMA))(Mn~46.3 kDa) (quaternised ratio: 50 %); 
ii) Quaternised p(DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 25 %); 
iii) Quaternised p(DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 50 %); 
iv) Quaternised p(DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 75 %); 
v) Quaternised p(DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 100 %). 
 
i) Quaternised p(DMAEMA) (P2) (Mn~46.3 kDa) (quaternised ratio: 
50 %) 
The following polymer solutions were prepared by using the above pH-altered 
buffer solution: quaternised p(DMAEMA) (P2) (Mn~46.3 kDa) (quaternised 
ratio: 50 %) 0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 10 %, 12 %, 14 %, 16 %, 18 % 
and 20 % (w/v) (Table 4-4). HEWL concentration: 50 mg/mL. 
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Table 4-4. HEWL crystallisation plate set up: quaternised p(DMAEMA) (P2) 
(Mn~46.3 kDa) (quaternised ratio: 50 %) 
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Figure 4-13 shows HEWL crystals obtained in the presence of quaternised 
p(DMAEMA) (P2) (Mn~46.3 kDa) (quaternised ratio: 50 %) at various 
concentrations (0.02 % to 20 % (w/v)), as solute in the crystallisation solutions. 
Each concentration was repeated six times for reproducibility. Cationic 
quaternised p(DMAEMA) (P2) (Mn~46.3 kDa) (quaternised ratio: 50 %) had 
an increased propensity for nucleating many small crystals. Along with the 
concentration of quaternised p(DMAEMA) (P2) in solution was increased, the 
number of HEWL crystals appeared to increase; the size of crystals appeared to 
decrease. Instead of tetragonal, two other forms of HEWL crystals, including 
needles and monoclinic crystals were obtained, which was confirmed by single 
crystal X-ray diffraction results later. As mentioned in Section 4.3.1, HEWL 
needles can be grown in solutions with high salt concentrations;222 or in the 
presence of acid-functionalised polymeric surfaces, such as cross-linked acrylic 
acid and methacrylic acid.159 However, HEWL monoclinic crystals have rarely 
been observed previously under conditions which otherwise promote tetragonal 
crystal-polymorphs. 
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Quaternised p(DMAEMA) (P2) (Mn~46.3 kDa) (quaternised ratio: 50 %) 
 
Figure 4-13. Photomicrographs showing changes in the size and shape of 
HEWL crystals, grown under the tetragonal protocol, in the presence of 
quaternised p(DMAEMA) (P2) (Mn~46.3 kDa) (quaternised ratio: 50 %) at 
various concentrations. HEWL concentration: 50 mg/mL. Image labelled 
µ&RQWURO¶UHSUHVHQWVFU\VWDOVJURZQIURPVDPSOHZHOOVZLWKRXWSRO\PHU 
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It was immediately clear that quaternised p(DMAEMA) had influenced the 
results of HEWL crystallisation experiments, especially the crystal morphology 
and form. For better understanding the mechanism of how quaternised 
p(DMAEMA) affected HEWL crystallisation, a series of crystallisation 
experiments in the presence of different quaternised p(DMAEMA) (Mn~17.1 
kDa) systems (quaternised ratios: 25 %, 50 %, 75 % and 100 %), with various 
concentrations of HEWL (25, 50, 75 and 100 mg/mL) were carried out 
(Section ii-v). 
 
ii) Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 
25 %) 
The following polymer solutions were prepared by using the above pH-altered 
buffer solution: quaternised p(DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 
25 %) 0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 10 %, 12 %, 14 %, 16 % and 18 % 
(w/v). Table 4-5 presents the crystallisation plating method and Figures 
4-14a-d show images of HEWL crystals obtained in the presence of 
quaternised p(DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 25 %) at various 
concentrations. HEWL concentrations: 25, 50, 75 and 100 mg/mL. 
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Table 4-5. HEWL crystallisation plate set up: quaternised p(DMAEMA) (P2) 
(Mn~17.1 kDa) (quaternised ratio: 25 %) 
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Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 25 %) 
a) HEWL concentration: 25 mg/mL 
 
Figure 4-14a. Photomicrographs of HEWL crystals, grown under the tetragonal 
protocol, in the presence of p(DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 
25 %) at various concentrations, with HEWL concentration: 25 mg/mL. Image 
ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP VDPSOH ZHOOV ZLWKRXW
polymer. The scale bar was 500 µm. 
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Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 25 %) 
b) HEWL concentration: 50 mg/mL 
 
Figure 4-14b. Photomicrographs of HEWL crystals, grown under the tetragonal 
protocol, in the presence of p(DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 
25 %) at various concentrations, with HEWL concentration: 50 mg/mL. Image 
ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP VDPSOH ZHOOV ZLWKRXW
polymer. The scale bar was 500 µm. 
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Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 25 %) 
c) HEWL concentration: 75 mg/mL 
 
Figure 4-14c. Photomicrographs of HEWL crystals, grown under the tetragonal 
protocol, in the presence of (DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 
25 %) at various concentrations, with HEWL concentration: 75 mg/mL. Image 
ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP VDPSOH ZHOOV ZLWKRXW
polymer. The scale bar was 500 µm. 
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Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 25 %) 
d) HEWL concentration: 100 mg/mL 
 
Figure 4-14d. Photomicrographs of HEWL crystals, grown under the tetragonal 
protocol, in the presence of (DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 
25 %) at various concentrations, with HEWL concentration: 100 mg/mL. 
,PDJHODEHOOHGµ&RQWURO¶UHSUHVHQWVFU\VWDOVJURZQIURPVDPSOHZHOOVZLWKRXW
polymer. The scale bar was 500 µm. 
 
 
 
CHAPTER 4. Application of Polymers to Hen Egg-white Lysozyme (HEWL) 
Crystallisation 
177 
 
iii) Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 
50 %) 
The following polymer solutions were prepared: quaternised p(DMAEMA) 
(Mn~17.1 kDa) (quaternised ratio: 50 %) 0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 
10 % and 12 % (w/v) (Table 4-6).  
Table 4-6. HEWL crystallisation plate set up: quaternised p(DMAEMA) (P2) 
(Mn~17.1 kDa) (quaternised ratio: 50 %) 
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Figures 4-15a-d show the optical photomicrographs of HEWL crystals formed 
under quaternised p(DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 50 %) at 
various concentrations, with HEWL concentrations: 25, 50, 75 and 100mg/mL. 
 
Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 50 %) 
a) HEWL concentration: 25 mg/mL 
 
Figure 4-15a. Photomicrographs of HEWL crystals, grown under the tetragonal 
protocol, in the presence of p(DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 
50 %) at various concentrations, with HEWL concentration: 25 mg/mL. Image 
ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP VDPSOH ZHOOV ZLWKRXW
polymer. The scale bar was 500 µm. 
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Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 50 %) 
b) HEWL concentration: 50 mg/mL 
 
Figure 4-15b. Photomicrographs of HEWL crystals, grown under the tetragonal 
protocol, in the presence of p(DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 
50 %) at various concentrations, with HEWL concentration: 50 mg/mL. Image 
labelled µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP VDPSOH ZHOOV ZLWKRXW
polymer. The scale bar was 500 µm. 
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Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 50 %) 
c) HEWL concentration: 75 mg/mL 
 
Figure 4-15c. Photomicrographs of HEWL crystals, grown under the tetragonal 
protocol, in the presence of p(DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 
50 %) at various concentrations, with HEWL concentration: 75 mg/mL. Image 
ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP VDPSOH ZHOOV ZLWKRXW
polymer. The scale bar was 500 µm. 
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Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 50 %) 
d) HEWL concentration: 100 mg/mL 
 
Figure 4-15d. Photomicrographs of HEWL crystals, grown under the tetragonal 
protocol, in the presence of p(DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 
50 %) at various concentrations, with HEWL concentration: 100 mg/mL. 
,PDJHODEHOOHGµ&RQWURO¶UHSUHVHQWVFU\VWDOVJURZQIURPVDPSOHZHOOVZLWKRXW
polymer. The scale bar was 500 µm. 
 
 
CHAPTER 4. Application of Polymers to Hen Egg-white Lysozyme (HEWL) 
Crystallisation 
182 
 
iv) Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 
75 %) 
The following polymer solutions were prepared: quaternised p(DMAEMA) (P2) 
(Mn~17.1 kDa) (quaternised ratio: 75 %) 0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 
10 %, 12 %, 14 %, 16 %, 18 % and 20 % (w/v) (Table 4-7).  
Table 4-7. HEWL crystallisation plate set up: quaternised p(DMAEMA) (P2) 
(Mn~17.1 kDa) (quaternised ratio: 75 %) 
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Figures 4-16a-d show images of HEWL crystals obtained under quaternised 
p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 75 %), with HEWL 
concentrations of 25, 50, 75 and 100mg/mL. 
Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 75 %) 
a) HEWL concentration: 25 mg/mL 
 
Figure 4-16a. Photomicrographs of HEWL crystals, grown under the tetragonal 
protocol, in the presence of p(DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 
75 %) at various concentrations, with HEWL concentration: 25 mg/mL. Image 
ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP VDPSOH ZHOOV ZLWKRXW
polymer. The scale bar was 500 µm. 
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Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 75 %) 
b) Lysozyme concentration: 50 mg/mL 
 
Figure 4-16b. Photomicrographs of HEWL crystals, grown under the tetragonal 
protocol, in the presence of p(DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 
75 %) at various concentrations, with HEWL concentration: 50 mg/mL. Image 
ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP VDPSOH ZHOOV ZLWKRXW
polymer. The scale bar was 500 µm. 
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Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 75 %) 
c) HEWL concentration: 75 mg/mL; d) HEWL concentration: 100 mg/mL 
 
Figure 4-16c & d. Photomicrographs of HEWL crystals, grown under the 
tetragonal protocol, in the presence of p(DMAEMA) (Mn~17.1 kDa) 
(quaternised ratio: 75 %) at various concentrations, with HEWL concentrations: 
75 and 100 mg/mL. Images ODEHOOHG µ&RQWURO¶ UHSUHVHQW FU\VWDOV JURZQ IURP
sample wells without polymer. The scale bar was 500 µm. 
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v) Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 
100 %) 
The following polymer solutions were prepared: quaternised p(DMAEMA) 
(Mn~17.1 kDa) (quaternised ratio: 100 %) 0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 
10 %, 12 %, 14 %, 16 %, 18 % and 20 % (w/v) (Table 4-8).  
Table 4-8. HEWL crystallisation plate set up: quaternised p(DMAEMA) (P2) 
(Mn~17.1 kDa) (quaternised ratio: 100 %) 
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Figures 4-17a-d present optical micrographs of HEWL crystals obtained under 
quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 100 %), 
with HEWL concentrations: 25, 50, 75 and 100 mg/mL. 
Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 100 %) 
a) HEWL concentration: 25 mg/mL 
 
Figure 4-17a. Photomicrographs of HEWL crystals, grown under the tetragonal 
protocol, in the presence of p(DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 
100 %) at various concentrations, with HEWL concentration: 25 mg/mL. 
,PDJHODEHOOHGµ&RQWURO¶UHSUHVHQWVFU\VWDOVJURZQIURPVDPSOHZHOOVZLWKRXW
polymer. The scale bar was 500 µm. 
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Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 100 %) 
b) HEWL concentration: 50 mg/mL 
 
Figure 4-17b. Photomicrographs of HEWL crystals, grown under the tetragonal 
protocol, in the presence of p(DMAEMA) (Mn~17.1 kDa) (quaternised ratio: 
100 %) at various concentrations, with HEWL concentration: 50 mg/mL. 
Image labelled µ&RQWURO¶UHSUHVHQWVFU\VWDOVJURZQIURPVDPSOHZHOOVZLWKRXW
polymer. The scale bar was 500 µm. 
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Quaternised p(DMAEMA) (P2) (Mn~17.1 kDa) (quaternised ratio: 100 %) 
c) HEWL concentration: 75 mg/mL; d) HEWL concentration: 100 mg/mL 
 
Figure 4-17c & d. Photomicrographs of HEWL crystals, grown under the 
tetragonal protocol, in the presence of p(DMAEMA) (Mn~17.1 kDa) 
(quaternised ratio: 100 %) at various concentrations, with HEWL 
concentrations: 75 and 100 mg/mL. Images ODEHOOHG µ&RQWURO¶ UHSUHVHQW
crystals grown from sample wells without polymer. The scale bar was 500 µm. 
 
 
CHAPTER 4. Application of Polymers to Hen Egg-white Lysozyme (HEWL) 
Crystallisation 
190 
 
All above HEWL crystal images, including Figures 4-14a-d, 4-15a-d, 4-16a-d 
and 4-17a-d, show that HEWL crystallisation was clearly affected by the 
presence of quaternised p(DMAEMA) in solution. The rate of HEWL crystals 
formed in sample wells containing quaternised p(DMAEMA) was faster than 
that without added polymer. Various quaternised ratios of p(DMAEMA) had 
similar effects on HEWL crystallisation, even with different HEWL 
concentrations. Tetragonal crystals only were formed at lower concentrations 
(0.02 % ~ 0.2 % (w/v)). Upon increasing the concentration to above 2 %, 
quaternised p(DMAEMA) showed a visible and pronounced effect on the 
HEWL crystal formation; needles and monoclinic crystals were obtained 
(Figures 4-14b & c, 4-15a-c, 4-16b and 4-17b). 
Therefore, quaternised p(DMAEMA) acted as solution additives significantly 
influenced the results of HEWL crystallisation. Moreover, quaternised 
p(DMAEMA) (P2) mediated-HEWL crystallisation followed a general 
morphology trend along with increasing polymer concentration: tetragonal ĺ 
monoclinic & needle ĺ needle, with tetragonal crystals forming at lower 
concentrations and monoclinic crystals & needle forming at higher polymer 
concentrations (Figure 4-18). In previous research, the absorption behavior of a 
high content of the cationic PDMAEMA on silicon wafers was controlled by a 
striving of the cationic segments for charge compensation by negative 
surface.226 Addition of quaternised p(DMAEMA), which exhibited a high 
cationic charge density, into HEWL solution, is therefore expected to alter the 
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electrostatic interactions between HEWL molecules and the solution.100, 118 
 
Figure 4-18. Schematic triangle graphs showing the changes in the morphology of 
HEWL crystals obtained in the presence of p(DMAEMA) with different degrees 
of quaternisation (25 %, 50 %, 75 % and 100 %). A) HEWL concentration: 25 
mg/mL; B) HEWL concentration: 50 mg/mL; C) HEWL concentration: 75 
mg/mL; D) HEWL concentration: 100 mg/mL. Three morphology phases: 
tetragonal, monoclinic and needle reside at the vertices of the triangle. The size of 
the colored squares quantitatively represents the possibility of crystal morphology 
shape. 
 
Among all the above HEWL crystallisation experiments under quaternised 
p(DMAEMA) (P2), the experiment with quaternised ratio 75 % and HEWL 
concentration 50 mg/mL was the best condition for the formation of 
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monoclinic HEWL crystals. Therefore, photomicrograph data of this 
experiment (Figure 4-16b) was chosen for further image analysis. Figure 4-19 
shows a full summary of HEWL crystals size and number distribution 
(tetragonal or monoclinic crystal). There was a significant effect on HEWL 
crystallisation depending on the concentration of cationic quaternised 
p(DMAEMA). For cationic HEWL, as the quaternised p(DMAEMA) (P2) 
concentration was increased, the size of monoclinic crystals decreased and the 
number of monoclinic crystals increased.  
 
Figure 4-19. Summary of photomicrograph analysis showing changes in the 
size and number of HEWL crystals, grown in the presence of quaternised 
p(DMAEMA) (quaternised ratio: 75 %) at various concentrations, with HEWL 
concentration 50 mg/mL. a) Average OHQJWK ȝP RI WKH ODUJHVW FU\VWDO
(tetragonal or monoclinic) diameter; b) Experiment count for the number of 
crystals (tetragonal or monoclinic) per sample well. The scale bar was 500ȝP. 
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Figure 4-20 illustrates the diffraction patterns of HEWL crystal, grown in the 
presence of quaternised p(DMAEMA) (quaternised ratio: 75 %) by X-ray 
crystallography and Table 4-9 shows unit cell dimension of the HEWL crystal. 
Therefore, HEWL crystals obtained from quaternised p(DMAEMA) 
(P2)-mediated HEWL crystallisation, were confirmed as the monoclinic form 
by single crystal X-ray diffraction. 
 
Figure 4-20. HEWL crystal photomicrograph and X-ray diffraction patterns 
yielded by the single HEWL crystal in the presence of cationic quaternised 
p(DMAEMA) (P2) (quaternised ratio: 75 %). Two scattering angles: 
0±1 degrees and 90±1 degrees. 
  
Table 4-9. Unit cell dimension of HEWL crystal formed in the presence of 
cationic quaternised p(DMAEMA) (P2) (quaternised ratio: 75 %) 
Polymer a, b, c (Å) ĮȕȖ Volume Unit cell lattice 
Quaternised 
p(DMAEMA) 26.82, 63.09, 58.73 90°, 93.2°, 90° 99,213 Monoclinic 
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Representative Tukey plots of DLS data show protein aggregate growth in size 
as a function of time during crystallisation experiment (Figure 4-21). At the 
beginning of the experiment (T0), the average size of the particles in the 
crystallisation solution was around 100 nm. After the addition of cationic 
quaternised p(DMAEMA) (P2), as the time increased, the rate of HEWL 
aggregates size increase was very slow. This may because cationic quaternised 
p(DMAEMA) (P2) could lower the interfacial energy between cationic HEWL 
macromolecules and water by charge-charge repulsions, thus promoting 
nucleation and the formation of multiple crystal nuclei. Therefore, the size of 
each HEWL aggregate or crystal would increase very slowly. The size of pure 
quaternised p(DMAEMA) (P2) in solution was around 18 nm. DLS data details, 
including autocorrelation functions and radii distribution by intensity are 
shown in the Appendix Page 337. 
 
Figure 4-21. Variations of the size of HEWL aggregates or crystals in the 
solution as a function of time during crystallisation experiment induced by 
cationic quaternised p(DMAEMA) (P2) (quaternised ratio: 75 %). 
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Figure 4-22 presents SEM micrograph of HEWL crystal formed in the presence 
of quaternised p(DMAEMA) (P2). The SEM result shows that with the 
addition of cationic quaternised p(DMAEMA), the HEWL produced poor 
needles. Because of the poor stability of monoclinic crystals, and because they 
were normally surrounded by lots of HEWL needles, monoclinic crystals were 
not handled easily and it proved impossible to obtain SEM images in this 
research. 
 
Figure 4-22. SEM micrograph of HEWL needles produced under tetragonal 
conditions in the presence of quaternised p(DMAEMA), -- x 4000 
magnifications; the scale bar was 5 ȝm. 
 
4.3.2.2 HEWL crystallisation in the presence of 
p(DMAEMA-stat-PEGMA475) (P3) 
P(DMAEMA-stat-PEGMA475) (P3) (Mn~52.9 kDa) solutions with 
concentrations of 0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 10 %, 12 %, 14 %, 16 %, 
18 %, 20 % and 22 % (w/v) in 0.25 M sodium acetate, 20 % NaCl at pH 4.8 
were prepared (Table 4-10). Each concentration was in triplicate for 
reproducibility. 
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Table 4-10. HEWL crystallisation plate: p(DMAEMA-stat-PEGMA475) (P3) 
 
 
Figure 4-23 shows images of HEWL crystals obtained in the presence of 
p(DMAEMA-stat-PEGMA475) (P3) at various concentrations, as solute in the 
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crystallisation solutions. Regular and small tetragonal HEWL crystals with the 
size of ~ 100 ȝP formed within one day. 
p(DMAEMA-stat-PEGMA475) (P3) copolymer 
 
Figure 4-23. Photomicrographs of HEWL crystals, grown under the tetragonal 
protocol, in the presence of p(DMAEMA-stat-PEGMA475) (P3) copolymer 
(Mn~52.9 kDa) at various concentrations. ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWs 
crystals grown from sample wells without polymer. The scale bar was 500 µm. 
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A full summary of HEWL crystals size distribution by measuring the average 
OHQJWK ȝP RI WKH ODUJHVW GLDPHWHU RI HDFK FU\VWDO and number distribution 
depending on p(DMAEMA-stat-PEGMA475) (P3) copolymer concentration 
was obtained by further image analysis (Figure 4-24). As the concentration of 
p(DMAEMA-stat-PEGMA475) (P3) copolymer in solution was increased, the 
number of HEWL crystals appeared to increase and the size of the crystals 
decreased very clearly. Upon increasing the copolymer concentration to 20 %, 
the size of HEWL crystal decreased to ~ 100 ȝP. 
 
Figure 4-24. Summary of photomicrograph analysis showing changes in the 
size and number of HEWL crystals, grown in the presence of 
p(DMAEMA-stat-PEGMA475) (P3) at various concentrations. a) Average 
OHQJWKȝPRIWKHODUJHVWFU\VWDOGLDPHWHUEExperiment count for the number 
of crystals per sample well. The scale bar was 500ȝP. 
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Figure 4-25 illustrates the diffraction patterns of HEWL crystal, grown in the 
presence of p(DMAEMA-stat-PEGMA475) (P3) by X-ray crystallography and 
Table 4-11 shows unit cell dimension of the HEWL crystal. Crystallisation of 
HEWL from the tetragonal-inducing protocol, when in the presence of cationic 
p(DMAEMA-stat-PEGMA475) (P3), resulted in tetragonal crystals, which were 
confirmed by single crystal X-ray diffraction. 
 
Figure 4-25. HEWL crystal photomicrograph and X-ray diffraction patterns 
yielded by the single HEWL crystal formed in the presence of cationic 
p(DMAEMA-stat-PEGMA475) (P3). Two scattering angles: 0±1 degrees and 
90±1 degrees. 
  
Table 4-11. Unit cell dimension of HEWL crystal in the presence of cationic 
p(DMAEMA-stat-PEGMA475) (P3) 
Polymer a, b, c (Å) ĮȕȖ Volume Unit cell lattice 
P3 78.49, 78.49, 36.71 90°, 90°, 90° 226,172 Tetragonal 
 
P(DMAEMA-stat-PEGMA475) (P3) copolymer might have different functions 
during HEWL crystallisation, due to the two components: neutral PEGMA475 
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and cationic DMAEMA. As mentioned earlier, the neutral PEGMA475 section 
might bind to water by H-bonding, compete with protein solutes for water and 
thus force protein solutes come out from the water solution. It could also lower 
the dielectric constant of the solution, leading to protein aggregation being 
promoted. At the crystallisation pH of 4.8, the cationic DMAEMA section had 
quaternary nitrogen with some positive charges, which could alter the 
electrostatic interactions between ionic HEWL macromolecules and the 
solution. There were likely to have been charge-charge repulsions between 
cationic DMAEMA and cationic HEWL macromolecules, which would lower 
the interface energy between HEWL macromolecules and water, consequently 
accelerated protein aggregation and the formation of multiple crystal nuclei for 
HEWL nucleation. 
 
4.3.2.3 HEWL crystallisation in the presence of a mixture of two polymers: 
p(PEGMA475) and p(DMAEMA) (P1 & P2) (molar ratio 9:1) 
As mentioned above, p(DMAEMA-stat-PEGMA475) (P3) affected the size of 
HEWL crystals very significantly. In order to compare the effects with 
p(DMAEMA-stat-PEGMA475) copolymer, we set out to prepare a mixture of 
two polymers: p(PEGMA475) and p(DMAEMA) (P1 & P2) for HEWL 
crystallisation. The following polymer solutions with a range of concentrations 
0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 10 %, 12 %, 14 %, 16 %, 18 % and 20 % 
(w/v) were prepared. Table 4-12 shows HEWL crystallisation plate in the 
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presents of a mixture of two polymers: p(PEGMA475) and p(DMAEMA) (P1 & 
P2). Each concentration was in triplicate for reproducibility. 
 
Table 4-12. HEWL crystallisation plate set up: a mixture of two polymers: 
p(PEGMA475) and p(DMAEMA) (P1 & P2) 
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Figure 4-26 shows the photomicrographs of HEWL crystals formed under a 
mixture of two polymers: p(PEGMA475) and p(DMAEMA) (P1 & P2). A few 
large HEWL crystals formed within one day. From visual inspection, it is 
immediately clear that the results of crystallisation experiments are different 
from that obtained in the presents of p(DMAEMA-stat-PEGMA475) (P3) 
copolymer, especially the crystal size and morphology shape. When the 
concentration of a mixture of two polymers: pPEGMA475 and p(DMAEMA) 
(P1 & P2) in solution was increased to 20 % (w/v), the size of HEWL crystal 
was around 300 ȝP and the shape of some crystals was rhombohedral. But 
when in the presents of p(DMAEMA-stat-PEGMA475) (P3) copolymer, the size 
was around 100 ȝP and the shape was exclusively tetragonal. 
A mixture of two polymers: p(PEGMA475) and p(DMAEMA) (P1 & P2) had 
two separate sections: neutral p(PEGMA475) and cationic p(DMAEMA. 
However, unlike p(DMAEMA-stat-PEGMA475) copolymer, those two sections 
affected HEWL crystallisation separately. It seems the influence of the neutral 
p(PEGMA475) section was dominant in the crystallisation process 
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A mixture of two polymers: p(PEGMA475) and p(DMAEMA) (P1 & P2) 
 
Figure 4-26. Photomicrographs of HEWL crystals, grown under the tetragonal 
protocol, in the presence of a mixture of two polymers: p(PEGMA475) and 
p(DMAEMA) (P1 & P2) (molar ratio 9:1) at various concentrations. Image 
ODEHOOHG µ&RQWURO¶ UHSUHVHQWs crystals grown from sample wells without 
polymer. The scale bar was 500 µm. 
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A full summary of HEWL crystals size distribution by measuring the average 
OHQJWK ȝP RI WKH ODUJHVW GLDPHWHU RI HDFK FU\VWDO and number distribution 
depending on a mixture of two polymers: p(PEGMA475) and p(DMAEMA) (P1 & 
P2) concentration was obtained by further image analysis (Figure 4-27). As the 
concentration of a mixture of two polymers: p(PEGMA475) and p(DMAEMA) (P1 
& P2) in solution was increased, the number of HEWL crystals appeared to 
increase and the size of the crystals appeared to decrease.  
 
Figure 4-27. Summary of photomicrograph analysis showing changes in the 
size and number of HEWL crystals, grown in the presence of a mixture of two 
polymers: p(PEGMA475) and p(DMAEMA) (P1 & P2) at various 
FRQFHQWUDWLRQV D $YHUDJH OHQJWK ȝP RI WKH ODUJHVW FU\VWDO GLDPHWHU E
Experiment count for the number of crystals per sample well. The scale bar 
waVȝP 
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Figure 4-28 illustrates the diffraction patterns of HEWL crystal, grown in the 
presence of a mixture of two polymers: p(PEGMA475) and p(DMAEMA) (P1 
& P2). Table 4-13 shows unit cell dimension of the HEWL crystal, identified as 
tetragonal by single crystal X-ray diffraction. 
 
Figure 4-28. HEWL crystal photomicrograph and X-ray diffraction patterns 
yielded by the single HEWL crystal in the presence of a mixture of two 
polymers: p(PEGMA475) and p(DMAEMA) (P1 & P2). Two scattering angles: 
0±1 degrees and 90±1 degrees. 
 
Table 4-13. Unit cell dimension of HEWL crystal in the presence of a mixture 
of two polymers: p(PEGMA475) and p(DMAEMA) (P1 & P2) 
Polymer a, b, c (Å) ĮȕȖ Volume Unit cell lattice 
A mixture of two polymers: 
p(PEGMA475) and 
p(DMAEMA) 
78.85, 
78.85, 
37.12 
90°, 
90°, 
90° 
230,779 Tetragonal 
 
Figure 4-29 shows Tukey plots of DLS data when in the presence of a mixture 
of two polymers: p(PEGMA475) and p(DMAEMA) (P1 & P2). At the beginning 
of the experiment (T0), the average size of the particles in the crystallisation 
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solution was around 180 nm. After the addition of a mixture of two polymers: 
p(PEGMA475) and p(DMAEMA) (P1 & P2), as the time increased, a 
characteristic increase in HEWL aggregate size can be observed. After 395 
minutes (T395min), the average size of the particles in the crystallisation solution 
was around 900 nm. DLS data details, including autocorrelation functions and 
radii distribution by intensity are shown in the Appendix Page 337. 
 
Figure 4-29. Variations of the size of HEWL aggregates or crystals in the 
solution as a function of time during crystallisation experiments induced by a 
mixture of two polymers: p(PEGMA475) and p(DMAEMA) (P1 & P2). 
 
4.3.2.4 HEWL crystallisation in the presence of p(DMAPMAm) (P4)  
DMAPMAm, containing tertiary amines group was homopolymerised to form 
another cationic polymer. The following polymer solutions were prepared: 
p(DMAPMAm) (P4) (DPs 38, 83 and 150) 0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 
10 %, 12 % and 14 % (w/v) in 0.25 M sodium acetate and 20 % NaCl at pH 4.8 
buffer solution. Tables 4-14a-c show HEWL crystallisation plating methods 
under p(DMAPMAm) (P4) (DPs 38, 83 and 150). 
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Table 4-14a. HEWL crystallisation plate set up: p(DMAPMAm) (P4) (DP 38) 
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Table 4-14b. HEWL crystallisation plate set up: p(DMAPMAm) (P4) (DP 83) 
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Table 4-14c. HEWL crystallisation plate set up: p(DMAPMAm) (P4) (DP 150) 
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Previous results showed that cationic quaternised p(DMAEMA) was able to 
control the morphology shape and alter the size of HEWL crystals. Similar as 
DMAEMA, monomer DMAPMAm has tertiary amine functionality, which can 
afford positive charges at crystallisation pH of 4.8. Figures 4-30a-c show the 
HEWL crystals obtained in the presence of p(DMAPMAm) (P4) (DPs 38, 83 
and 150) with various concentrations (0.02 % ~ 20 % (w/v)), as solute in 
crystallisation solutions. From visual observation, cationic p(DMAPMAm) had 
an increased propensity for nucleating much more small crystals. It nucleated 
many uniform and small tetragonal HEWL crystals with the size of ~ 100 ȝP 
within one day. These HEWL crystals were identified as tetragonal by single 
crystal X-ray diffraction. Upon increasing the DP of p(DMAPMAm), the size 
of HEWL crystals slightly increased. The possible reason is that 
p(DMAPMAm) with higher DP had a larger molecular weight, which would 
increase the viscosity of the solution and slow the rate of protein crystal 
growth.227 
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a) p(DMAPMAm) (P4) (DP 38) 
 
Figure 4-30a. Photomicrographs of HEWL crystals, grown under tetragonal 
crystal condition, in the presence of p(DMAPMAm) (P4) (DP 38) at various 
FRQFHQWUDWLRQV ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP
sample wells without polymer. The scale bar was 500 µm. 
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b) p(DMAPMAm) (P4) (DP 83) 
 
Figure 4-30b. Photomicrographs of HEWL crystals, grown under tetragonal 
crystal condition, in the presence of p(DMAPMAm) (P4) (DP 83) at various 
FRQFHQWUDWLRQV ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV grown from 
sample wells without polymer. The scale bar was 500 µm. 
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c) p(DMAPMAm) (P4) DP 150 
 
Figure 4-30c. Photomicrographs of HEWL crystals, grown under tetragonal 
crystal condition, in the presence of p(DMAPMAm) (P4) (DP 150) at various 
FRQFHQWUDWLRQV ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP
sample wells without polymer. The scale bar was 500 µm. 
 
A full coverage of crystal size distribution by measuring the average length 
ȝPRIWKHODUJHVWFU\VWDOGLDPHWHU and number distribution was obtained from 
p(DMAPMAm) (P4) (DP 83) (Figure 4-31). As the p(DMAPMAm) 
concentration was increased, the size of crystals decrease and the number of 
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crystals increased.  
 
Figure 4-31. Summary of photomicrograph analysis of HEWL crystals, grown 
in the presence of p(DMAPMAm) (P4) (DP 83) at various concentrations. a) 
$YHUDJH OHQJWK ȝPRI WKH ODUJHVW FU\VWDO GLDPHWHU E([SHULPHQW FRXQW IRU
the number of crystals per sample well. The scale bar waVȝP 
 
Figure 4-32 shows Tukey plots of DLS data of HEWL crystallisation in the 
presence of p(DMAPMAm) (P4). P(DMAPMAm) (P4) did not alter the size of 
HEWL aggregates or crystals clearly after 420 min. The size of pure 
p(DMAPMAm) (P4) in the solution without any protein was around 3 nm. 
Similar as quaternised p(DMAEMA) (P2), cationic p(DMAPMAm) (P4) could 
lower the interfacial energy between cationic HEWL macromolecules and 
water by charge-charge repulsions, thus promoted nucleation and the formation 
of multiple crystal nuclei. In turn, HEWL aggregates or crystals would grow 
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very slowly. DLS data details, including autocorrelation functions and radii 
distribution by intensity are shown in the Appendix Page 338. 
 
Figure 4-32. Variations of the size of HEWL aggregates or crystals in the 
solution as a function of time during crystallisation experiments induced by 
p(DMAPMAm) (P4). 
 
In summary, cationic polymers had an increased propensity for nucleating 
small crystals. Figure 4-33 shows the hypothesis of mechanism of how cationic 
polymers mediated HEWL crystallisation.108, 226, 228, 229 There were likely to 
have been charge-charge repulsions between cationic polymer molecules and 
cationic HEWL macromolecules, lowering the interfacial energy between 
HEWL macromolecules and water, thus promoting protein-protein interactions 
at hydrophobic sites or anionic-cationic pair sites and subsequent 
crystallisation. In addition, cationic polymers might have bound to anionic 
residues on the HEWL chain leading to charge compensation by electrostatic 
interaction,108 an increase of local concentration of HEWL macromolecules 
and the promotion of nucleation. 
CHAPTER 4. Application of Polymers to Hen Egg-white Lysozyme (HEWL) 
Crystallisation 
216 
 
 
Figure 4-33. Hypothesis of mechanism of cationic polymer mediated HEWL 
crystallisation. Cationic polymer: charge-charge repulsions between cationic 
polymer and cationic HEWL. HEWL macromolecules are positively charged at 
tetragonal crystallisation pH of 4.8, i.e. cationic. Na+ and Cl- ions are from the 
crystallisation buffer solutions. 
 
4.3.3 HEWL crystallisation in the presence of anionic polymers in solution 
4.3.3.1 HEWL crystallisation in the presence of p(AMPS) (P5) 
Monomer AMPS, containing ionisable sulfonic acid group can introduce some 
negative charges and homopolymerise to generate an anionic polymer P5. The 
following polymer solutions were prepared: p(AMPS) (P5) (DPs 53, 99 and 
200): 0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 10 %, 12 % and 14 % (w/v) in 0.25 
M sodium acetate, 20 % NaCl, pH 4.8 buffer solution (Tables 4-15a-c). 
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Table 4-15a. HEWL crystallisation plate set up: p(AMPS) (P5) (DP 53) 
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Table 4-15b. HEWL crystallisation plate set up: p(AMPS) (P5) (DP 99) 
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Table 4-15c. HEWL crystallisation plate set up: p(AMPS) (P5) (DP 200) 
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Figures 4-34a-c show the images of HEWL crystals obtained in the presence of 
p(AMPS) (P5) (DPs 53, 99 and 200) with various concentrations (0.02 % ~ 20 % 
(w/v)). Anionic p(AMPS) nucleated a few large crystals, which were then 
identified as tetragonal by single crystal X-ray diffraction. 
 
a) p(AMPS) (P5) (DP 53) 
 
Figure 4-34a. Photomicrographs of HEWL crystals, grown under tetragonal 
crystal condition, in the presence of p(AMPS) (P5) (DP 53) at various 
FRQFHQWUDWLRQV ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP
sample wells without polymer. The scale bar was 500 µm. 
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b) p(AMPS) (P5) (DP 99) 
 
Figure 4-34b. Photomicrographs of HEWL crystals, grown under tetragonal 
crystal condition, in the presence of p(AMPS) (P5) (DP 99) at various 
FRQFHQWUDWLRQV ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP
sample wells without polymer. The scale bar was 500 µm. 
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c) p(AMPS) (P5) (DP 200) 
 
Figure 4-34c. Photomicrographs of HEWL crystals, grown under tetragonal 
crystal condition, in the presence of p(AMPS) (P5) (DP 200) at various 
FRQFHQWUDWLRQV ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP
sample wells without polymer. The scale bar was 500 µm. 
 
The HEWL images data obtained from the experiment in the presence of 
p(AMPS) (P5) (DP 99) was used for further image analysis. Figure 4-35 shows 
crystal size distribution by measuring the aYHUDJH OHQJWK ȝP RI WKH ODUJHVW
crystal diameter and number distribution was obtained from p(AMPS) (P5) 
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(DP 99). As the concentration of p(AMPS) (P5) in solution was increased, the 
number of HEWL crystals appeared to decrease and the size of the crystals 
appeared to increase. 
 
Figure 4-35. Summary of photomicrograph analysis showing changes in the 
size and number of HEWL crystals, grown in the presence of p(AMPS) (P5) 
(DP 99) DWYDULRXVFRQFHQWUDWLRQVD$YHUDJHOHQJWKȝPRIWKHODUJHVWFU\VWDO
diameter; b) Experiment count for the number of crystals per sample well. The 
VFDOHEDUZDVȝP 
 
Figure 4-36 presents Tukey plots of DLS data when crystallised in the presence 
of p(AMPS) (P5). DLS data details, including autocorrelation functions and 
radii distribution by intensity are shown in the Appendix Page 338. At the 
beginning of the experiment (T0), HEWL macromolecules were 
non-interacting in the solution. The average size of the particles in the 
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crystallisation solution was around 100 nm, measured by size distribution. 
With the addition of p(AMPS) (P5), HEWL crystallisation initiated and 
aggregates formed. As the time increased, HEWL aggregates grew in size. 
After 360 minutes, the average size of the particles in the crystallisation 
solution was around 400 nm. The size of pure p(AMPS) (P5) (DP 99) without 
any protein in the solution was around 4 nm. 
 
Figure 4-36. Variations of the size of HEWL aggregates or crystals in the 
solution as a function of time during crystallisation experiments induced by 
p(AMPS) (P5) (DP 99). 
 
HEWL crystals were then taken out from the crystallisation plate, washed with 
crystallisation buffer solution. Then they were loaded onto aluminium stubs for 
SEM analysis. The SEM micrograph result (Figure 4-37) shows that with the 
addition of anionic p(AMPS) (P5), high quality HEWL crystal with sharp 
edges was formed. Moreover, HEWL crystals formed in the presence of 
anionic p(AMPS) (P5) were much more stable than that obtained without 
polymer. 
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Figure 4-37. SEM micrograph of HEWL crystal produced under tetragonal 
conditions in the presence of p(AMPS) (P5), -- x 500 magnifications; the scale 
bar was 50 ȝm. 
 
4.3.3.2 HEWL crystallisation in the presence of p(2-AmAA) (P6) 
Another acrylamide monomer 2-AmAA, which has carboxyl group, was 
chosen to generate anionic homopolymers. The following polymer solutions 
were prepared: p(2-AmAA) (P6) (DP 18): 0.02 %, 0.2 %, 2 %, 3 %, 4 %, 5 %, 
6 %, 7 % and 8 % (w/v); p(2-AmAA) (P6) (DP 46): 0.02 %, 0.2 %, 2 %, 3 %, 
4 %, 5 %, 6 %, 7 % and 7.5 % (w/v); p(2-AmAA) (P6) (DP 72): 0.02 %, 0.2 %, 
2 %, 4 %, 6 %, 8 %, 10 %, 12 % and 14 % (w/v); p(2-AmAA) (P6) (DP 150): 
0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 10 %, 12 % and 14 % (w/v) in 0.25 M 
sodium acetate and 20 % NaCl at pH 4.8 buffer solution. Tables 4-16a-d show 
HEWL crystallisation plates contained p(2-AmAA) (P6) (DPs 18, 46, 72 and 
150) as solution additives.  
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Table 4-16a. HEWL crystallisation plate set up: p(2-AmAA) (P6) (DP 18) 
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Table 4-16b. HEWL crystallisation plate set up: p(2-AmAA) (P6) (DP 46) 
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Table 4-16c. HEWL crystallisation plate set up: p(2-AmAA) (P6) (DP 72) 
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Table 4-16d. HEWL crystallisation plate set up: p(2-AmAA) (P6) (DP 150) 
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Figures 4-38a-d show the images of HEWL crystals formed in the presence of 
p(2-AmAA) (P6) (DPs 18, 46, 72 and 150) at various concentrations. From 
visual observation, HEWL needles formed under p(2-AmAA) (P6) with lower 
DPs of 18 and 46 at lower concentrations (Figures 4-38a, < 4 %; Figures 4-38b, 
< 7 % (w/v)). However, as the concentration of p(2-AmAA) (P6) with DPs of 
18 and 46 was increased, there were no HEWL needles formed. It is reported 
that HEWL needles can be grown in the presence of acid-functionalised 
polymers.104 When HEWL crystallisation in the presence of p(2-AmAA) (P6) 
with higher DPs of 79 and 108, smaller uniform HEWL crystals were obtained 
(Figure 4-38c and d). The pKa of p(2-AmAA) (P6) was 5.92, measured by 
titration. At pH 4.8, p(2-AmAA) (P6) was a weakly anionic polymer. Because 
the crystallisation pH of HEWL being close (pH 4.8) to the pKa value of 
p(2-AmAA) (P6), and thus a smaller number of anionic carboxyls remaining 
on the p(2-AmAA) (P6) at pH of 4.8 compared to anionic p(AMPS) (P5). All 
these small HEWL crystals formed in the presence of anionic p(2-AmAA) (P6) 
were identified as tetragonal by single crystal X-ray diffraction later. 
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a) p(2-AmAA) (P6) (DP 18) 
 
Figure 4-38a. Photomicrographs of HEWL crystals, grown under tetragonal 
crystal condition, in the presence of p(2-AmAA) (P6) (DP 18) at various 
FRQFHQWUDWLRQV ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP
sample wells without polymer. The scale bar was 500 µm. 
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b) p(2-AmAA) (P6) (DP 46) 
 
Figure 4-38b. Photomicrographs of HEWL crystals, grown under tetragonal 
crystal condition, in the presence of p(2-AmAA) (P6) (DP 46) at various 
FRQFHQWUDWLRQV ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP
sample wells without polymer. The scale bar was 500 µm. 
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c) p(2-AmAA) (P6) (DP 72) 
 
Figure 4-38c. Photomicrographs of HEWL crystals, grown under tetragonal 
crystal condition, in the presence of p(2-AmAA) (P6) (DP 72) at various 
FRQFHQWUDWLRQV ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP
sample wells without polymer. The scale bar was 500 µm. 
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d) p(2-AmAA) (P6) (DP 150) 
 
Figure 4-38d. Photomicrographs of HEWL crystals, grown under tetragonal 
crystal condition, in the presence of p(2-AmAA) (P6) (DP 150) at various 
FRQFHQWUDWLRQV ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP
sample wells without polymer. The scale bar was 500 µm. 
 
The HEWL images data obtained from p(2-AmAA) (P6) (DP 72) was used for 
further image analysis. Figure 4-39 shows crystal size distribution by 
measuring the aYHUDJHOHQJWKȝPRIWKHODUJHVWFU\VWDOGLDPHWHU and number 
distribution was obtained from p(2-AmAA) (P6) (DP 72). As the concentration 
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of p(2-AmAA) (P6) in solution was increased, the number of HEWL crystals 
decreased and the size of the crystals appeared to increase slightly. 
 
Figure 4-39. Summary of photomicrograph analysis showing changes in the 
size and number of HEWL crystals, grown in the presence of p(2-AmAA) (P6) 
(DP 72) at various concentrations. a) AveUDJHOHQJWKȝPRIWKHODUJHVWFU\VWDO
diameter; b) Experiment count for the number of crystals per sample well. The 
VFDOHEDUZDVȝP 
 
Figure 4-40 illustrates the diffraction patterns of HEWL crystal grown in the 
presence of p(2-AmAA) (P6) (DPs 18 and 46) using X-ray crystallography. 
Table 4-17 shows unit cell dimensions of those HEWL crystals. All the HEWL 
crystals formed in the presence of anionic p(2-AmAA) (P6) were identified as 
tetragonal by single crystal X-ray diffraction. 
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Figure 4-40. HEWL crystal photomicrographs and X-ray diffraction patterns 
yielded by the single HEWL crystal in the presence of p(2-AmAA) (P6) with 
DP of 18 and 46. Two scattering angles: 0±1 degrees and 90±1 degrees. 
  
Table 4-17. Unit cell dimensions of HEWL crystal in the presence of anionic 
p(2-AmAA) (P6) with DP of 18 and 46 
Polymer a, b, c (Å) ĮȕȖ Volume Unit cell lattice 
p(2-AmAA) 
DP 18 78.87, 78.87, 37.10 
90°, 90°, 
90° 230,794 Tetragonal 
p(2-AmAA) 
DP 46 79.13, 79.13, 37.16 
90°, 90°, 
90° 232,678 Tetragonal 
 
Figure 4-41 shows Tukey plots of DLS data when crystallised under 
p(2-AmAA) (P6). DLS data details, including autocorrelation functions and 
radii distribution by intensity are shown in the Appendix Page 339. At the 
beginning of the experiment (T0), the average size of the particles in 
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crystallisation solution was around 30 nm, measured by size distribution. With 
the addition of p(2-AmAA) (P6), HEWL aggregates grew in size. After 360 
minutes, the average size of the particles in crystallisation solution was around 
180 nm. The size of pure p(2-AmAA) (P6) without any protein was around 3 
nm. 
 
Figure 4-41. Variations of the size of HEWL aggregates or crystals in the 
solution as a function of time during crystallisation experiments induced by 
p(2-AmAA) (P6). 
 
4.3.3.3 HEWL crystallisation in the presence of p(4-AmBA) (P7) 
4-AmBA, which has the carboxyl group and a higher molar mass than 
2-AmAA, was also chosen to generate anionic homopolymers. The following 
polymer solutions were prepared: p(4-AmBA) (P7) (DP 21): 0.02 %, 0.2 %, 
2 %, 3 %, 4 %, 5 %, 6 %, 7 % and 8 % (w/v); p(4-AmBA) (P7) (DPs 50, 100 
and 200): 0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 10 %, 12 % and 14 % (w/v) in 
0.25 M sodium acetate, 20 % NaCl, pH 4.8 buffer solution. Tables 4-18a-d 
show HEWL crystallisation plates contained p(4-AmBA) (P7) (DPs 21, 50, 
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100 and 200) as solution additives.  
Table 4-18a. HEWL crystallisation plate set up: p(4-AmBA) (P7) (DP 21) 
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Table 4-18b. HEWL crystallisation plate set up: p(4-AmBA) (P7) (DP 50) 
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Table 4-18c. HEWL crystallisation plate set up: p(4-AmBA) (P7) (DP 100) 
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Table 4-18d. HEWL crystallisation plate set up: p(4-AmBA) (P7) (DP 200) 
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Figures 4-42a-d present images of HEWL crystals obtained in the presence of 
p(4-AmBA) (P7) (DPs 21, 50, 100 and 200) at various concentrations. From 
visual observation, large HEWL crystals were formed under p(4-AmBA) with 
lower DP of 21 (Figure 4-42a). However, smaller uniform HEWL crystals were 
obtained when in the presence of p(4-AmBA) (P7) with higher DPs of 50, 100 
and 200 (Figure 4-42b-d). The pKa of p(4-AmBA) (P7) was 6.26, measured by 
titration. At pH 4.8, p(4-AmBA) (P7) was a weakly anionic polymer. Similar to 
p(2-AmAA) (P6), due to the crystallisation pH of HEWL being close (pH 4.8) 
to the pKa value of p(4-AmBA) (P7), a small number of anionic carboxyls 
remaining on the p(4-AmBA) (P7) at pH of 4.8. p(4-AmBA) with lower DP of 
21 might have very few anionic carboxyls, and therefore might compete with 
protein solutes for water and result in dehydration of protein macromolecules 
rather than by electrostatic interaction. All these HEWL crystals formed in the 
presence of anionic p(4-AmBA) (P7) were identified as tetragonal by single 
crystal X-ray diffraction. 
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a) p(4-AmBA) (P7) (DP 21) 
 
Figure 4-42a. Photomicrographs of HEWL crystals, grown under tetragonal 
crystal condition, in the presence of p(4-AmBA) (P7) (DP 21) at various 
FRQFHQWUDWLRQV ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP
sample wells without polymer. The scale bar was 500 µm. 
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b) p(4-AmBA) (P7) (DP 50) 
 
Figure 4-42b. Photomicrographs of HEWL crystals, grown under tetragonal 
crystal condition, in the presence of p(4-AmBA) (P7) (DP 50) at various 
FRQFHQWUDWLRQV ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP
sample wells without polymer. The scale bar was 500 µm. 
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c) p(4-AmBA) (P7) (DP 100) 
 
Figure 4-42c. Photomicrographs of HEWL crystals, grown under tetragonal 
crystal condition, in the presence of p(4-AmBA) (P7) (DP 100) at various 
FRQFHQWUDWLRQV ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP
sample wells without polymer. The scale bar was 500 µm. 
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d) p(4-AmBA) (P7) (DP 200) 
 
Figure 4-42d. Photomicrographs of HEWL crystals, grown under tetragonal 
crystal condition, in the presence of p(4-AmBA) (P7) (DP 200) at various 
FRQFHQWUDWLRQV ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ IURP
sample wells without polymer. The scale bar was 500 µm. 
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The HEWL images data obtained from p(4-AmBA) (P7) (DP 100) was used for 
further image analysis. Crystal size and number distribution data (Figure 4-43) 
shows that as the concentration of p(4-AmBA) (P7) (DP 100) in solution was 
increased, the number of HEWL crystals decreased and the size of the crystals 
appeared to increase slightly.  
 
Figure 4-43. Summary of photomicrograph analysis showing changes in the 
size and number of HEWL crystals, grown in the presence of p(4-AmBA) (P7) 
(DP 100) DW YDULRXV FRQFHQWUDWLRQV D $YHUDJH OHQJWK ȝP RI WKH ODUJHVW
crystal diameter; b) Experiment count for the number of crystals per sample 
ZHOO7KHVFDOHEDUZDVȝP 
 
Figure 4-44 illustrates the diffraction patterns of HEWL crystal, grown in the 
presence of p(4-AmBA) (P7) using X-ray crystallography. Table 4-19 shows 
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unit cell dimension of the HEWL tetragonal crystal. 
 
Figure 4-44. HEWL crystal photomicrograph and X-ray diffraction patterns 
yielded by the single HEWL crystal in the presence of p(4-AmBA) (P7). Two 
scattering angles: 0±1 degrees and 90±1 degrees. 
  
Table 4-19. Unit cell dimension of HEWL crystal in the presence of anionic 
p(4-AmBA) (P7) 
Polymer a, b, c (Å) ĮȕȖ Volume Unit cell lattice 
p(4-AmBA) 78.75, 78.75, 37.08 90°, 90°, 90° 229,956 Tetragonal 
 
Figure 4-45 shows Tukey plots of DLS data when HEWL crystallised in the 
presence of p(4-AmBA) (P7). DLS data details, including autocorrelation 
functions and radii distribution by intensity are shown in the Appendix Page 
339. At the beginning of the experiment (T0), the average size of the particles 
in crystallisation solution was around 20 nm, measured by size distribution. 
With the addition of p(4-AmBA) (P7), HEWL aggregates grew in size. After 
360 minutes, the average size of the particles in crystallisation solution was 
around 70 nm. The size of pure p(4-AmBA) (P7) without any protein was 
around 3 nm. 
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Figure 4-45. Variations of the size of HEWL aggregates or crystals in the 
solution as a function of time during crystallisation experiments induced by 
p(4-AmBA) (P7). 
 
In summary, the influence of anionic polymers on HEWL crystallisation was 
less than that of the cationic polymers regarding crystal shape, but the anionic 
polymers did alter the size of HEWL crystals. Figure 4-46 shows the 
hypothesis of how anionic polymers mediated HEWL crystallisation. As 
mentioned earlier, some researchers reported polymers containing cationic 
segments had an absorption behavior on negative surface, which controlled by 
charge compensation.226, 108 We proposed that anionic polymers might favor 
binding cationic HEWL macromolecules for charge compensation via 
electrostatic interaction,108 thus, they would either lower the protein and water 
interfacial energy and act as nucleation centers by the absorption of HEWL 
macromolecules, or slow down the rate of HEWL crystal further growth. 
Therefore, they acted as not only nucleators in solution but also as inhibitors.100  
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Figure 4-46. Hypothesis of mechanism of anionic polymer mediated HEWL 
crystallisation. Anionic polymer: binding cationic HEWL for charge 
compensation. HEWL macromolecules are positively charged at tetragonal 
crystallisation pH of 4.8, i.e. cationic. Na+ and Cl- ions come from the 
crystallisation buffer solutions. 
 
4.3.4 HEWL crystallisation in the presence of cationic/zwitterionic 
polymer in solution: p(METMAC-co-MEDSAH) (P8) 
A cationic/zwitterionic copolymer with both positive charges and zwitterionic 
components was applied to HEWL crystallisation. The following polymer 
solutions were prepared: p(METMAC-co-MEDSAH) (P8): 0.02 %, 0.2 %, 2 %, 
4 %, 6 %, 8 %, 10 %, 12 % and 14 % (w/v) in 0.25 M sodium acetate, 20 % 
NaCl, pH 4.8 buffer solution (Table 4-20).  
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Table 4-20. HEWL crystallisation plate: p(METMAC-co-MEDSAH) (P8) 
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Figure 4-47 shows the HEWL crystals obtained in the presence of 
p(METMAC-co-MEDSAH) (P8) at various concentrations. With the effects of 
both cation and zwitterionic sulfobetaine, p(METMAC-co-MEDSAH) (P8) 
nucleated a few crystals with complex shape. There were significant etch 
defects on the surface of crystals. 
p(METMAC-co-MEDSAH) (P8) 
 
Figure 4-47. Photomicrographs of HEWL crystals, grown under tetragonal 
crystal condition, in the presence of p(METMAC-co-MEDSAH) (P8) at 
YDULRXV FRQFHQWUDWLRQV ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ
from sample wells without polymer. The scale bar was 500 µm. 
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Figure 4-48 presents image analysis of HEWL crystals grown in the presence 
of p(METMAC-co-MEDSAH) (P8). As the concentration of 
p(METMAC-co-MEDSAH) (P8) in solution was increased, the size of the 
crystals did not vary clearly, but, the shape of crystals appeared to be more 
complex.  
 
Figure 4-48. Summary of photomicrograph analysis showing changes in the 
size and number of HEWL crystals, grown in the presence of 
p(METMAC-co-MEDSAH) (P8)D$YHUDJHOHQJWKȝPRIWKHODUJHVWFU\VWDO
diameter; b) Experiment count for the number of crystals per sample well. 
 
Cationic/zwitterionic copolymer might have different functions during HEWL 
crystallisation (Figure 4-49). It might complex with HEWL macromolecules 
for charge compensation and promoted nucleation; or may have charge-charge 
repulsions between cationic/zwitterionic polymer and cationic HEWL 
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macromolecules; after nucleation, it also might absorb on certain faces of 
crystals and influence the direction of crystal further growth.100 In these ways, 
the HEWL crystals might have complex shape; however, the crystal form was 
still tetragonal. 
 
Figure 4-49. Hypothesis of mechanisms of cationic/zwitterionic polymer 
mediated HEWL crystallisation. It can act via multiple mechanisms, i.e. 
charge-charge repulsions between cationic/zwitterionic polymer and cationic 
HEWL macromolecules; or it can complex with HEWL macromolecules for 
charge compensation; or it can absorb on certain faces of crystals and influence 
the direction of crystal further growth. HEWL macromolecules are positively 
charged at tetragonal crystallisation pH of 4.8, i.e. cationic. Na+ and Cl- ions 
are from the crystallisation buffer solutions. 
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4.4 Conclusions 
In this chapter, four classes of materials with varying degrees of charge, 
molecular weight and backbone structure were investigated for their roles as 
additives in HEWL solution, including one neutral polymer: p(PEGMA475) 
(P1); three cationic polymers: quaternised p(DMAEMA) (P2) with a series of 
quaternised ratios: 25 %, 50 %, 75 % and 100 %, a random copolymer 
p(DMAEMA-stat-PEGMA475) (P3) and p(DMAPMAm) (P4) (DPs: 38, 83 and 
150); three anionic polymers: p(AMPS) (P5) (DPs: 53, 99 and 200), 
p(2-AmAA) (P6) (DPs: 18, 46, 72 and 150) and p(4-AmBA) (P7) (DPs: 21, 50, 
100 and 200); and one cationic/zwitterionic copolymer: 
p(METMAC-co-MEDSAH) (P8) (Table 4-21). Crystallisation experiments 
were performed on 96-well plates, by using the sitting drop vapour diffusion 
technique. The results show that these polymers have different effects on 
protein crystallisation, depending on the functionality and charge of polymers. 
 
Table 4-21. Summary of polymers applied to HEWL crystallisation 
Poly-neutral p(PEGMA475) 
Poly-cationic 
Quaternised p(DMAEMA) (quaternised ratios: 
25 %, 50 %, 75 % and 100 %) 
p(DMAEMA-stat-PEGMA475) 
p(DMAPMAm) (DPs: 38, 83 and 150) 
Poly-anionic 
p(AMPS) (DPs: 53, 99 and 200) 
p(2-AmAA) (DPs: 18, 46, 72 and 150) 
p(4-AmBA) (DPs: 21, 50, 100 and 200) 
Poly-cationic/zwitterionic p(METMAC-co-MEDSAH) 
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The first protein we selected was HEWL. The pI of HEWL is 11.35, therefore 
when at its crystallisation pH 4.8, HEWL macromolecules are positively 
charged, i.e. cationic. HEWL crystallisation under conditions favouring the 
tetragonal form resulted in exclusively tetragonal crystals within 1-2 days 
without any polymer. Neutral p(PEGMA475) (P1) as a precipitant, competed 
with protein solutes for water and thus promoted HEWL crystallisation via a 
dehydration mechanism,125 resulting in a few large tetragonal crystals. Cationic 
polymers had an increased propensity for nucleating many small crystals by 
altering the electrostatic interactions between HEWL molecules and the 
solution. Moreover, instead of tetragonal crystals, two other forms of HEWL 
crystals were obtained when crystallised in the presence of quaternised 
p(DMAEMA) (P2): needles and monoclinic crystals. Anionic polymers could 
influence the size of HEWL crystals by attracting cationic HEWL 
macromolecules for charge compensation.108 Anionic p(AMPS) (P5) nucleated 
a few large crystals. However, smaller HEWL crystals were obtained when 
applied weakly anionic p(2-AmAA) (P6) and p(4-AmBA) (P7), due to the pKa 
values of p(2-AmAA) (P6) and p(4-AmBA) (P7) being close to the 
crystallisation pH 4.8. With the effects of both cation and zwitterionic 
sulfobetaine, p(METMAC-co-MEDSAH) (P8) nucleated a few crystals with 
complex shape. 
In conclusion, all these results illustrate that polymers acting as solution 
additives can mediate protein crystallisation through favourable interactions 
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between polymer and protein or the surrounding solvent system. They are 
found to influence strongly the resultant crystal size and shape, even crystal 
packing motifs; and have the ability to obtain multiple polymorphs from one 
crystallisation condition, which could save time for new constructs. 
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CHAPTER 5 
 
5. Application of Polymers to Concanavalin A (Con A) 
Crystallisation 
5.1 Introduction 
Concanavalin A (Con A) was first crystallised by Sumner and Howell,168, 169 
and Greer et al. preliminarily reported its crystallographic studies.170 Currently, 
there are several common structurally characterised crystal forms of 
concanavalin A (Con A), which bound to manganese and calcium ions, 
including orthorhombic I222 (form I),181 triclinic P1 (form II),171 orthorhombic 
C2221 (form III)172, orthorhombic C2221 (form IV)99 and orthorhombic P212121 
(form V).99 
As mentioned in Chapter 4, various polymers we prepared have clear effects on 
HEWL crystal size, shape, crystal packing motifs, and polymorphic forms 
under crystallisation conditions favouring HEWL tetragonal polymorph. In 
addition to HEWL, which is cationic under conditions in which it is normally 
crystallised, we also aimed to evaluate whether those polymers were suitable 
for other proteins, especially anionic proteins. Therefore, concanavalin A (Con 
A) was chosen as first model anionic protein for further crystallisation studies. 
The isoelectric point (pI) of Con A is 4.5,227 but crystallisation of this protein is 
normally carried out at pH 8.5, at which point Con A molecules are negatively 
charged overall (Table 5-1).  
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Table 5-1. Summary of concanavalin A (Con A) 
Protein pIa Mw (kDa) Crystallisation pH 
Con A 
4.5 25.5 8.5 
a Isoelectric point (pI) is the pH at which a particular molecule or surface 
carries no net electrical charge. 
 
Three classes of polymers were selected for further Con A crystallisation 
experiments, including neutral, cationic and anionic polymers. Based on the 
results of HEWL crystallisation, polymers with different degrees of charge and 
backbone structure have dramatically influenced the crystallisation results, 
especially the cationic quaternised p(DMAEMA) (P2). Among the anionic 
polymers we prepared, the expected pKa value of p(AMPS) (P5) (~ 0.86) was 
the smallest; thus, it would have more negative charges at the crystallisation 
pH of 8.5 than other two anionic polymers: p(2-AmAA) (P6) and p(4-AmBA) 
(P7). Therefore, in this chapter, we chose three key polymers from each class 
for their role as additives in Con A crystallisation: neutral p(PEGMA475) (P1), 
cationic quaternised p(DMAEMA) (P2) (quaternised ratio: 75 %) and anionic 
p(AMPS) (P5) (DP 99). Figure 5-1 shows a summary of hypothesis of the 
interaction of various polymers with anionic concanavalin A (Con A) in the 
protein crystallisation process. 
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Figure 5-1. Schematic representation of the interaction of various polymers 
with anionic concanavalin A (Con A) in the protein crystallisation process. (A) 
Neutral polymer: H-bonding with water and thus promoting protein 
crystallisation via a dehydration mechanism. (B) Cationic polymer: attracting 
anionic Con A for charge compensation. (C) Anionic polymer: charge-charge 
repulsions between anionic polymer and anionic Con A. Con A 
macromolecules are anionic when at crystallisation pH 8.5. NH4+ ions are 
derived from the crystallisation buffer solutions. 
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5.2 Methods 
5.2.1 Crystallisation technique and plate 
Con A was crystallised using the sitting drop vapour diffusion technique as 
described in Chapter 4 for HEWL. MRC 2 Well Crystallisation Plates (Swissci) 
(UVP plate, 96 reservoir wells) were purchased from Hampton Research. 
Specifically, a solution (50 µL) of tested polymer buffer was pipetted in 
triplicate in the reservoir wells. Protein solution (1 µL) and buffered polymer 
solution (as described above, 1 µL) were pipetted into sample wells of the 
crystallisation plate. 
 
5.2.2 Preparation of polymer solutions and stock buffer solutions 
The stock polymer solutions in H2O at a concentration of ~ 40 % (w/v) were 
prepared. In order to use polymers as part of the solution in Con A 
crystallisation, it was necessary, to alter the pH to around 8.5 by using HCl (1 
M) or NaOH (2 M). The stock buffer solutions of 1 M ammonium sulfate and 
10 mM Tris buffer at pH 8.5 and 20 mM Tris buffer at pH 8.0 were also 
prepared and filtered using a 0.2 ȝPFHOOXORVHDFHWDWHPHPEUDQHILOWHU 
The following polymer solutions were prepared at a final volume of 2 mL, 1 
mL, 500 ȝ/ or 250 ȝ/: 0.02 % (w/v), 0.2 % (w/v), 2 % (w/v), 4 % (w/v), 6 % 
(w/v), 8 % (w/v), 10 % (w/v), 12 % (w/v), 14 % (w/v), 16 % (w/v), 18 % (w/v), 
20 % (w/v), 22 % (w/v) and 24 % (w/v) in 1 M ammonium sulfate and 10 mM 
Tris buffer at pH 8.5. Polymers had dissolved completely in all solutions. 
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5.2.3 Crystallisation protocol for Con A crystals181, 209 
Con A from Canavalia ensiformis (Jack bean) was purchased from Sigma 
(Product Number: C7275, CAS Number: 11028-71-0, pI: 4.5, 4.7, 5.1, 5.5). 20 
mM Tris buffer at pH 8.0 ZDVSUHSDUHGDQGILOWHUHGWKURXJKDȝPFHOOXORVH
acetate membrane filter. This was used to prepare the 70 mg/mL Con A 
solution, which was then centrifuged at 13,000 rpm for 5 min at 4 °C. 
Con A was crystallised using the sitting drop vapour diffusion technique as 
described in Chapter 4 for HEWL. A drop of 1:1 protein:polymer solution was 
usually used here. Con A solution (1 µL, 70 mg/mL Con A in 20 mM Tris 
buffer at pH 8.0) and buffered polymer solution (1 µL, 1 M ammonium sulfate 
and 10 mM Tris buffer at pH 8.5) were pipetted into each sample well, and 
buffered polymer solution (50 µL) was pipetted into each reservoir well of the 
crystallisation plate. Con A in each sample well was 35 mg/mL. For control, 
some wells contained no polymer in their reservoir and sample solutions. The 
entire crystallisation plate system was sealed using transparent sealing tape and 
monitored using optical microscopy. Crystallisation occurred over a couple of 
days at 19 °C. 
 
5.2.4 Crystal imaging 
Optical images of Con A crystals were directly collected by a Leica 
Stereomicroscope (63 x magnifications), with a Leica fan-cooled light source, 
connected to a Nikon Coolpix 4500 digital camera (4.0 megapixels). 
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5.2.5 X-ray crystallography 
Con A crystals were determined by single crystal X-ray diffraction recorded at 
room temperature on an X-ray generator with high-flux Osmic confocal 
multi-layer optics. Con A crystals were cryoprotected with mother liquor 
containing 30 % glycerol, then flash-frozen in a nitrogen-gas stream.99, 210 
 
5.2.6 DLS studies 
For the DLS experiments on Con A crystal growth, Con A was crystallised 
using the batch crystallisation method. A protein solution of 30 mg/mL Con A 
in 20 mM Tris buffer at pH 8.0 was mixed with a polymer solution of 1 M 
ammonium sulfate and 10 mM Tris buffer at pH 8.5. Three classes of polymers, 
containing neutral polymer: p(PEGMA475) (P1), cationic polymer: quaternised 
p(DMAEMA) (P2) (quaternised ratio: 75 %) and anionic polymer: p(AMPS) 
(P5) (DP 99) were used here. Crystal growth time: 2 hours. Control 
experiments contained no polymer in the crystallisation solution. 
 
5.2.7 SEM analysis 
Con A crystals grown in the presence of selected polymers neutral 
p(PEGMA475) (P1), cationic quaternised p(DMAEMA) (P2) (quaternised ratio: 
75 %) and anionic p(AMPS) (P5) by using sitting drop vapour diffusion 
method were subjected to SEM analysis in this project. 
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5.3 Results and discussion 
5.3.1 Con A crystallisation in the presence of neutral polymer in solution: 
p(PEGMA475) (P1) 
By using the above mentioned pH-altered stock buffer solution, the following 
p(PEGMA475) (P1) solutions with various concentrations were prepared: 
0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 10 % and 12 % (w/v) (Table 5-2). 
Table 5-2. Con A crystallisation plate set up: p(PEGMA475) 
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Figure 5-2 shows images of Con A crystals formed in the presence of 
p(PEGMA475) (P1). Con A solutions produced small crystals with sizes of 
around 60 µm within 1 week in the absence of polymer (Figure 5-2, Control). 
When p(PEGMA475) (P1) was added to the solution, the size and number of 
Con A crystals were found to vary very clearly. Neutral polymer p(PEGMA475) 
(P1) resulted in a few large rectangular crystals. 
 
Figure 5-2. Selected photomicrographs of Con A crystals, grown in the 
presence of p(PEGMA475) (P1) at various concentrations. Image labelled 
µ&RQWURO¶UHSUHVHQWVCon A crystals grown from sample wells without polymer. 
The scale bar was 200 µm. 
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Con A crystal size and number distribution depending on neutral p(PEGMA475) 
(P1) concentration was obtained by further image analysis (Figure 5-3). For 
anionic Con A, as the concentration of p(PEGMA475) (P1) in solution was 
increased, the number of Con A crystals appeared to decrease, and the size of 
the crystals appeared to increase. 
 
Figure 5-3. Summary of photomicrograph analysis of Con A crystals, grown in 
the presence of p(PEGMA475) (P1) at various concentrations. a) Average length 
ȝP RI WKH ODUJHVW FU\VWDO GLDPHWHU E ([SHULPHQW FRXQW IRU WKH QXPEHU RI
crystals per sample well. 
 
Diffraction data were collected for Con A crystals by single crystal X-ray 
diffraction recorded at room temperature. Figure 5-4 illustrates the diffraction 
patterns of Con A crystals formed in the absence of polymer (Control) and in 
the presence of p(PEGMA475) (P1) by X-ray crystallography; and Table 5-3 
shows diffraction data of Con A crystals, which confirmed as orthorhombic 
(space group: C2221, form IV). 
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Figure 5-4. Con A crystals photomicrographs and X-ray diffraction patterns 
yielded by the single Con A crystal in the presence of neutral p(PEGMA475) 
(P1). ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV Con A crystals grown from sample 
wells without p(PEGMA475) (P1). Two scattering angles: 0±1 degrees and 
90±1 degrees. 
 
Table 5-3. Diffraction data collection for Con A crystals formed in the absence 
(Control) and presence of neutral p(PEGMA475) (P1) 
 Control p(PEGMA475) (P1) 
Space group C2221 C2221 
Unit cell lattice Orthorhombic Orthorhombic 
Cell dimentions: a, b, c (Å) 
              ĮȕȖ 
101.4, 119.2, 250.2 
90°, 90°, 90° 
102.0, 119.4, 251.0 
90°, 90°, 90° 
Resolution (Å) 50-2.8 50-2.8 
Crystal-to-detector distance 170 mm 170 mm 
Con A form Form IV Form IV 
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100 ȝ/ of 2 mg/mL p(PEGMA475) (P1) in 1 M ammonium sulfate and 10 mM 
Tris buffer at pH 8.5 was mixed with 100 ȝ/ of 30 mg/mL Con A in 20 mM 
Tris buffer at pH 8.0; then dispensed to a VISCOTEK DLS Quartz cell. Figure 
5-5 shows a summary of DLS data of Con A crystallisation under neutral 
p(PEGMA475) (P1) at time points T0 and T120min. Figure 5-5a shows 
autocorrelation functions, which were analysed by DLS to obtain the 
distribution of particle radii, as shown in Figure 5-5b. 
 
Figure 5-5. Summary of DLS data of Con A crystallisation under neutral 
p(PEGMA475) (P1) at time points T0 and T120min: a) representative 
autocorrelation functions; b) radii distribution by intensity. 
 
Representative Tukey plots of DLS data further illustrate protein aggregates 
growing in size as a function of time during Con A crystallisation experiments 
                         
  
T=0 T=120 min 
b) T=0 T=120 min 
a) 
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under neutral p(PEGMA475) (P1) (Figure 5-6). At the beginning of the 
experiment (T0), the average size of the particles in the crystallisation solution 
was around 4 µm, measured by size distribution. With the addition of 
p(PEGMA475) (P1), Con A crystallisation initiated and aggregates formed. As 
the time increased, Con A aggregates grew in size. After 120 minutes, the 
average size of the particles in the crystallisation solution was around 9 µm. 
The size of pure neutral p(PEGMA475) (P1) without any protein in solution was 
around 7 nm. 
 
Figure 5-6. Variations of the size of Con A aggregates or crystals in the solution 
as a function of time during crystallisation experiments induced by neutral 
p(PEGMA475) (P1). Tukey plots ODEHOOHGµ&RQWURO¶UHSUHVHQW Con A aggregates 
or crystals grown from in the absence of polymer. 
 
Con A crystals were taken out from the crystallisation plates then washed with 
crystallisation buffer solutions for SEM analysis. Figure 5-7 contains 
micrographs of Con A crystals grown in the absence (a) and presence of neutral 
p(PEGMA475) (P1) (b). Con A crystals were poorly defined and had significant 
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etch defects without applied polymer (Figure 5-7a). With the addition of 
neutral p(PEGMA475) (P1), Con A crystals had round edges with significant 
etch defects, however, p(PEGMA475) (P1) still improved the size and shape of 
Con A crystal (Figure 5-7b). Compared with optical microscopy images, SEM 
images of Con A crystals did not look so well. This may because of poor 
mechanical properties and stability of protein crystals. 
 
Figure 5-7. SEM micrographs of Con A crystals formed by sitting drop method: 
a) control, without any polymer, -- x 600 magnifications; the scale bar was 20 
ȝm; b) in the presence of p(PEGMA475) (P1), -- x 330 magnifications; the scale 
bar was 50 ȝm. 
 
All above results suggest neutral p(PEGMA475) (P1) had a similar effect on 
crystal formation to that which occurred in HEWL crystallisation. Figure 5-8 
presents a proposed mechanism of neutral polymer mediated Con A 
crystallisation. Neutral p(PEGMA475) (P1) competed with protein solutes for 
water and dehydrated protein macromolecules.125 Moreover, p(PEGMA475) 
might KDYH µYROXPH-H[FOXGHG HIIHFWV¶ E\ K\GURSKRELF H[FOXVLRQ RI SURWHLQ
a b 
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solutes.224 It could also lower the dielectric constant of the solution, 
consequently protein aggregation and phase separation was promoted. 
Therefore, Con A macromolecules were compelled to associate with each other. 
 
Figure 5-8. Schematic representation of hypothesis of anionic Con A 
crystallisation process in the absence of polymer (A); and the interaction of 
neutral p(PEGMA475) (P1) with anionic Con A in the protein crystallisation 
process (B). Con A macromolecules are negatively charged at crystallisation 
pH of 8.5, i.e. anionic. NH4+ and SO4- ions come from the crystallisation buffer 
solutions. 
 
5.3.2 Con A crystallisation in the presence of cationic polymer in solution: 
quaternised p(DMAEMA) (P2) 
The following quaternised p(DMAEMA) (P2) (quaternised ratio: 75 %) 
solutions with various concentrations were prepared: 0.02 %, 0.2 %, 2 %, 4 %, 
6 %, 8 %, 10 %, 12 % and 14 % (w/v) (Table 5-4). 
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Table 5-4. Con A crystallisation plate set up: quaternised p(DMAEMA) (P2) 
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Figure 5-9 shows Con A crystals formed in the presence of quaternised 
p(DMAEMA) (P2). Cationic polymer was likely to nucleate a few large block 
shape crystals. 
Quaternised p(DMAEMA) (P2) 
 
Figure 5-9. Photomicrographs showing changes in the size and shape of Con A 
crystals, grown in the presence of quaternised p(DMAEMA) (P2) (quaternised 
ratio: 75 %) at various concentrations. ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV
crystals grown from sample wells without polymer. The scale bar was 200 µm. 
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Figure 5-10 shows image analysis of Con A crystal size distribution by 
PHDVXULQJWKHDYHUDJHOHQJWKȝPRIWKHODUJHVWGLDPHWHURIHDFKFU\VWDOand 
number distribution depending on quaternised p(DMAEMA) (P2) 
concentration. For anionic Con A, as the concentration of quaternised 
p(DMAEMA) (P2) in solution was increased, the number of Con A crystals 
appeared to decrease, and the size of the crystals appeared to increase. 
 
Figure 5-10. Summary of photomicrograph analysis of Con A crystals, grown 
in the presence of quaternised p(DMAEMA) (P2) at various concentrations. a) 
$YHUDJH OHQJWK ȝP RI WKH ODUJHVW FU\VWDO GLDPHWHU. b) Experiment count for 
the number of crystals per sample well. 
 
100 ȝ/ of 2 mg/mL quaternised p(DMAEMA) (P2) in 1 M ammonium sulfate 
and 10 mM Tris buffer at pH 8.5 was mixed with 100 ȝ/ of 30 mg/mL Con A 
in 20 mM Tris buffer at pH 8.0 for DLS study. Figure 5-11 shows a summary 
of DLS data of Con A crystallisation under cationic quaternised p(DMAEMA) 
(P2) at time points T0 and T120min. Figure 5-11a shows autocorrelation functions, 
which were analysed by DLS to obtain the distribution of particle radii, as 
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shown in Figure 5-11b.  
 
Figure 5-11. Summary of DLS data of Con A crystallisation under quaternised 
p(DMAEMA) (P2) at time points T0 and T120min: a) representative 
autocorrelation functions; b) radii distribution by intensity. 
 
Representative Tukey plots of DLS data show Con A aggregates growing in 
size in the presence of quaternised p(DMAEMA) (P2) as a function of time 
during crystallisation experiments as shown in Figure 5-12. At the beginning of 
the experiment (T0), the average size of the particles in the crystallisation 
solution was around 300 nm, measured by size distribution. With the addition 
of quaternised p(DMAEMA) (P2), an increase in size of the Con A aggregates 
was observed. After 120 minutes (T120min), the average size of the aggregates in 
the crystallisation solution was around 1000 nm. The size of pure quaternised 
p(DMAEMA) (P2) in solution was around 18 nm. 
                        
      
a) 
T=0 T=120 min 
b) T=0 T=120 min 
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Figure 5-12. Variations of the size of Con A aggregates or crystals in the 
solution as a function of time during crystallisation experiments induced by 
cationic quaternised p(DMAEMA) (P2). 
 
The SEM micrograph result of Con A crystals is shown in Figure 5-13. Con A 
crystals formed under quaternised p(DMAEMA) (P2) also had round edges 
with significant etch defects, due to poor mechanical properties and stability of 
protein crystals. 
 
Figure 5-13. SEM micrographs of Con A crystals formed in the presence of 
quaternised p(DMAEMA) (P2), -- x 200 magnifications; the scale bar was 100 
ȝm. 
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In summary of all above results obtained in the presence of cationic 
quaternised p(DMAEMA) (P2), for anionic proteins, such as Con A, the 
cationic polymer was likely to have attracted anionic Con A macromolecules 
by electrostatic interaction for charge compensation in the crystallisation 
process (Figure 5-14). Therefore, the cationic polymer would either lower the 
protein and water interfacial energy and act as nucleation centers by the 
absorption of Con A macromolecules, or slow down the rate of further growth 
of Con A crystal. 
 
Figure 5-14. Hypothesis of mechanism of cationic polymer mediated Con A 
crystallisation. Cationic polymer attracted anionic Con A for charge 
compensation. Con A macromolecules were anionic when at crystallisation pH 
8.5. NH4+ and SO4- ions were from the crystallisation buffer solutions. 
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5.3.3 Con A crystallisation in the presence of anionic polymer in solution: 
p(AMPS) (P5) 
The following p(AMPS) (P5) (DP 99) solutions with various concentrations 
were prepared: 0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 10 %, 12 % and 14 % (w/v) 
(Table 5-5). 
Table 5-5. Con A crystallisation plate set up: p(AMPS) (P5) (DP 99) 
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Figure 5-15 shows images of Con A crystals formed in the presence of 
p(AMPS) (P5) (DP 99). Anionic p(AMPS) (P5) accelerated Con A aggregation 
and the formation of multiple nuclei, produced many small crystals with sizes 
of ~ 20µm. 
p(AMPS) (P5) (DP 99) 
 
Figure 5-15. Photomicrographs of Con A crystals, grown in the presence of 
p(AMPS) (P5) (DP 99) DW YDULRXV FRQFHQWUDWLRQV ,PDJHV ODEHOOHG µ&RQWURO¶
represent crystals grown from sample wells without polymer. The scale bar 
was 200 µm. 
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Image analysis of photomicrograph data E\PHDVXULQJWKHDYHUDJHOHQJWKȝP
of the largest diameter of each crystal depending on p(AMPS) (P5) 
concentration was obtained (Figure 5-16). However, it was not easy to obtain 
the number distribution, due to the amount of small crystals in the whole 
sample well was too large. For anionic Con A, as the concentration of p(AMPS) 
(P5) in solution was increased, the size of crystals appeared to decrease. At the 
concentration of 14 % (w/v), the size of Con crystal was around 20 µm. 
 
Figure 5-16. Summary of photomicrograph analysis of Con A crystals, grown 
in the presence of p(AMPS) (P5) at various concentrations. 
 
100 ȝ/ of 2 mg/mL p(AMPS) (P5) in 1 M ammonium sulfate and 10 mM Tris 
buffer at pH 8.5 was mixed with 100 ȝ/ of 30 mg/mL Con A in 20 mM Tris 
buffer at pH 8.0; then dispensed to a VISCOTEK DLS Quartz cell for DLS 
study. Figure 5-17 shows a summary of DLS data of Con A crystallisation 
under anionic p(AMPS) (P5) at time points T0 and T100min. Figure 5-17a shows 
autocorrelation functions, which were analysed by DLS to obtain the 
distribution of particle radii, as shown in Figure 5-17b and c. 
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Figure 5-17. Summary of DLS data of Con A crystallisation under anionic 
p(AMPS) (P5) DP (99) at time points T0 and T100min: a) representative 
autocorrelation functions; b) radii distribution by intensity; c) radii distribution 
by number. 
 
Representative Tukey plots of above DLS data show an increase in the size of 
protein aggregates when in the presence of p(AMPS) (P5) as a function of time 
during crystallisation experiments (Figure 5-18). Con A aggregates growing in 
size can be observed during the crystallisation experiment. At the beginning of 
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the experiment (T0), Con A macromolecules were non-interacting in the 
solution. The decay time was very short. The average size of the particles in 
crystallisation solution was around 5 nm, measured by size distribution. With 
the addition of anionic p(AMPS) (P5), Con A crystallisation initiated and 
aggregates formed. As the time increased, Con A aggregates grew in size. 
Large particles diffused slower than small particles, and the correlation 
function decayed at a slower rate. After 120 minutes (T120min), the average size 
of the particles in crystallisation solution was around 700 nm. The size of pure 
p(AMPS) (P5) (DP 99) without any protein was around 4 nm. 
 
Figure 5-18. Variations of the size of Con A aggregates or crystals in the 
solution as a function of time during crystallisation experiments induced by 
anionic p(AMPS) (P5). 
 
Con A crystals were then taken out from the crystallisation plates, washed with 
1 M ammonium sulfate and 10 mM Tris buffer solution at pH 8.5 for SEM 
study. The SEM micrograph result (Figure 5-19) shows that although Con A 
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crystals had slight rounded edges under p(AMPS) (P5), however, they were 
better than that obtained under neutral p(PEGMA475) (P1) and cationic 
quaternised p(DMAEMA) (P2). This may suggest that p(AMPS) (P5) could 
enhance the stability of Con A crystals. 
 
Figure 5-19. SEM micrograph of Con A crystals formed in the presence of 
p(AMPS) (P5), -- x 220 magnifications; the scale bar was 100 ȝm. 
 
In summary of the above results obtained in the presence of p(AMPS) (P5), we 
proposed that at Con A crystallisation pH of 8.5, anionic polymer molecules 
had some negative charges, resulting LQ µFKDUJH-FKDUJH¶ UHSXOVLRQV EHWZHHQ
anionic polymer molecules and anionic Con A macromolecules, lowering the 
interfacial energy between Con A macromolecules and water, thus, leading to 
the promotion of the nucleation rate and formation of multiple nuclei (Figure 
5-20).226, 108 
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Figure 5-20. Hypothesis of mechanism of anionic polymer mediated Con A 
crystallisation. Anionic polymer: charge-charge repulsions between anionic 
polymer and anionic Con A. Con A macromolecules were anionic when at 
crystallisation pH 8.5. NH4+ and SO4- ions were from the crystallisation buffer 
solutions. 
 
5.4 Conclusions 
In this chapter, three polymers with varying degrees of charge, molecular 
weight and backbone structure were selected from each class and investigated 
as solution additives for Con A crystallisation, including neutral p(PEGMA475) 
(P1), cationic quaternised p(DMAEMA) (P2) with quaternised ratio: 75 % and 
anionic p(AMPS) (P5). Crystallisation experiments were performed on 96-well 
plates using the sitting drop vapour diffusion technique as well. 
Con A crystallisation experiments produced small orthorhombic crystals (space 
group: C2221, form IV) with sizes of ~ 60 ȝP within 1 week in the absence of 
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polymer. When polymers were utilised, the sizes and numbers of crystals were 
found to vary with the types of polymers added to solution, however, the form 
of crystals was still orthorhombic. Neutral polymers resulted in a few large 
block-shaped crystals with sizes of ~ 200 ȝP VXJJHVWLQJ D VLPLODU effect on 
crystal formation to that which occurred in HEWL crystallisation. Cationic 
polymers were likely to have attracted anionic Con A macromolecules by 
electrostatic interaction for charge compensation, and nucleated a few large 
crystals as well with sizes of ~ 150 ȝP Anionic polymers accelerated Con A 
aggregation and produced many smaller crystals with sizes of ~ 20 ȝPwithin 
four days. In conclusion, all these results illustrate that polymers with varying 
net charges, acted as solution additives to mediate protein crystallisation and 
have the ability to alter the size of protein crystals. 
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CHAPTER 6 
 
6. Application of Polymers to Bovine Liver Catalase (BLC) 
Crystallisation 
6.1 Introduction 
Bovine liver catalase (BLC) was crystallised by Sumner and Dounce in 
1937.185 BLC has three structurally characterised crystal forms: trigonal P3221 
(form I),186 orthorhombic P212121 (form II)187 and another orthorhombic (form 
III).188 Forms I and II of BLC have been fully characterised using single X-ray 
diffraction previously. Form III only has previously been analysed by electron 
microscopy and powder X-ray diffraction.230, 231, 232, 233 It is very difficult to 
obtain high quality single BLC crystals, by using traditional growth methods. 
Moreover, BLC crystals are H[WUHPHO\ WKLQȝP231 it is therefore hard to 
get X-ray diffraction pattern. Recently, Matzger et al. utilised polymer-induced 
heteronucleation (PIHn) approach; i.e. cross-linked polymer films as 
heteronucleants, for BLC crystallisation, and got crystals suitable for single 
crystal X-ray diffraction (form III).188, 99 However, whether polymers were 
used DVµDGGLWLYHV¶ in solution can mediate BLC crystallisation successfully or 
not, rarely has been studied. 
Therefore, in addition to HEWL and Con A, a third model protein: bovine liver 
catalase (BLC), was chosen as model anionic protein for further crystallisation 
studies. The isoelectric point (pI) of BLC is 5.4,222 and when at crystallisation 
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pH of 6.8, BLC macromolecules will carry some negative charges, hence being 
a weekly anionic protein at this pH (Table 6-1). 
Table 6-1. Summary of bovine liver catalase (BLC) 
Protein pIa Mw (kDa) Crystallisation pH 
BLC 
5.4 60 6.8 
a Isoelectric point (pI) is the pH at which a particular molecule or surface 
carries no net electrical charge. 
 
As described in Chapter 5, in order to evaluate the effect of those polymers 
with different degrees of charge and backbone structure on other proteins, 
especially anionic proteins, three key polymers from each class, neutral 
p(PEGMA475) (P1), cationic quaternised p(DMAEMA) (P2) (quaternised ratio: 
75 %) and anionic p(AMPS) (P5) (DP 99) were also applied for BLC 
crystallisation by using sitting drop vapour diffusion crystallisation protocols. 
The crystallisation condition used here was first reported by McPherson and 
co-workers.210 Figure 6-1 shows a summary of hypothesis of the interaction of 
various polymers with weakly anionic bovine liver catalase (BLC) in the 
protein crystallisation process. 
CHAPTER 6. Application of Polymers to Bovine Liver Catalase (BLC) Crystallisation 
288 
 
 
Figure 6-1. Schematic representation of the interaction of various polymers 
with anionic bovine liver catalase (BLC) in the protein crystallisation process. 
(A) Neutral polymer: H-bonding with water and thus promoting protein 
crystallisation via a dehydration mechanism. (B) Cationic polymer: attracting 
anionic BLC for charge compensation. (C) Anionic polymer: charge-charge 
repulsions between anionic polymer and anionic BLC. BLC macromolecules 
are weakly anionic when at crystallisation pH 6.8. Na+ ions are derived from 
the crystallisation buffer solutions. 
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6.2 Methods 
6.2.1 Crystallisation technique and plate 
BLC was also crystallised using the sitting drop vapour diffusion technique as 
described in Chapter 4 for HEWL. MRC 2 Well Crystallisation Plates (Swissci) 
(UVP plate, 96 reservoir wells) were purchased from Hampton Research. 
Specifically, a solution (50 µL) of tested polymer buffer was pipetted in 
triplicate in the reservoir wells. Protein solution (1 µL) and buffered polymer 
solution (as described above, 1 µL) were pipetted into sample wells of the 
crystallisation plate. 
 
6.2.2 Preparation of polymer solutions and stock buffer solutions 
Similar as procedures described in Chapter 4, the stock polymer solution was 
prepared and adjusted to the BLC crystallisation pH of 6.8. The stock buffer 
solutions of 12 % PEG 4000 and 0.05 M sodium phosphate buffer at pH 6.8 
and 0.05 M sodium phosphate buffer at pH 6.8 were prepared and filtered 
using a 0.2 ȝP FHOOXORVH DFHWDWH PHPEUDQH ILOWHU By using the above 
mentioned pH-altered polymer solutions and the stock buffer solutions, the 
following polymer solutions were prepared: 0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 
10 %, 12 %, 14 %, 16 %, 18 %, 20 %, 22 % and 24 % (w/v) in 12 % PEG 4000 
and 0.05 M sodium phosphate buffer at pH 6.8. All polymers dissolved 
completely in the buffer solutions.  
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6.2.3 Crystallisation protocol for BLC crystals209, 211 
Catalase from bovine liver (BLC) was purchased from Sigma (Product Number: 
C40, EC Number: 1.11.1.6, CAS Number: 9001-05-2, pI: 5.4). 0.05 M sodium 
phosphate buffer at pH 6.8 ZDV SUHSDUHG DQG ILOWHUHG WKURXJK D  ȝP
cellulose acetate membrane filter. A protein solution of 40 mg/mL BLC was 
prepared and then centrifuged at 13,000 rpm for 5 min at 4 °C. 
BLC was crystallised following the sitting drop vapour diffusion procedures, in 
a similar manner to HEWL crystallisation in Chapter 4, with a BLC solution of 
40 mg/mL BLC in 0.05 M sodium phosphate buffer at pH 6.8 and a polymer 
solution of 12 % PEG 4000 and 0.05 M sodium phosphate buffer at pH 6.8 in 
the sample well, and 50 µL of tested polymer buffer in the reservoir well.210 
For control experiments, some reservoir and sample wells contained no 
polymer. The entire crystallisation plate system was sealed using transparent 
sealing tape and incubated at 19 °C. 
 
6.2.4 Crystal imaging 
Optical photomicrographs of BLC crystals were directly collected by a Leica 
Stereomicroscope (63 x magnifications), with a Leica fan-cooled light source, 
connected to a Nikon Coolpix 4500 digital camera. 
  
6.2.5 X-ray crystallography 
BLC crystallographic parameters were determined by single crystal X-ray 
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diffraction recorded at room temperature on an X-ray generator with high-flux 
Osmic confocal multi-layer optics. BLC crystals were cryoprotected with 
mother liquor containing 30 % ethylene glycol, then flash-frozen in a 
nitrogen-gas stream.99, 210 
 
6.2.6 DLS studies 
Similar to HEWL, the batch crystallisation method was applied for a DLS time 
study of BLC crystallisation. Because the optimum intensity range for DLS 
measurement is 300-8000, a protein solution of 20 mg/mL BLC in 0.05 M 
sodium phosphate buffer at pH 6.8 was mixed with a polymer solution in 12 % 
PEG 4000 and 0.05 M sodium phosphate buffer at pH 6.8 to induce BLC 
crystallisation. Three classes of polymers, comprising neutral polymer: 
p(PEGMA475) (P1), cationic polymer: quaternised p(DMAEMA) (P2) 
(quaternised ratio: 75 %) and anionic polymer: p(AMPS) (P5) (DP 99) were 
utilised here. Temperature: 19 °C. Crystal growth time: 2 hours. 
 
6.3 Results and discussion 
6.3.1 BLC crystallisation in the presence of neutral polymer in solution: 
p(PEGMA475) (P1) 
By using the above mentioned pH-altered stock buffer solution, the following 
p(PEGMA475) (P1) solutions with various concentrations were prepared: 
0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 10 %, 12 % and 14 % (w/v) in 12 % PEG 
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4000 and 0.05 M sodium phosphate buffer at pH 6.8. Table 6-2 shows BLC 
crystallisation plate set up and Figure 6-2 shows images of BLC crystals grown 
from solutions containing neutral p(PEGMA475) (P1). 
Table 6-2. BLC crystallisation plate set up: p(PEGMA475) 
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p(PEGMA475) (P1) 
 
Figure 6-2. Selected photomicrographs of BLC crystals, grown in the presence 
of p(PEGMA475) (P1) DW YDULRXV FRQFHQWUDWLRQV ,PDJH ODEHOOHG µ&RQWURO¶
represents BLC crystals grown from sample wells without polymer. The scale 
bar was 200 µm. 
 
BLC crystal formation in the absence of added polymer occurred after two 
weeks and resulted in needle crystals outgrowth from a single point in a 
µZKHDWVKHDI¶PRUSKRORJ\(Figure 6-2, Control). However, it proved difficult to 
obtain good quality single crystals without any added polymer. The literature 
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reports that orthorhombic BLC crystals typically exhibite an extremely high 
defect density and incorporate great numbers of misoriented microcrystals.210 
Neutral polymer p(PEGMA475) (P1) nucleated a few long crystals at lower 
concentrations (< 4 %, w/v). However, the quality of these crystals was poor 
and it was not possible to determine their structure by single crystal X-ray 
diffraction. 
The solutions in the sample wells were not clear enough for fully automated 
image analysis; therefore, we did both manual and automated analysis. A full 
summary of BLC crystals size distribution by measuring the average length 
ȝPRIWKHODUJHVWGLDPHWHURIHDFKFU\VWDOand number distribution depending 
on neutral p(PEGMA475) (P1) concentration was obtained by further image 
analysis (Figure 6-3). For anionic BLC, as the concentration of p(PEGMA475) 
(P1) in solution was increased, the size of crystals increased first. However, as 
shown in Figure 6-2 above, when the concentration of neutral p(PEGMA475) 
(P1) was above 4 %, µZKHDWVKHDI¶ shape BLC crystals formed rather than large 
and thin crystals. As the concentration of p(PEGMA475) (P1) was increased, the 
size of µZKHDWVKHDI¶ shape BLC crystals decreased slightly. 
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Figure 6-3. Summary of photomicrograph analysis of BLC crystals, grown in 
the presence of p(PEGMA475) (P1) at various concentrations. a) Average length 
ȝP RI WKH ODUJHVW FU\VWDO GLDPHWHU. b) Experiment count for the number of 
crystals per sample well. 
 
For the DLS study, a protein solution of 20 mg/mL BLC in 0.05 M sodium 
phosphate buffer at pH 6.8 mixed with a polymer solution in 12 % PEG 4000 
and 0.05 M sodium phosphate buffer at pH 6.8 was employed, which was then 
dispensed to a VISCOTEK DLS Quartz cell. The control experiment contained 
no polymer in the crystallisation solution. Figure 6-4 shows a summary of DLS 
data of BLC crystallisation under neutral p(PEGMA475) (P1) at time points T0 
and T120min. Figure 6-4a shows autocorrelation functions, which were analysed 
by DLS to obtain the distribution of particle radii, as shown in Figure 6-4b. 
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Figure 6-4. Summary of DLS data of BLC crystallisation under neutral 
p(PEGMA475) (P1) at time points T0 and T120min: a) representative 
autocorrelation functions; b) radii distribution by intensity. 
 
Figure 6-5 illustrate representative Tukey plots of the above DLS data. The 
characteristic increase in the size of BLC aggregates can be observed in all 
cases. At the beginning of the experiment (T0) under p(PEGMA475) (P1), the 
average size of the particles in the crystallisation solution was around 0.9 µm, 
measured by size distribution. With the addition of p(PEGMA475) (P1), BLC 
crystallisation initiated and aggregates formed. As the time increased, BLC 
aggregates grew in size. After 120 minutes (T120min), the average size of the 
particles in the crystallisation solution was around 2 µm. As a control, the 
experiment was also carried out without polymer. 
                      
      
a) 
T=0 T=120 min 
b) T=0 T=120 min 
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Figure 6-5. Variations of the size of BLC aggregates or crystals in the solution 
as a function of time during crystallisation experiments induced by neutral 
p(PEGMA475) (P1). Tukey plots ODEHOOHG µ&RQWURO¶ UHSUHVHQW crystals grown 
from solutions without polymer. 
 
The above results suggest that neutral p(PEGMA475) (P1) competed with 
protein solutes for water, and thereby acted as a precipitant to mediate BLC 
crystallisation, leading to protein aggregation similar to HEWL and Con A 
(Figure 6-6B).125 Therefore, BLC macromolecules were compelled to associate 
with each other. However, as the concentration of p(PEGMA475) (P1) in 
solution increased, the increased number of nucleation sites caused by the high 
concentration of precipitant in combination with the increased viscosity of 
these solutions, promoted the formation of needle crystal outgrowth from a 
single point in the µZKHDWVKHDI¶PRUSKRORJ\.210 
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Figure 6-6. Schematic representation of hypothesis of anionic BLC 
crystallisation process in the absence of polymer (A); and the interaction of 
neutral p(PEGMA475) (P1) with anionic BLC in the protein crystallisation 
process (B). BLC macromolecules are negatively charged at crystallisation pH 
of 6.8, i.e. weakly anionic. Na+ and PO43- ions are from the crystallisation 
buffer solutions. 
 
6.3.2 BLC crystallisation in the presence of cationic polymer in solution: 
quaternised p(DMAEMA) (P2) 
The following quaternised p(DMAEMA) (P2) (quaternised ratio: 75 %) 
solutions with various concentration were prepared: 0.02 %, 0.2 %, 2 %, 4 %, 
6 %, 8 %, 10 % and 12 % (w/v). Table 6-3 shows BLC crystallisation plate set 
up and Figure 6-7 shows images of BLC crystals formed in the presence of 
quaternised p(DMAEMA) (P2).  
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Table 6-3. BLC crystallisation plate set up: quaternised p(DMAEMA) (P2) 
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Quaternised p(DMAEMA) (P2) 
 
Figure 6-7. Photomicrographs of BLC crystals, grown in the presence of 
quaternised p(DMAEMA) (P2) at various concentrations. Images labelled 
µ&RQWURO¶ UHSUHVHQW FU\VWDOV JURZQ IURP VDPSOH ZHOOV ZLWKRXW SRO\PHU 7KH
scale bar was 200 µm. 
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From visual inspection of Figure 6-7, when cationic quaternised p(DMAEMA) 
(P2) was utilised, long and thin crystals were formed at concentration of 0.02 % 
(w/v). A few needles with a µVHD-XUFKLQ¶ PRUSKRORJ\ IRUPHG DW ORZHU
concentrations (0.2 % ~ 2 %, w/v). However, as the concentration of cationic 
quaternised p(DMAEMA) (P2) in solution increased, it was hard to get BLC 
crystals, almost no BLC crystals were formed by using cationic quaternised 
p(DMAEMA) (P2) at higher concentrations. There may be several reasons. 
First, BLC was not easy to crystallise by using orthorhombic P212121 
crystallisation condition because orthorhombic BLC growth mechanism was 
complicated.210 Moreover, at pH 8.5, cationic quaternised p(DMAEMA) (P2) 
might favor attracting anionic BLC macromolecules by electrostatic interaction, 
resulting in the suppression of BLC crystallisation. Thus, insufficient BLC 
macromolecules could aggregate together and form nuclei. 
Figure 6-8 shows a summary of DLS data of BLC crystallisation from solution 
containing cationic quaternised p(DMAEMA) (P2) at time points T0 and 
T120min. Moreover, representative Tukey plots of DLS data are shown in Figure 
6-9. An increase in size of BLC aggregates was observed during the 
crystallisation experiments. At the beginning of the experiment (T0), the 
average size of the particles in the crystallisation solution was around 400 nm, 
measured by size distribution. With the addition of quaternised p(DMAEMA) 
(P2), BLC aggregates grew in size. After 120 minutes (T120min), the average 
size of the particles in crystallisation solution was around 8000 nm. 
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Figure 6-8. Summary of DLS data of BLC crystallisation under cationic 
quaternised p(DMAEMA) (P2) at time points T0 and T120min: a) representative 
autocorrelation functions; b) radii distribution by intensity. 
 
 
Figure 6-9. Variations of the size of BLC aggregates or crystals in the solution 
as a function of time during crystallisation experiments induced by cationic 
quaternised p(DMAEMA) (P2). 
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6.3.3 BLC crystallisation in the presence of anionic polymer in solution: 
p(AMPS) (P5) 
The following p(AMPS) (P5) solutions with various concentrations were 
prepared: 0.02 %, 0.2 %, 2 %, 4 %, 6 %, 8 %, 10 %, 12 %, 14 % and 16 % (w/v) 
in 12 % PEG 4000 and 0.05 M sodium phosphate buffer at pH 6.8 (Table 6-4). 
Table 6-4. BLC crystallisation plate set up: p(AMPS) (P5) (DP 99) 
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Figure 6-10 shows photomicrographs of BLC crystals formed in the presence 
of p(AMPS) (P5). When p(AMPS) (P5) was used for BLC crystallisation, the 
size and shape of BLC crystals were found to vary very clearly. Anionic 
p(AMPS) (P5) promoted BLC aggregation, with single crystals being obtained 
in 10 days. 
p(AMPS) (P5) (DP 99) 
 
Figure 6-10. Photomicrographs of BLC crystals formed in the presence of 
p(AMPS) 3 DW YDULRXV FRQFHQWUDWLRQV ,PDJHV ODEHOOHG µ&RQWURO¶ UHSUHVHQW
crystals grown from sample wells without polymer. The scale bar was 200 µm. 
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Figure 6-11 shows image analysis of BLC crystals size distribution by 
PHDVXULQJWKHDYHUDJHOHQJWKȝPRIWKHODUJHVWGLDPHWHURIHDFKFU\VWDOand 
number distribution depending on anionic p(AMPS) (P5) concentration. For 
weakly anionic BLC, as the concentration of p(AMPS) (P5) in solution was 
increased, the number of BLC crystals appeared to increase and the size of the 
crystals appeared to decrease slightly. 
 
Figure 6-11. Summary of photomicrograph analysis of BLC crystals, grown in 
the presence of p(AMPS) (P5) at various concentrations. a) AvHUDJHOHQJWKȝP
of the largest crystal diameter; b) Experiment count for the number of crystals 
per sample well. 
 
Figure 6-12 illustrates the diffraction patterns of BLC crystal formed in the 
presence of anionic p(AMPS) (P5) by X-ray crystallography. X-ray diffraction 
identified the crystal form was orthorhombic (space group: P212121, form III) 
(Table 6-5). BLC crystals of form III reported previously were extremely thin 
(< ȝPDQGKDUGWRFKDUDFWHULse fully using single crystal X-ray diffraction.231 
Furthermore, BLC form III has rarely been studied; thus the use of polymers as 
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solution additives might be useful in further BLC crystal characterisation. 
 
Figure 6-12. BLC crystal photomicrograph and X-ray diffraction patterns 
yielded by the single BLC crystal in the presence of anionic p(AMPS) (P5). 
Two scattering angles: 0±1 degrees and 90±1 degrees. 
 
Table 6-5. Diffraction data collection for BLC crystal 
 BLC form III 
Space group P212121 
Unit cell lattice Orthorhombic 
Cell dimentions: a, b, c (Å) 
           ĮȕȖ 
69.3, 174.1, 191.5 
90°, 90°, 90° 
Resolution (Å) 50-2.8 
Crystal-to-detector distance 170 mm 
 
Figure 6-13 shows a summary of DLS data of BLC crystallisation under 
anionic p(AMPS) (P5) at time points T0 and T120min. Figure 6-13a shows 
autocorrelation functions, which were analysed by DLS to obtain the 
distribution of particle radii, as shown in Figure 6-13b.  
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Figure 6-13. Summary of DLS data of BLC crystallisation under anionic 
p(AMPS) (P5) at time points T0 and T120min: a) representative autocorrelation 
functions; b) radii distribution by intensity. 
 
Furthermore, representative Tukey plots of above DLS data are shown in 
Figure 6-14. At the beginning of the experiment (T0), the average size of the 
particles in the crystallisation solution was around 1.5 µm, measured by size 
distribution. With the addition of anionic p(AMPS) (P5), BLC aggregates grew 
in size. After 120 minutes (T120min), the average size of the particles in the 
crystallisation solution was around 5 µm. 
       
        
a) 
b) 
T=0 T=120min 
T=0 T=120min 
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Figure 6-14. Variations of the size of BLC aggregates or crystals in the solution 
as a function of time during crystallisation experiments induced by anionic 
p(AMPS) (P5). 
 
Figure 6-15 illustrates the proposed mechanism of anionic polymer mediated 
BLC crystallisation. Similar to Con A, at BLC crystallisation pH of 6.8, anionic 
p(AMPS) (P5) molecules had some negative charges. There were expected to 
be µFKDUJH-FKDUJH¶UHSXOVLRQVEHWZHHQanionic polymer molecules and anionic 
BLC macromolecules, thus, anionic polymer lowered the interfacial energy 
between BLC macromolecules and water, leading to the promotion of BLC 
nucleation rate.226, 108 
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Figure 6-15. Hypothesis of mechanism of anionic polymer mediated BLC 
crystallisation. Anionic polymer: charge-charge repulsions between anionic 
polymer and anionic BLC. BLC macromolecules are weakly anionic when at 
crystallisation pH 6.8. Na+ and PO43- ions come from the crystallisation buffer 
solutions. 
 
6.4 Conclusions 
In this chapter, similar to Con A, three key polymers with varying degrees of 
charge were selected from each class and utilised as solution additives for BLC 
crystallisation: neutral p(PEGMA475) (P1), cationic quaternised p(DMAEMA) 
(P2) with quaternised ratio: 75 % and anionic p(AMPS) (P5). BLC 
crystallisation experiments were also performed on 96-well plates using the 
sitting drop vapour diffusion technique.  
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The isoelectric point (pI) of BLC is 5.4 therefore at its crystallisation pH of 6.8 
BLC is a weakly anionic protein. BLC crystal formation in the absence of 
added polymers occurred after two weeks and resulted in needle crystals 
outgrowth in a µZKHDWVKHDI¶PRUSKRORJ\ Neutral p(PEGMA475) (P1) nucleated 
a few long crystals at lower concentrations (< 4 %, w/v). However, it was not 
possible to determine their structure by single crystal X-ray diffraction. When 
cationic quaternised p(DMAEMA) (P2) was utilised, a few needles with a 
µVHD-XUFKLQ¶ PRUSKRORJ\ IRUPHG DW ORZHU FRQFHQWUDWLRQV  2 %, w/v). 
However, as the concentration of quaternised p(DMAEMA) (P2) in solution 
increased, suppression of BLC crystallisation occurred. By contrast, anionic 
polymers promoted BLC aggregation, with single crystals being obtained in 10 
days. X-ray diffraction identified these crystals as orthorhombic (space group: 
P212121, form III). These results illustrate that polymers can nucleate protein 
crystals produce diffraction-quality single crystals, which makes structural 
elucidation possible. 
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CHAPTER 7 
 
7. Discussion, Conclusions and Future Work 
7.1 Discussion and conclusions 
Protein assemblies, either in the form of crystals or supramolecular 
nanoparticles, are important in areas ranging from basic biochemical research 
through to pharmaceutical application. In addition to characterisation 
purposes,3, 5 there are other applications where defined assemblies of proteins, 
either crystals or self-assembled protein nanoparticles are desirable, including 
industrial biocatalysis9 and therapeutic protein formulations.25, 28 The ability to 
prepare a given crystal or self-assembled structure from protein molecules, 
however, remains extremely challenging. A variety of approaches have been 
used to aid the production of protein crystals; the most common involves the 
addition of nucleants, or surface-active materials into the crystallisation 
solution.70 Synthetic polymers are important additives for protein 
crystallisation control as there are many possible chemistries which can be 
introduced into the backbone and side-chains, giving a very wide range of 
functional behaviour.5, 100, 101 Proteins have become particular targets for 
polymer-mediated crystallisation in recent years owing to their growing 
importance in pharmaceutical applications. Soluble polymeric additives can 
influence the biomolecule crystallisation process leading to changes in size, 
habit and even polymorph of the final crystals.71 Literature reviews in Chapter 
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1 introduced previous studies of synthetic polymers used as solution additives 
for the control of crystallisation. Although tremendous efforts have been made, 
only a very few functional polymers have been studied as additives in protein 
crystallisation. There are many factors which can affect crystallisation, the 
majority of which are still poorly understood. Moreover, the mechanisms 
governing the interactions between polymer additives and emerging protein 
assemblies are elusive and need to be further confirmed. 
The work presented in this thesis has concentrated on the application of 
polymers DVµDGGLWLYHV¶LQWRWKHSURWein solution, i.e. dissolved polymers in the 
solution to mediate proteins crystallisation. In order to probe some of the 
factors involved in polymer-mediated protein crystallisation, we set out to 
prepare different classes of polymers with varying degrees of charge, molecular 
weight and backbone structure, and then to study their roles as additives in 
model protein solutions. The guiding hypothesis was that specific functional 
polymers in solution could alter the rate of protein crystallisation from 
solutions, and thereby LQÀXHQFH the shape, size, and/or polymorph of the 
resultant crystals. 
Four classes of materials were investigated for their effects on protein 
crystallisation studies: neutral, cationic, anionic and cationic/zwitterionic 
polymers. We chose poly(ethylene glycol) methyl ether methacrylate475 
(PEGMA475), as a neutral methacrylate derivative of PEG to obtain a polymer, 
p(PEGMA475), analogous to PEG but with hydrophilic side-chain functionality 
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and a hydrophobic main-chain. Two monomers containing tertiary amines 
groups were selected to afford positive charges, including one methacrylate 
monomer 2-(dimethylamino)ethyl methacrylate (DMAEMA) which was either 
homopolymerised or copolymerised with PEGMA475, and one methacrylamide 
monomer N-(3-(dimethylamido)propyl)methacrylamide (DMAPMAm), which 
was also homopolymerised to form cationic polymers. Three acrylamide-based 
main chain monomers, including 2-acrylamido-2-methyl-1-propanesulfonic 
acid (AMPS), 2- acrylamidoacetic acid (2-AmAA) and 4- acrylamidobutanoic 
acid (4-AmBA), which have ionisable sulfonic acid or carboxyl groups, were 
selected to generate anionic water soluble homopolymers. Moreover, a 
cationic/zwitterionic copolymer of 
[2-(methacryloyloxy)ethyl]trimethylammonium chloride (METMAC) and 
N-[2-(methacryloyloxy)ethyl]-dimethyl-(2-sulfoethan)aminium hydroxide 
(MEDSAH) with both positive charges and zwitterionic components was 
prepared in order to span an even wider range of charge-charge interactions. 
P(PEGMA475) (P1), p(DMAEMA) (P2), and p(DMAEMA-stat-PEGMA475) 
(P3) were prepared via ATRP routes.143 N-Methylation of p(DMAEMA) with 
different degrees of quaternisation was carried out to vary the total permanent 
cation content.199, 200 P(DMAPMAm) (P4), p(AMPS) (P5), p(2-AmAA) (P6) 
and p(4-AmBA) (P7) were synthesised using RAFT methods.202 A 
cationic/zwitterionic copolymer of p(METMAC-co-MEDSAH) (P8) was 
prepared at a METMAC:MEDSAH molar ratio of 1:1. Polymers with different 
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charge, molecular weight and backbone structure were prepared in good yields. 
Three model proteins crystallisation systems were studied here: hen egg white 
lysozyme (HEWL); concanavalin A (Con A); and bovine liver catalase (BLC). 
A simple model linking polymer charge to protein pI and crystallisation rate 
was proposed. Crystallisation experiments were performed on 96-well plates, 
by using the sitting drop vapour diffusion technique.  
The first study was carried out on HEWL crystallisation. Figure 7-1 presents 
selected optical photomicrographs of HEWL crystals grown utilising different 
polymers as additives in the crystallisation process. The pI of HEWL is 11.35, 
therefore when at its crystallisation pH 4.8, HEWL macromolecules are 
positively charged, i.e. cationic. HEWL crystallisation under conditions 
favouring the tetragonal form resulted in exclusively tetragonal crystals within 
1-2 days without any polymer (Figure 7-1, Control). When in the presence of 
polymers, most of the HEWL crystals were readily identified by their 
distinctive morphology as tetragonal. However, different polymers have clearly 
influenced the results of the crystallisation experiments, especially the crystal 
morphology. 
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Figure 7-1. Selected optical photomicrographs of HEWL crystals formed under 
conditions of tetragonal crystal-inducing protocol, in the presence of neutral, 
cationic, anionic and cationic/zwitterionic polymers as solutes in the 
FU\VWDOOLVDWLRQ VROXWLRQV ,PDJH ODEHOOHG µ&RQWURO¶ UHSUHVHQWV FU\VWDOV JURZQ
from sample wells without polymer. Neutral polymer: P1. Cationic polymers: 
P2-4. P2a: 0.02 % w/v p(DMAEMA), P2b: 2 % w/v p(DMAEMA), P2c: 12 % 
w/v p(DMAEMA). Anionic polymers: P5-7, P6 and P7 were weakly anionic at 
pH 4.8. Cationic/zwitterionic polymer: P8. 
 
Neutral p(PEGMA475) (P1) nucleated a few large HEWL tetragonal crystals 
(Figure 7-1, P1). It was expected that p(PEGMA475), as a neutral methacrylate 
derivative of PEG and an H-bond acceptor, might competed with protein 
solutes for water and thus promote protein crystallisation via a dehydration 
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mechanism (Figure 7-2, A).125 Moreover, p(PEGMA475) may have 
µYROXPH-H[FOXGHG HIIHFWV¶ E\ K\GURSKRELF exclusion of protein solutes.224 
Neutral polymers of this type could also reduce the dielectric constant of the 
crystallisation solution, leading to an increase of the effective distance over 
which protein electrostatic effects would take place,225 consequently protein 
aggregation and phase separation was promoted.108 In turn, HEWL 
macromolecules may have been more able to associate with each other. 
Cationic polymers had an increased propensity for nucleating many small 
crystals (Figure 7-1, P2c, P3 and P4). In Figure 7-1, P2a-c show the images of 
HEWL crystals obtained using quaternised p(DMAEMA) at three different 
concentrations. The HEWL crystal form was tetragonal when crystallised from 
0.02 % (w/v) quaternised p(DMAEMA) (Figure 7-1, P2a). Upon increasing the 
concentration to above 2 % (w/v), the HEWL crystal form was clearly different 
from a typical tetragonal character (Figure 7-1, P2b). Instead of tetragonal, two 
other forms of HEWL crystals, including needles and monoclinic crystals were 
obtained, when crystallised from otherwise identical solutions in the presence 
of 12 % (w/v) quaternised p(DMAEMA) (Figure 7-1, P2c). Moreover, 
quaternised p(DMAEMA) mediated-HEWL crystallisation followed a general 
trend, with tetragonal crystals forming at lower concentrations of polymer and 
monoclinic crystals & needle forming at higher polymer concentrations. 
Addition of quaternised p(DMAEMA) into HEWL solution, which exhibited a 
high cationic charge density, was expected to alter the electrostatic interactions 
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between HEWL molecules and the solution.118, 100 Cationic 
p((DMAEMA)-stat-PEGMA475) (P3) and p(DMAPMAm) (P4) nucleated many 
uniform and small tetragonal HEWL crystals with the sizes around 100 ȝP 
within one day (Figure 7-1, P3 and P4). There were likely to have been 
charge-charge repulsions between cationic polymers molecules and cationic 
HEWL macromolecules, lowering the interfacial energy between HEWL 
macromolecules and water, thus promoting protein-protein interactions at 
hydrophobic sites or anionic-cationic pair sites and subsequent crystallisation 
(Figure 7-2, B). In addition, cationic polymers might have bound to anionic 
residues on the HEWL chain leading to charge compensation by electrostatic 
interaction,108 an increase of local concentration of HEWL macromolecules 
and the promotion of nucleation. Mixed polymers solutions of p(DMAEMA) 
and p(PEGMA475) (molar ratio 1:9) were also applied for HEWL crystallisation 
to compare the effects with P3 and formed a few large tetragonal crystals with 
sizes of ~ 300 ȝP, implying the influence of the neutral p(PEGMA475) section 
was dominant in the crystallisation process (Figure 7-1, P1 & P2 mix). 
The influence of anionic polymers on HEWL crystallisation was less than that 
of the cationic polymers regarding crystal shape, but the anionic polymers did 
alter the size of HEWL crystals (Figure 7-1, P5-7). Anionic p(AMPS) 
nucleated a few large crystals with mean size around 300 ȝP)LJXUH7-1, P5). 
However, smaller HEWL crystals were obtained when p(2-AmAA) and 
p(4-AmBA) were added (Figure 7-1, P6 and P7). This was likely a 
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consequence of the crystallisation pH of HEWL being close (pH 4.8) to the 
expected pKa values of p(2-AmAA) and p(4-AmBA), and thus a smaller 
number of anionic carboxyl groups remaining on these polymers compared to 
the cationic polymers at the same pH. The HEWL crystals formed in the 
presence of anionic polymers were identified as tetragonal by single crystal 
X-ray diffraction. Anionic polymers might favor attracting cationic HEWL 
macromolecules for charge compensation by electrostatic interaction (Figure 
7-2, C),108 thus, they would either lower the protein and water interfacial 
energy and act as nucleation centers by the absorption of HEWL 
macromolecules, or slow down the rate of further growth. Therefore, they acted 
as not only nucleators in solution but also as inhibitors.100 
Cationic and zwitterionic sulfobetaine p(METMAC-co-MEDSAH) nucleated a 
few crystals with complex shape (Figure 7-1, P8). The combined 
cationic/zwitterionic copolymer was expected to have a variety of functions 
during HEWL crystallisation (Figure 7-2, D). One expected action was 
complexation with HEWL macromolecules, leading to charge compensation 
and promotion of nucleation. After nucleation, this polymer also might absorb 
on certain faces of crystals and influence the direction of crystal further 
growth.100 From a first principles hypothesis, the HEWL crystals would thus be 
expected to be of different shape when crystallised with zwitterionic polymers 
compared to the purely cationic; however, the crystal form was still tetragonal. 
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Figure 7-2. Schematic representation of the interaction of various polymers 
with cationic HEWL in the protein crystallisation process. (A) Neutral polymer: 
H-bonding with water and thus promoting protein crystallisation via a 
dehydration mechanism. (B) Cationic polymer: charge-charge repulsions 
between cationic polymer and cationic HEWL. (C) Anionic polymer: binding 
cationic HEWL for charge compensation. (D) Cationic/zwitterionic polymer: 
have a variety of functions during HEWL crystallisation. HEWL 
macromolecules are positively charged at tetragonal crystallisation pH of 4.8. 
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To investigate further the influence of these polymers on protein crystallisation, 
we selected representative polymers from each class and carried out 
crystallisation assays with a range of polymer concentrations. Figure 7-3 
outlines a summary evaluation of HEWL crystal size distribution, which was 
REWDLQHGE\PHDVXULQJWKHDYHUDJHOHQJWKȝPRIWKHODUJHVWGLDPHWHURIHDFK
crystal at each polymer concentration using ImageJ software. There was a clear 
effect on HEWL crystallisation depending on the concentration of polymer. For 
HEWL (cationic at crystallisation pH), as the concentration of neutral polymer 
in solution was increased, the size of crystals increased (Figure 7-3, P1). 
However, the size of HEWL crystals decreased when the concentration of 
cationic polymer was increased (Figure 7-3, P2-4). A slight increase in average 
size of HEWL crystals formed was observed when anionic polymer 
concentration increased (Figure 7-3, P5-7). Perhaps surprisingly, the hybrid 
cationic/zwitterionic copolymer P8 caused a slight increase in crystal size, 
suggesting perhaps a greater role for the pendant sulfonate anions at the 
side-chain termini than the trimethylammonium headgroups on the 
co-monomer (Figure 7-3, P8). At lower concentrations, polymers may have 
served as nucleation centres via bridging interactions to promote nucleation, 
whereas when the concentration was increased, it is possible that charged 
polymers could stabilise or coat emergent small protein aggregates and inhibit 
further growth of crystals,100, 234 and that multiple mechanisms can be involved. 
Indeed, the influence of polymers in protein crystallisation has been suggested 
CHAPTER 7. Discussion, Conclusions and Future Work 
321 
 
to include the stages before nucleation, as well as initial nucleation and 
subsequent crystal growth.100 Therefore, in addition to the chemical 
functionality of polymers, it is likely that the concentration of polymers can 
play significant roles in modifying the protein crystallisation process. 
 
Figure 7-3. Summary of photomicrograph analysis showing changes in the size 
of HEWL crystals, grown in the presence of different classes of polymers at 
various concentrations. Neutral polymer: P1; cationic polymers: P2-4; anionic 
polymers: P5-7, P6 and P7 were weakly anionic at pH 4.8. 
Cationic/zwitterionic polymer: P8 
 
The second model protein investigated was Con A. The pI of Con A is 4.5, but 
crystallisation of this protein is normally carried out at pH 8.5, at which point 
Con A molecules are negatively charged overall. Three polymers were then 
selected from each class for further experiments: neutral p(PEGMA475) (P1), 
cationic quaternised p(DMAEMA) (P2) and anionic p(AMPS) (P5). Con A 
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solutions produced small crystals with sizes of ~ 60 ȝP within 1 week without 
any polymer, which were orthorhombic (Figure 7-4, Control). When polymers 
were utilised, the sizes and numbers of crystals were found to vary with the 
types of polymers added to solution, however, the form of the crystals was still 
orthorhombic. Neutral polymer P1 resulted in a few large block-shaped crystals 
(Figure 7-4, P1), suggesting a similar dehydration mechanism to that which 
occurred in HEWL crystallisation. Cationic polymer P2 was expected to bind 
anionic Con A and nucleated a few large crystals (Figure 7-4, P2). By contrast 
the anionic polymer P5 was postulated to decrease the interfacial energy 
between Con A macromolecules and water by charge-charge repulsions 
between anionic polymer and anionic Con A, resulting in the promotion of 
protein aggregation and formation of many smaller crystals within four days 
(Figure 7-4, P5). 
 
Figure 7-4. Optical images showing changes of Con A crystals, in the presence 
of different polymers: neutral p(PEGMA475) (P1), cationic quaternised 
p(DMAEMA) (P2) and anionic p(AMPS) (P5) ,PDJH ODEHOOHG µ&RQWURO¶
represents crystals grown from sample wells without polymer. 
 
Moreover, for anionic Con A, as the concentration of neutral polymer in 
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solution was increased, the size of Con A crystals increased (Figure 7-5, P1). 
The effects of cationic and anionic polymers on Con A crystallisation were 
predicted from this simple model to be opposite from the effects on HEWL. 
The size of Con A crystals increased when the concentration of cationic 
polymer was increased (Figure 7-5 P2). However, the size of Con A crystals 
decreased when the concentration of anionic polymer was increased (Figure 
7-5, P5). All these results together illustrate that polymers with varying net 
charges have the ability to control the size of protein crystals. 
 
Figure 7-5. Summary of photomicrograph analysis showing changes in the size 
of Con A crystals, grown in the presence of different classes of polymers at 
various concentrations. Neutral polymer: P1; cationic polymer: P2; anionic 
polymer: P5. 
 
The third model protein was BLC. The pI of BLC is 5.4 but at its 
crystallisation pH of 6.8 BLC is a weakly anionic protein. Similar to Con A, 
three polymers were also selected from each class for further BLC 
crystallisation experiments: neutral p(PEGMA475) (P1), cationic quaternised 
p(DMAEMA) (P2) and anionic p(AMPS) (P5). BLC crystal formation in the 
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absence of added polymers occurred after two weeks and resulted in needle 
crystal outgrowth with a µZKHDWVKHDI¶PRUSKRORJ\ (Figure 7-6, Control). It was 
hard to get single crystals without any polymer. When in the presence of 
neutral p(PEGMA475) (P1), poor quality crystals were obtained and it was not 
possible to determine their structure by single crystal X-ray diffraction. 
Cationic quaternised p(DMAEMA) (P2) produced a few needles with a 
µVHD-XUFKLQ¶ PRUSKRORJ\ IRUPHG DW ORZHU FRQFHQWUDWLRQV, but suppression of 
BLC crystallisation occurred at higher concentration. By contrast, anionic 
polymers promoted BLC aggregation and produced single crystals in 10 days, 
which were identified as orthorhombic (space group: P212121, form III) by 
X-ray diffraction. BLC crystals of form III reported previously were extremely 
thin (<  ȝP DQG KDUG WR FKDUDFWHULse fully using single crystal X-ray 
diffraction.231 It should be noted that BLC form III has rarely been studied; 
thus the use of polymers as solution additives might be useful in further BLC 
crystal characterisation. 
 
Figure 7-6. Optical images showing changes of BLC crystals, in the presence 
of different polymers: neutral p(PEGMA475) (P1), cationic quaternised 
p(DMAEMA) (P2) and anionic p(AMPS) (P5) ,PDJH ODEHOOHG µ&RQWURO¶
represents crystals grown from sample wells without polymer. 
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Light scattering experiments were carried out to evaluate the HEWL and Con A 
aggregation process directly in the presence of crystallisation solutions and 
polymers with varying net charges. Protein crystallisation was initiated by 
mixing protein with polymer solutions, leading to immediate supersaturation 
and formation of protein aggregates. Based on the effects of each polymer on 
crystal size and morphology in prior experiments, we predicted (Figure 7-7, A) 
and subsequently evaluated (Figure 7-7, B-D) the effects of each polymer on 
the growth of cationic HEWL and anionic Con A crystals.  
 
Figure 7-7. Predicted growth of HEWL ((i)A) and Con A ((ii)A) particles 
during crystallisation; and actual variations in the size of HEWL ((i)B-D) and 
Con A ((ii)B-D) aggregates or crystals in the solution as a function of time 
during crystallisation experiments induced by different polymers by DLS. 
Black represents the application of neutral polymers; blue represents the 
application of cationic polymers; red represents the application of anionic 
polymers. 
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At the beginning of the experiment, protein macromolecules were free and 
non-interacting in the solution. After the addition of various polymers, a 
characteristic increase in protein aggregate size can be observed in all cases. As 
time increased, the rate of protein aggregation growth followed two distinct 
sequences. With the addition of neutral p(PEGMA475) (P1), cationic 
quaternised p(DMAEMA) (P2) and anionic p(AMPS) (P5) in crystallisation 
solutions, the size of HEWL aggregates increased up to around 600 nm, 120 
nm and 400 nm respectively, while Con A aggregates increased up to around 
10000 nm, 1000 nm and 800 nm. Therefore, for HEWL, particle size increased 
most rapidly for neutral polymer > anionic polymer > cationic polymer (Figure 
7-7(i), B-D), whereas for the rate of the growth of Con A aggregation the 
sequence was: neutral polymer > cationic polymer > anionic polymer (Figure 
7-7(ii), B-D). These DLS data indicated that as time increased, protein 
aggregates increased in size, presumably until the critical nuclei were reached 
and crystals began to grow. As mentioned above, neutral polymers competed 
with proteins for water and thus promoted protein crystallisation. Cationic 
polymers were expected to lower the interfacial energy between cationic 
HEWL macromolecules and water by charge-charge repulsions, thus 
promoting nucleation; while the same polymers were likely to attract anionic 
Con A macromolecules for charge compensation, thus slowing down the rate of 
crystal growth. The effects of anionic polymer on HEWL and Con A 
crystallisation were predicted from this simple model to be opposite from 
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cationic polymers, and to a first approximation this pattern was observed. We 
thus propose that DLS measurements can be used as a simple qualitative screen 
to predict the outcome for protein crystallisation experiments. 
In conclusion, a series of polymers with varying degrees of charge, molecular 
weight and backbone structure have been successfully prepared and applied to 
the crystallisation of HEWL, Con A and BLC via sitting drop vapour diffusion 
techniques. These polymers acted as solution additives to mediate protein 
crystallisation through favourable interactions between polymer and protein or 
the surrounding solvent system; and were found to influence strongly the 
resultant crystal sizes, shapes and polymorphs. Experiments in which polymers 
and proteins exhibited different charges suggested possible mechanisms of how 
these polymers PLJKWDIIHFWSURWHLQFU\VWDOOLVDWLRQ0RUHRYHUµILUVWSULQFLSOHV¶ 
structure-function relationships linking the types of polymers used in these 
experiments and the protein crystal habits produced were generated. These 
relationships might be used as models to guide a wide range of protein 
crystallisation experiments in the future. Therefore, polymers as solution 
additives may perhaps be tuned to control the size, quality, shape and even 
polymorph of protein crystals for use in pharmaceutical, biotechnological or 
chemical applications. 
 
7.2 Future work 
In this study, we used the whole range of polymers with varying degrees of 
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charge, molecular weight and backbone structure as solution µDGGLWLYHV¶ for 
HEWL crystallisation experiments, however, due to the time limit, we selected 
three key polymers from each class for Con A and BLC crystallisation 
experiments. Therefore, the whole range of polymers should be applied in the 
future Con A and BLC crystallisation experiments. 
Based on the effects of each polymer on crystal size and morphology in the 
experiments, we suggested some mechanisms of how the polymers affect 
protein crystallisation, and proposed possible models of µILUVW SULQFLSOHV¶ 
structure-function relationships linking the types of polymers used in these 
experiments and the protein crystal habits produced. However, the study of 
these models is still on its early stage. Because there are so many factors which 
can affect crystallisation, many of which are still poorly understood, these 
mechanisms are still somewhat tenuous and need to be further investigated. 
Obviously, this is the key issue to solve in the future. 
A series of polymers were prepared and successfully applied as µDGGLWLYHV¶ to 
influence protein crystal size, outer crystal shape, even crystal packing motifs. 
However, future work should involve the investigation of more polymer 
additives with various possible functionalities, including soluble polymer 
additives and insoluble polymer surfaces, such as molecularly imprinted 
polymers (MIPs). The results will aid in better understanding of the 
mechanisms we proposed. 
Moreover, the structure-function relationships linking the types of polymers 
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and the protein crystal habits produced might be used as models to guide a 
wide range of protein crystallisation experiments in the future. Therefore, 
polymers as solution additives may perhaps be tuned to control the size, quality, 
shape and even polymorph of protein crystals for use in pharmaceutical, 
biotechnological or chemical applications. 
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Monomer AMPS 
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DLS analysis - HEWL crystal growth: control without polymer 
Combined correlation function 
 
Intensity distribution 
 
 
 
 
 
 
T=0 T=35min T=60min T=90min 
T=120min T=180min T=240min T=256min 
T=270min T=300min T=360min T=410min 
    
    
    
T=0 T=35min T=60min T=90min 
T=120min T=180min T=240min T=256min 
T=270min T=300min T=360min T=410min 
APPENDIX ± Supporting spectroscopy graphs 
336 
 
DLS analysis - HEWL+ p(PEGMA475) 
Combined correlation function 
 
Intensity distribution 
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DLS analysis - HEWL+ quaternised p(DMAEMA)  
Combined correlation function 
 
Intensity distribution 
 
DLS analysis - HEWL+ mixed polymers of p(PEGMA475) & p(DMAEMA)  
Combined correlation function 
 
Intensity distribution 
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DLS analysis - HEWL + p(DMAPMAm) 
Combined correlation function 
 
Intensity distribution 
 
DLS analysis - HEWL + p(AMPS) 
Combined correlation function 
 
Intensity distribution 
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DLS analysis - HEWL+ p(2-AmAA)  
Combined correlation function 
 
Intensity distribution 
 
DLS analysis - HEWL+ p(4-AmBA) 
Combined correlation function 
 
Intensity distribution 
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